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  Introduction 
1. Introduction 
 
 
1.1 Insulin signaling 
 
1.1.1 Insulin receptor 
 
The insulin receptor (IR) and the related insulin-like-growth factor-1 receptor (IGF-
1R) belong to the receptor tyrosine kinase family (RTKs). The tyrosine kinases are 
classified in membrane bound tyrosine kinases (e.g. EGF receptor) and non 
membrane bound kinases (e.g. Janus kinases). The IR and IGF-1R are membrane 
bound tyrosine kinases with an intrinsic tyrosine kinase activity, meaning that the 
kinase domain is part of the receptor. RTKs have common structural and functional 
characteristics. They all consist of an extracellular glycosylated ligand binding 
domain, a hydrophobic transmembrane domain, linking the ligand binding to the 
protein kinase domain, and an intracellular domain, subdivided in juxtamembrane 
region, the tyrosine kinase domain and the C-terminal part (Van Obberghen, 1994; 
Fantl et al., 1993; Hanks et al., 1988; Robertson et al., 2000; Schlessinger, 1988; 
Ullrich and Schlessinger 1990; Yarden and Ullrich 1988). RTKs are present in 
monomeric or dimeric form. After ligand binding the monomeric receptors form a 
dimeric structure (Massague and Czech, 1982). Src homology (SH) 2 proteins are 
able to bind and interact directly with the phophorylated RTKs (Pawson and Gish, 
1992).  
 
The IR is composed of two alpha (130 kDa) and two beta subunits (90 kDa). The 
extracellular alpha subunit is crosslinked to the extracellular part of the beta subunit 
by disulfide bonds, to form a functional transmembrane receptor. The extracellular 
alpha subunit represents the ligand binding domain; the cytoplasmic beta subunit 
harbours the receptor tyrosine kinase (AS 947-1343) transducing the ligand signal 
into the cell (Kasuga et al., 1983, Kahn et al. 1978, White et al. 1986). For 
dimerization an alpha-beta subunit is linked to another alpha-beta subunit via 
disulfide bonds, resulting in a α2β2 heterotetramer structure (Van Obberghen, 1994).  
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Binding of the ligand (insulin) to the extracellular domain of the IR leads to a 
conformational change in the kinase inhibiting alpha subunit followed by a trans-
autophosphorylation of the intracellular β subunit at seven tyrosine residues (Y953, 
Y960, Y1146, Y1150, Y1151, Y1316 and Y1322), transforming the inactive receptor 
into an active form (Heldin et al., 1995; Hubbard et al., 1994; DeMeyts et al., 1995; 
Ottensmeyer et al., 2000; Kahn et al., 1978; White and Kahn, 1994). Strong 
conformational changes occur in the tyrosine protein kinase after phosphorylation of 
the tyrosine residues Y1146, Y1150, Y1151, resulting in an open form (regulatory 
loop), allowing protein substrates to interact with the catalytical domain. 
Autophosphorylation of all three tyrosines in the regulatory loop leads to a 10-fold 
more active kinase (White et al., 1988; White and Kahn 1994; Hubbard et al., 1998). 
Tyrosine phosphorylation at Y960 allows the binding and phosphorylation of 
intracellular and multifunctional docking proteins (insulin receptor substrates (IRS)) to 
the activated receptor. These IRS proteins can recruit other intracellular signaling 
proteins thus transmitting the ligand signal from the cell surface into the cell (White, 
1997; White 1998; White 2003). 
 
 
 
Fig. 1.1   Illustration of the insulin receptor 
Insulin binding to the α-subunit of the tetrameric insulin receptor leads to autophosphorylation in the 
catalytic domain of the IR β-subunit. Four insulin binding domains are present in the α-subunit. The 
ATP binding site Lys-1018 is essential for the kinase activity of the IR β-subunit (White, 1997).   
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Besides phosphorylation of tyrosine residues, also serine and threonine residues of 
the IR are phosphorylated. In contrast to the activating tyrosine phosphorylation, 
serine or threonine phosphorylation inactivates the IR by inhibiting phosphorylation of 
receptor tyrosine residues. Serine kinases (e.g. AKT/PKB) and the receptor itself by 
autophosphorylation are able to phosphorylate IR at Ser 1275 and Ser 1309 (Pang et 
al., 1994; Mothe et al. 1996; Liu and Roth, 1994; Heidenreich et al., 1994; Al-Hasani 
et al., 1997; Tennagels  et al., 2001).  
Insulin is the predominant ligand binding to the IR inducing the dimerization and 
activation of the receptor. Insulin is a peptide hormone with a molecular weight of 
5808 Da. The molecule is composed of 51 amino acids and synthesized in the islets 
of Langerhans in the pancreas. Insulin is responsible for glucose uptake and storage, 
food intake and cellular metabolism. Structurally it is a member of the superfamily of 
related insulin-like hormones. Insulin shares a 50% amino acid homology with IGF-1, 
another member of this superfamily (Rinderknecht et al., 1978; Le Roith, 1997; 
Adams et al., 2000; Brüning et al., 2000). Insulin binds to the IR with high affinity 
whereas no significant binding to IGF-1 is detected although its 50% homology to 
insulin. Due to the primary structural similarity of the IR and IGF-1R, hybrid receptors 
consisting of one IR isoform (IRa/IRb) and IGF1R are found. These receptors are 
dominated by the IGF-1 half thus IGF1 is bound with higher affinity and insulin with 
various affinities depending on the IR isoform. The physiological role of these hybrid 
receptors is not clear but they might play a role in switching from insulin to IGF1 
signaling (Pandini et al., 2002).  
The insulin peptide is derived from the precursor molecule proinsulin, processed by 
proteolytic enzymes (prohormone convertases 1 and 2, carboxypeptidase E). In this 
proteolytic process C-peptide is removed from the centre of the molecule, resulting in 
two polypetides of 21 and 30 amino acids, the A- and B-chain, bound to each other 
via intermolecular disulfide bonds (Steiner and Oyer, 1967). The bioavailability of 
insulin is regulated by hormones. Besides glucose itself gastrin, secretin, gastric 
inhibitory polypeptide (GIP) and glucagons-like-peptide (GLP) are mainly responsible 
for the secretion of insulin from the pancreas after food intake. Main target tissues for 
insulin action are liver, muscles and white adipose tissue (Vilsboll and Holst, 2004).  
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1.1.2 Insulin receptor substrate (IRS) proteins  
 
The four different IRS proteins are functionally and structurally homolog and 
represent one protein family. IRS-1 was the first identified and cloned member of the 
IRS family (Sun et al., 1991). Subsequent alternative insulin receptor substrates 
(IRS-2, IRS-3 and IRS-4) have been identified (Sun et al., 1995; Lavan et al. 1997; 
Smith-Hall et al., 1997). IRS proteins function as adapter for numerous SH2 proteins, 
allowing different SH2 proteins attaching to the insulin receptor. The C-terminus of 
the IRS proteins harbours 8 to 18 potential tyrosine phosphorylation sites enabling 
IRS proteins the binding of diverse SH2 proteins. Thus phosphorylation of IRS 
protein tyrosine residues of the insulin receptor allows interaction with specific SH2 
proteins, resulting in activation of different signaling pathways, depending on the 
recruited SH2 proteins (Myers et al., 1993). Differential distribution of IRS proteins on 
cellular and subcellular level and different affinities of the IRS proteins to a variety of 
SH2 proteins (due to variations of the sequence surrounding the tyrosine 
phosphorylation sites) can impact the activation of different signaling pathways. In 
addition the IR is able to interact with different IRS proteins resulting in an activation 
of diverse signaling pathways. With the IRS proteins acting as adapter a single 
receptor is able to amplify its signal via interaction with a large number of SH2 
docking proteins (Myers et al., 1996).  
IRS-1 and IRS-2 are ubiquitously expressed and mediate insulin and IGF-1 action in 
most tissues. IRS-3 expression is restricted to rodent adipocytes, expression of IRS-
4 was mainly detected in the hypothalamus and pituitary gland, the thymus and 
kidneys (Schubert et al., 2003; Numan et al., 1999).  
IRS proteins consist of defined functional domains. The pleckstrin homology (PH) 
domain is located at the N-terminus. This PH domain can bind to inositolphosphates 
of the plasma membrane therefore this region is supposed to play a role in the 
membrane localisation of the IRS proteins. The phosphotyrosine binding domain 
(PTB) is located C-terminal of the PH domain and essential for the interaction of IRS 
proteins with phosphorylated Y960 and the NPEY motive of the juxtamembrane 
region in the β subunit of the activated IR (White 2003; White 1997; Wang et al., 
1993). After the phosphorylation IRS proteins can bind various SH2 effector proteins 
                                                                    5
  Introduction 
e.g. phosphatidylinositol 3-kinase (PI3 kinase), growth-factor-receptor-binding protein 
(Grb2) or protein-phosphatase 2 (SHP-2) (Myers et al., 1994; Wang et al., 1993).  
 
 
Fig. 1.2  Schematic structure of IRS proteins 
Structure of the insulin receptor substrate family IRS-1, -2, -3 and -4 illustrated with their conserved N-
terminal potential tyrosine phosphorylation sites PH and PTB. Interaction sites with SH2 proteins are 
shown in black boxes (Emkey and Kahn, 2001).  
 
Insulin receptor substrate 1 (IRS-1) is widely expressed 185 kDa large protein. IRS-1 
contains 22 potential tyrosine phosphorylation sites recruiting different SH2 proteins 
like PI-3 kinase, Grb2 (an upstream regulator of p21ras), Nck, Crk, c-Fyn (Src family 
tyrosine kinase) and phospholipase Cγ (White et al., 1985, White 1997; Sun et al., 
1991). IRS-1 is a key component of the cellular signaling system since it plays an 
important role in insulin/IGF-1 signaling and might also be phosphorylated indirectly 
by the Janus kinase, which in turn is phosphorylated by different cytokines, growth 
hormones, interferones (IFNα, INFβ, INFγ) and interleukins (IL-2, IL-4, IL-9, IL-13) 
(Burks et al., 2001; Chuang et al., 1994; Johnston et al., 1995; Myers et al., 1996; 
Uddin et al., 1995; Yenush et al., 1997). In addition inhibiting signals of TNFα and 
other factors can be transmitted via IRS-1 (Hotamisligil et al., 1994; Velloso et al., 
1996). One of the best investigated downstream SH2 protein binding to the tyrosine 
phosphorylated IRS-1 protein is PI3-kinase. PI3-kinase is a dimeric enzyme 
composed of a catalytic subunit (p110α, p110β, p110δ) and regulatory subunit (p85α, 
p85β, p55PIK) containing two SH2 domains (Myers et al., 1996). Following insulin 
stimulation IRS-1 tyrosine residues get phosphorylated, the regulatory subunit of PI3-
kinase binds to IRS-1 and its activity increases and diminishes after prolonged insulin 
exposure due to serine phosphorylation and inhibition/degradation of IRS-1. Hence 
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insulin effects on gene expression as well as on cell proliferation are mediated and 
enhanced by IRS-1. These data suggest that IRS-1 plays an important role in cell 
growth, mitogenesis and proliferation in response to insulin (Myers et al., 1996; Rose 
et al., 1994; Sun et al., 1991; Sun et al., 1992; Waters et al., 1993; Yamauchi et al. 
1994). 
Besides the tyrosine phosphorylation sites IRS-1 contains over 30 potential 
serine/threonine phosphorylation sides (Sun et al., 1991, 1995). In an unstimulated 
state IRS-1 is mainly serine and weakly threonine phosphorylated. Upon insulin 
stimulation and IRS-1 tyrosine phosphorylation downstream target proteins like 
AKT/PKB are activated. AKT/PKB is a serine/threonine kinase, inducing a feed back 
loop by phosphorylating mTOR/P70-S6 kinase. Subsequently mTOR phosphorylates 
IRS-1 at Ser 636/639 mediating its proteasomal degradation (Zhande et al., 2002; 
O´Reilly et al., 2006).  
Another effect upon insulin stimulation is the translocation of the GLUT-4 transporter 
to the plasma membrane. GLUT-1 and GLUT-4 transporters are responsible for 
removing glucose from the blood stream. GLUT-1 is predominantly expressed on the 
cell surface and does not respond to insulin; therefore it is supposed to provide basal 
glucose transport into the cells. GLUT-4 is nearby exclusively present in insulin 
sensitive tissues (e.g. muscle and adipose tissue). In a non active state GLUT-4 is 
incorporated in an intracellular vesicular compartment. Binding of PI3-kinase to 
phosphorylated IRS-1 causes activation of PKB/AKT and translocates GLUT-4 
containing vesicles to the plasma membrane. Thus insulin stimulated glucose uptake 
is mediated by GLUT-4 and its translocation to the plasma membrane (Lienhard et 
al., 1992; Okada et al., 1994). Since PI3-kinase is a downstream target of IRS 
proteins, the IRS proteins play an important role in translocation of GLUT-4 to the cell 
surface upon insulin stimulation and in glucose uptake into insulin sensitive tissues 
(Backer et al. 1992; Lavan et al., 1997; Sun et al., 1991). Insulin stimulation has also 
a major impact on protein synthesis of cells by increasing mRNA levels and 
promoting translation initiation. P70-S6 kinase phosphorylates S6 protein of the 40s 
ribosomal subunit leading to increased mRNA cap binding and initiation of the mRNA 
– protein translation (Proud 1994; O´Brien 1994, Hu et al., 1994; Pause et al., 1994). 
Different experiments show that IRS-1 regulates protein synthesis via PI3-kinase and 
not as first supposed via the MAP kinases (Lin et al., 1994; Lin et al., 1995; Graves et 
al., 1995).   
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Insulin receptor substrate 2 (IRS-2) was the first identified alternative insulin receptor 
substrate. IRS-2 is about 100 amino acids longer than IRS-1. The C-terminal region 
of IRS-2 is poorly conserved compared with IRS-1 (35% identity) whereas the PH 
and PTB domains of both proteins show a 65% and 75% sequence identity, 
respectively. Overall both proteins show a 43% homology. In the middle of the IRS-2 
protein (AS 591-786) a unique region, not existing in the IRS-1 protein, was 
identified. This so called kinase regulatory loop binding domain interacts with three 
phosphotyrosines (Tyr 1146, 1150, 1151) of the insulin receptor β subunit and /or 
accessible regions in this regulatory loop after the autophosphorylation of the 
tyrosines. Via this domain the receptor is able to differentiate between the two 
substrates and this heterogeneity contributes to the unique signaling potential of 
each IRS protein (Giovannone et al., 2000; He et al., 1996; Sawka-Verhelle et al., 
1996; Sun et al., 1995; Sun et al., 1997; White, 1997). Like IRS-1, IRS-2 can interact 
with PI3-kinase, Grb2 and the phospholipase Cγ but unlike IRS-1, IRS-2 is not 
interacting with Src homology protein tyrosin phosphatase 2 (SH-PTP2, Syp). In 
adipocytes phosphorylation of IRS-1 increases after insulin stimulation whereas IRS-
2 phosphorylation remains almost in basal state. Immunoprecepetation of p85 
(regulatory subunit of PI3-kinase) upon insulin stimulation showed a strong 
interaction of PI3-kinase with phosphorylated IRS-1 and IRS-2. Co-
immunoprecipitation with α-PY (phosphotyrosine) antibody revealed the majority of 
active PI3-kinase bound to IRS-1. 
But IRS-2 is able to compensate for IRS-1 deficiency in adipocytes of IRS-1 knockout 
mice sustaining insulin signaling in these cells. This shows that inhibition of IRS-1 is 
not sufficient to abrogate insulin signaling because of the presence of IRS-2 in most 
tissues and a likely compensation (Araki et al., 1994; Sun et al., 1997; Yamauchi et 
al., 1996).  
 
1.1.3 Insulin signaling cascades 
 
The insulin signal transduction cascade starts with the autophosphorylation of the IR, 
after ligand binding to the corresponding α subunit of the receptor, and the 
subsequent binding of the IRS proteins to the IR. Initially a conformational change 
leading to an activation of the intrinsic receptor tyrosine kinase is followed by 
intracellular phosphorylation. Full activation of the receptor kinase domain leads to 
                                                                    8
  Introduction 
phosphorylated tyrosine residues in the IR representing docking sites for SH2 
domain containing signaling proteins. The consensus sequence of the receptor 
phosphotyrosines is LxxxxNPxYxSxP (Keegan et al., 1994). IRS and Shc proteins 
interact with the receptor by recognizing this phophotyrosine motive. 
The IRS proteins bind to the receptor via their PTB domain by interacting with 
phosphorylated Y960 of the activated receptor (White 1997). Deletion of the PH 
domain of IRS proteins leads to an attenuation of IR-IRS binding, indicating that 
besides PTB also the PH domain represents an essential domain for IRS receptor 
binding (Yenush et al., 1996). After being phosphorylated by the tyrosine receptor 
kinase at specific tyrosine phosphorylation sites, these proteins function as adapter, 
binding SH2 domains of downstream effector proteins linking the receptor to 
signaling molecules, like PI3K regulatory subunit (p85) or the MAP kinase pathway 
(White et al., 1998; Sun et al., 1993, Myers et al., 1994). As a downstream target PI3-
kinase represents a key molecule for various cellular processes like proliferation, 
survival and glucose uptake (Okada et al., 1994). PI3K also functions as a signaling 
relay for the insulin receptor transmitting insulin´s signal to AKT (proteinkinase B 
(PKB)), protein S6 kinase or PKC (Franke et al., 1995, Diaz-Meco et al., 1994, 
Mendez et al., 1996). Upon insulin stimulation PI3K binds to phosphorylated IRS 
proteins via its two SH2 domains of the p85 subunit. IRS-1 contains nine potential c-
terminal tyrosine phosphorylation sites harbouring phosphorylation motives detected 
by SH2 domains. Following p85 subunit binding to phosphorylated IRS, 
conformational changes in the regulatory subunit activate the catalytic subunit of 
PI3K, p110 (Backer et al., 1992; Myers et al., 1992).   
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Fig. 1.3  IR/IGF-1R signaling cascade 
Binding of Insulin or IGF-1 to the IR/IGF-1R causes autophosphorylation and activation of the 
receptor. Insulin receptor substrates are recruited to the activated receptor. Phosphorylation of IRS 
proteins activating signaling cascades via MAP kinase (MAPK, mitogen activated protein kinase) and 
phosphatidylinositide (PI)3-kinase (PI3K) pathway, transducing insulin signal into the cell (Freude and 
Schubert, 2010).  
 
The PI3-kinase (PI3K) pathway: PI3K binds via its p85 regulatory subunit to the 
activated IRS adapter proteins and activates the p110 catalytic subunit of PI3K, to 
switches on a cascade of several downstream serine and threonine kinases like the 
serine kinase PDK1 (3-phosphoinositide dependent kinase), PKB (protein kinase B, 
AKT) and protein kinase C (PKC) (Alessi and Cohen 1998; Myers et al., 1994). 
Phosphorylation of phospatidylinositol (4, 5)-bisphosphate (PIP2) at the inner plasma 
membrane results in the production of phospatidylinositol (3, 4, 5)-trisphosphate 
(PIP3) (Shepherd et al., 1998). In the PI3-kinase-signaling transduction PIP3 recruits 
PDK to the inner plasma membrane which leads to an activation of PDK which in turn 
interacts with and phosphorylates AKT at Thr 308 and Ser 473 for full activation. PI3-
kinase pathway is negatively regulated by PTEN, a phospholipid phosphatase and 
tumor suppressor, dephosphorylating PIP3 and shutting down PI3K and downstream 
activity. Three isoforms of AKT (AKT 1-3) exist in mammals with a high degree of 
amino acid homology and indistinguishable substrate specifity in vitro. AKT-1 
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represents the dominating isoform in the majority of tissues and AKT-2 might be the 
dominating isoform in insulin responsive tissues (Maira et al., 2001; Du et al., 2003; 
Gao et al., 2005; Bhaskar et al., 2007; Sulis and Parsons, 2003; Burgering et al., 
1995, Walker et al., 1998). AKT phosphorylates and thereby deactivates GSK3α/β (at 
Ser21/9) and the forkhead-O transcription factor (FoxO1) (Virkamäki et al., 1999; Jiang 
et al., 2003). Phosphorylated forms of transcription factor FoxO1 are excluded from 
the nucleus resulting in reduced transcription of FoxO1 target genes leading to 
various cellular consequences since FoxO1 target genes are involved in different 
cellular processes like proliferation, metabolic regulation, apopotosis and longevity 
(Barthel et al., 2005). AKT interacts with another protein called mTOR (mammalian 
target of rapamycin), a Ser/Thr kinase. mTOR can be found intracellular in two 
different complexes, mTORC1 and mTORC2. mTORC1 is sensitive to and inhibited 
by rapamycin whereas TORC2 is not regulated by rapamycin (Loewith et al., 2002).  
Both complexes have different downstream targets and both complexes have age 
specific functions and been linked to longevity. Raptor (regulatory associated protein 
of mTOR) is a unique protein of mTORC1 whereas Rictor (rapamycin insensitive 
companion of mTOR) is unique for mTORC2. mTORC2 itself can phosphorylate AKT 
independently of the PI3-kinase pathway (Wullschleger et al., 2006). mTORC1 on the 
other hand is activated indirectly by AKT. By phosphorylation TSC2 is inhibited a 
protein dimerized with TSC1. AKT phosphorylation of TSC2 disrupts the TSC1/TSC2 
GAP activity thus allowing GTP bound Rheb to activate mTOR. Since TSC1/TSC2 
complex is regulating mTORC1 in mammalian cells by integrating intracellular and 
extracellular signals, AKT regulates mTOR activity and the downstream targets of 
mTOR eukaryotic initiation factor 4E (eIF-4E) binding protein-1 (4E-BP) and protein 
S6 kinase 1 (P70-S6K) as upstream kinase. Following mTOR phosphorylation eIF-4E 
is released from 4E-BP and mRNA translation is initiated leading to synthesis of 
proteins controlling cell proliferation. Phosphorylation of P70-S6K by mTORC1 
causes activation of ribosomal proteins and finally an initiation of protein synthesis. 
TSC2 is also regulated by other growth factor induced kinases like ERK2 (Bhaskar et 
al., 2007; Ma et al., 2005). The extracellular regulation of mTORC2 is not clear so far 
but it has been shown that insulin stimulates mTORC2 activity.  Additionally 
mTORC2 was identified as responsible kinase for AKT Ser 473 phosphorylation and 
therefore has to act upstream of AKT. But besides mTOR other kinases like ATM can 
activate AKT by Ser 473 phosphorylation. For full activation of AKT both Ser 473 and 
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Thr 308 have to be phosphorylated and mentionable in this case is that Thr 308 is 
phosphorylated independently of Ser 473 (Woodgett 2005; Shiota etal., 2006; 
Sarbassov et al., 2006; Guertin et al., 2006; Frias et al., 2006; Bhaskar et al., 2007). 
Lately it has been shown in C. elegans and yeast that mutations mTOR pathway are 
associated with lifespan extension by inhibition of IIS signaling and thus activation of 
FoxO transcription factors (Kenyon, 2010; Kaeberlein et al., 2005). 
Inhibition of GSK3α/β by AKT phosphorylation has a strong impact on glycogen 
synthesis. Glycogen is the major form of glucose storage in the muscle and is 
controlled by two pathways the PI3-kinase-pathway and the MAP kinase pathway 
(Cross et al., 1995; Dent et al., 1990).  
 
MAP-kinase pathway: The MAP-kinase pathway is the second pathway activated 
after IR activation. Growth factor receptor binding protein 2 (Grb2) links the IR signal 
to the MAP-kinase pathway by binding to phosphorylated IRS proteins. Grb2 is an 
adaptor protein for the p21ras guanine exchange factor son of sevenless (SOS) and 
thus connecting SOS to IRS proteins.  
IRS-Grb2-SOS complex interacts with another protein; a membrane bound protein 
named Ras at which SOS induces the nucleotide exchange of guanosine-
diphosphate (GDP) to guanosine-triphosphate (GTP). This exchanges leads to the 
activation of Ras by converting the protein into its active form. Activated Ras causes 
the membrane recruitment and activation of Raf-1 (c-Raf; MAPKKK). This enables 
Raf-1 to phosphorylate Ser and Thr residues of mitogen-activated protein kinase 
kinase -1/-2 (MEK-1/-2; MAPKK). Phosphorylated MEK-1/-2 in turn transduce insulin 
signaling further downstream by activation of extracellular signal-regulated kinases 
(ERK-1/-2; MAPK) by phosphorylation of Tyr and Thr residues (Anderson et al., 
1990; Davis 1993; Sasaoka and Kobayashi 2000; Skolnik et al., 1991). The MAP-
kinase pathway activates various downstream targets like MAPK-activated protein 
kinase 1 (p90rsk), MYC and ELK. One target of p90rsk is GSK3α/β, inactivating 
glycogen-synthase-kinase 3 leads to an insulin stimulated elevation of glycogen 
synthesis since the enzyme for this process glycogen synthase is active and not 
inhibited by GSK3α/β (Sutherland et al., 1993; Sutherland and Cohen 1994). Besides 
increasing glycogen synthesis MAP-kinase pathway activates genes important for 
cell cycle progression and hence affecting cell proliferation and differentiation. In 
order to enhance gene expression MAP kinases migrate to the nucleus 
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phosphorylating transcription factors like ELK resulting in increased gene activity 
(Seth et al., 1992). c-Fos promoter and activation of other transcription factors like c-
Jun connecting MAP-kinase pathway to mitogenesis (Pulverer et al., 1991; Shaw et 
al., 1989).  
 
 
1.2 Mouse model 
 
The mouse model used in present thesis to investigate the influence of the IRS-1 
signaling transduction on energy homeostasis was kindly provided by Professor 
Takashi Kadowaki. The transgenic mouse model was generated by conventional 
mutagenesis.  
For a conventional gene targeting homologous recombination is used to delete, add 
or to disrupt a gene. To target a specific gene first a DNA construct with a selectable 
marker is generated in bacteria. This exogenous DNA construct is then inserted into 
mouse embryonic stem cells (ES) and exposed to selection. Cells with inserted 
exogenous DNA construct (or selection marker, respectively) are used for embryonic 
injection. On the basis of homologous recombination the DNA construct is able to 
integrate into the host DNA and to displace the natural gene (Sedivy and Joyner, 
1992). 
To obtain an IRS-1 knockout mouse the first exon of the IRS-1 gene was targeted. 
The targeting vector was inserted 3´ of the translation initiation site of the IRS-1 
gene. The inserted construct contained a pgk-1 promotor with several stop codons, 
so that the insertion of the pgk-1 gene promoter results in a destabilized mRNA of 
IRS-1 (Tamemoto et al., 1994).  
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Fig. 1.4  Cloning strategy for conventional IRS-1 knockout in mouse 
Schematic representation of mouse IRS-1 gene, targeting vector and targeted allele. Exact principle 
creating IRS-1 knockout mouse described in the text above (Tamemoto et al., 1994). 
 
The homozygous IRS-1 knockout mouse shows normal development but is retarded 
in embryonic and postnatal growth, with a weight reduction compared to wild type of 
about 40-50%. Levels of IGF-1 and growth hormone (GH) were normal and no 
histological abnormalities have been observed. These mice show a mild to moderate 
insulin resistance with normal glucose tolerance (Araki et al., 1994; Tamemoto et al., 
1994). The IRS-1 deficiency is compensated by elevated production and secretion of 
insulin from the pancreatic β-cells. The elevated insulin production is achieved by 
islet hyperplasia meaning that the number of β-cells in these mice is about 2-fold 
increased compared to wild type mice (Patti et al., 1995). Another aspect of 
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compensation in these mice leading to a relative unaltered insulin/glucose 
metabolism is that IRS-1 might be functionally replaced by IRS-2 in some tissues 
(e.g. liver), whereas in another insulin sensitive target tissue, the muscle insulin 
response is diminished to 20%. This results in a normal glucose homeostasis by 
preventing gluconeogenesis via IRS-2 in the liver and a slowed down but not 
diminished glycogen synthesis in the muscle (Yamauchi et al., 1996). In contrast 
heterozygous IRS-1/IR knockout mice display a strong diabetic phenotype indicating 
that these combined gene defects can not be compensated by any other mechanism 
(Brüning et al., 1997). Overall these data show that IRS-1 deficiency might be 
compensated in some tissue like liver and pancreatic β-cells more effectively than in 
skeletal muscle and fibroblasts. Although suffering mild insulin resistance IRS-1 
knockout females (not males) demonstrated increased life span, due to resistance to 
several age related pathologies, age related glucose intolerance and age associated 
changes of T-cell population (Selman et al., 2008). 
IRS-2 knockout mice in contrast to the IRS-1 knockout mouse display a typical 
diabetic phenotype similar to human type 2 diabetes. They show insulin resistance 
and glucose intolerance from birth on or a few weeks after birth, respectively. Male 
IRS-2 knockout mice die due to massive hyperglycaemia and β-cell failure in 10 to 16 
weeks after birth (Burks et al., 2000; Withers et al., 1999). Causative for that are 
peripheral insulin resistance (glucose uptake disruption of the muscle) and failure to 
inhibit gluconeogenesis in the liver. Accordingly these mice progressively develop a 
fasting hyperglycemia as a consequence of reduced β-cell mass, leading to β-cell 
dysfunction (β-cell mass is about 50% declined compared to wild type mice) and 
peripheral insulin resistance (Withers et al., 1998). In contrast to IRS-1 knockout 
mice these defects in muscle and liver of IRS-2 mice are not compensated by 
elevated insulin levels as a result of accelerated insulin production in the β-cells. 
Since IRS-2 plays an important role in development, neogenesis, proliferation and 
survival of β-cells IRS-2 knockout mice show the expected diabetic phenotype 
(Kornmann et al., 1998; Withers et al., 1999). Hepatic insulin resistance and β-cell 
failure, rather than the lack of IRS-2 are the main mechanisms and causative for 
diabetic phenotyp in these mice (Higaki et al., 1999).  
In summary IRS-1 is supposed to be a major factor for insulin signaling in muscle 
and adipose tissue whereas IRS-2 is important for insulin signaling in liver. In 
addition to insulin signaling in peripheral tissues IRS-1 and IRS-2 are involved in 
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insulin secretion and development of pancreatic β-cells, respectively (Aspinwall et al., 
2000; Kido et al., 2000).  
 
 
1.3 Mitochondria 
 
Mitochondria are organelles of eukaryotic cells of 1 to 5 µm length migrating in the 
cytoplasm essential for various processes like glucose and fat oxidation and energy 
production. Mitochondria produce the majority of ATP required for cellular processes. 
Depending on cell type and energy demand of the tissue the mass of mitochondria 
differ from about 10 up to 1000 per cell. Mitochondria are maternal inherited. The 
structure of mitochondria is defined by a phospholipid bilayer membrane consisting of 
highly specific macromolecular structures, the inner mitochondrial membrane (IMM) 
and the outer mitochondrial membrane (OMM). Mitochondria are subdivided by this 
double membrane layer into two different aqueous compartments. In between OMM 
and IMM the non-plasmic mitochondrial intermembrane space is located (IMS) and 
the IMM covers the plasmatic mitochondrial matrix. The mitochondrial matrix is 
further subdivided into mitochondrial inner boarder membrane and the mitochondrial 
cristae membrane. These cristae represent invagination of the IMM function as 
surface extension of this membrane, pointing into the mitochondrial matrix. Cristae 
structure can vary from lamellar to vesicular or tubular morphology depending on cell 
type and metabolic conditions. Metabolic activity of tissues or cells depend on the 
characteristic shape of cristae and mitochondrial quantity (Gilkerson et al., 2003; 
Mannella et al., 2001; Perkins et al., 1998; Prince et al., 2002; Zick et al., 2009; Vogel 
et al., 2006). The outer mitochondrial membrane is permeable for small metabolic 
products. In addition to this passive transport active transport of molecules from 5000 
to 10000 kDA is achieved via porine channel proteins. In contrast to the outer 
membrane the inner membrane is impermeable for almost any molecule and ion 
unless specialized transport systems are used (Bernardi, 1999). 
Mitochondria have the ability to fuse and to fission. Hence mitochondria are dynamic 
organelles. Fusion and fission events influence activity of mitochondria. Fused 
mitochondria form a mitochondrial network. Fusion is an essential event for 
mitochondria since besides exchange of proteins dysfunctional mitochondria might 
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be erased by autophagy during this process (Chan, 2006; Bereiter-Hahn and Voth 
1994; Bleazard et al., 1999; Nunnari et al., 1997).     
The fact mitochondria are surrounded by a double lipid layer promote the idea of the 
endosymbiotic theory. Mitochondria originated from a process 1,5 billion years ago in 
which precursor of α-proteobakteria merged with an eukaryotic precursor cell. This 
process became essential as a consequence of raising oxygen levels in the 
atmosphere to avoid toxic effects. Under these conditions the aerobic production of 
ATP via the mitochondrial respiratory chain was of central interest for survival and 
evolution. In anaerobic conditions energy is generated by glycolysis and met the 
energy demand of cells. Symbiotic invading of aerobic into anaerobic cells enabled 
the cells to cellular respiration and adaptation to an aerobic situation by using an 
effective system for energy production. The merging of two different cells designed a 
cell type existing with two different originated sets of DNA. Via different metabolic 
pathways these two sets of DNA were linked to each other and therefore are not 
independent of each other. During evolution numerous mitochondrial genes were 
transferred to the nucleus of the eukaryotic cell causing that mitochondrial DNA is 
coding for only a few of its essential proteins. The characteristic circular DNA in the 
mitochondrial matrix (mtDNA) and an own machinery for protein synthesis 
(mitochondrial ribosomes) support the idea of bacterial background of mitochondria 
(Lang et al., 1999; Chen and Butow, 2005; Burger et al., 2003; Margulis, 1971; Gray 
et al., 1999; Reichert and Neupert, 2004; Andersson et al., 1998; Kurland and 
Andersson, 2000; Lopez et al., 2000).  
mtDNA is mainly encoding for subunits of the mitochondrial respiratory chain 
complexes. Since the major part of mitochondrial proteins is encoded and transcribed 
in the nucleus, translated and synthesised in the cytoplasm, a coordinated transport 
of these nuclear encoded mitochondrial proteins into the mitochondria has to be 
accomplished by the cell. By fusing short signaling peptides to the synthesised 
protein, these proteins are guided to and into the mitochondria. The conduction of 
these proteins into the mitochondria is unidirectional and taken over by specialized 
channel proteins in the mitochondrial membranes, the translocase complexes TIM 
(translocase of the inner membrane of mitochondria) and TOM (translocase of the 
outer membrane of mitochondria). TOM complex is located and integrated in the 
outer mitochondrial membrane directing protein import from cytosol to mitochondria. 
TIM complex is located and integrated in the inner mitochondrial membrane 
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mediating protein import over the IMM into the mitochondrial matrix. Only in the case 
of apoptosis mitochondrial proteins are released into cytoplasm (Danial and 
Korsmeyer, 2004; Pfanner und Meijer 1997, Neupert, 1997; Ryan et al., 2000; 
Sirrenberg et al., 1996).  
Mitochondria are important for various cell functions e.g. energy supply, fat and 
glucose oxidation, phospholipid synthesis, amino acid metabolism, apoptosis, 
calcium homeostasis, synthesis of iron sulfur cluster and heme molecule (Lill and 
Kispal, 2000; Green and Kroemer, 2004; Bianchi et al., 2004; Szabadkai and 
Rizzuto, 2004). Proteins and enzymes located in the mitochondrial matrix are largely 
involved in metabolic processes e.g. β-oxidation (oxidation of FFA), Krebs cycle 
(oxidation of pyruvate) and oxidative phosphorylation. The IMM contains five 
integrated multi subunit enzyme complexes. Four of them form the respiratory chain, 
consisting of NADH-coenzyme Q oxidoreductase (complex I), succinate-coenzyme Q 
oxidoreductase (complex II), Q-cytochrome c oxidoreductase (complex III), 
cytochrom c oxidase (complex IV). Complex V represents the ATPase or F0F1-
synthase, depending of the direction of the catalyzed enzymatic reaction. Electrons 
of the reductive equivalents NADH and FADH2 generated in enzymatic reactions of 
the Krebs cycle by oxidation of acetyl-CoA (product of the glycolysis and β-oxidation 
end product pyruvate) enter the respiratory chain in the case of NADH via complex I 
and for FADH2 via complex II. Charged electrons are taken over by Coenzyme Q and 
transported through the hydrophobic surrounding of the IMM to complex III. The 
transport of the electrons from complex III to complex IV is provided by cytochrome c. 
In complex IV electrons are passed to molecular oxygen via cytochrome a reducing 
molecular oxygen to H2O (1/2 H2O + 2 H+ + 2 e- → H2O). Redox reactions of 
stepwise electron transfer from complex to complex in the respiratory chain are 
extremely exergonic reactions, the energy of these reactions is used by mitochondria 
to pump protons (H+) from the matrix against the present gradient of the IMM into the 
mitochondrial inter membrane space. This leads to changes in the pH value of the 
inter membrane space. The gradient harbours energy used by complex V for 
generating ATP. Protons reflux back to the mitochondrial matrix through a proton 
channel of the ATP synthase restoring chemical equilibration. Energy released in this 
process is used by the F0 subunit of the ATP synthase to phosphorylate ADP, 
producing ATP with an intrinsic energy of 19,3 kJ/mol conserved in the chemical 
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bond of ADP and anorganic phosphate (Mitchell, 1961; Bernardi, 1999; Janssen et 
al., 2006; Sun et al., 2005, Eichler and Schertel 1988; Jockel et al., 1998).  
 
 
Fig. 1.5  Mitochondrial respiratory chain 
Electrons are transferred by the reductive equivalents NADH to complex I and FADH2 to complex II. 
The electron transport is used by complex I, II and IV to build up a proton gradient. Additionally 
electrons cause the reduction of oxygen to water at complex IV. The proton gradient is used by 
complex V to catalyze binding of inorganic phosphate to ADP (Smeitink et al., 2001).  
 
 
1.4 Mitochondrial dysfunction and insulin resistance 
 
Mitochondrial function is required for normal glucose stimulated β-cell insulin 
secretion, oxidation of fatty acids, amino acid metabolism as well as ATP production 
(Luft, 1994). Free fatty acids (FFA) are important energy carrier for muscles and have 
a striking impact on the pathogenesis of insulin resistance. Decreased mitochondrial 
activity might be linked to increased intramyocellular fat content (Groop, et al., 1991; 
Bajaj et al., 2005; Petersen et al., 2003; Petersen et al., 2004). Lipids and 
intermediates of lipid metabolism accumulate if fatty acid delivery in tissues exceeds 
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mitochondrial fat (β-)oxidation (Schrauwen-Hinderling et al., 2007). Cytokines 
secreted by adipose tissue and intracellular fatty acids negatively influence insulin 
sensitivity of insulin target tissues liver and muscle and hence attenuate their insulin 
responsiveness. (Lazar, 2005; Boden and Shulman, 2002). Intracellular fatty acids 
induce insulin resistance by inhibition of glucose uptake. Type 2 diabetes subjects 
show reduced fat oxidation and a failure of insulin to inhibit lipolysis leading to 
increased plasma FFA levels and enhanced influx in muscles. Elevated levels of fatty 
acid metabolites like acetyl coenzyme A (CoA) and diacylglyerol due to impaired 
mitochondrial fat oxidation, thought to play a critical role in activating pathways 
leading to suppression of insulin signaling. Diacylglycerol is an activator for protein 
kinase C (PKC), PKC in turn switches on a serine kinase cascade causing increased 
serine phosphorylation of IRS-1. Phosphorylation of IRS-1 at Ser 307 inhibits insulin 
receptor stimulated tyrosine phosphorylation of IRS-1 thus shutting down insulin 
signaling. Since IRS-1 is important for GLUT-4 translocation to the plasma 
membrane, hence deactivation of IRS-1 causes suppression of insulin stimulated 
glucose uptake and inhibits removal of glucose out of the blood stream. Therefore 
metabolic disturbances like decreased mitochondrial fatty acid oxidation and/or 
reduced mitochondrial content results in defective fatty acid metabolism and 
intracellular accumulation of fatty acids and might be responsible for insulin 
resistance. Obese and type 2 diabetes patients reveal reduced PGC1α/β mRNA 
levels up to 71% and consequently downregulated protein levels of PGC-1α and 
PGC-1β as well as their target genes. Reduction in PGC-1 expression is a result of 
elevated plasma free fatty acids (FFA) demonstrated by high fat feeding causing 
decrease of PGC-1 mRNA levels (Sparks et al., 2005; Hoeks et al., 2006; 
Richardson et al., 2005; Heilbronn et al., 2007; Lowell and Shulman, 2005; Dresner 
et al., 1999; Shulman, 2000, Wu et al., 1999; St-Pierre et al., 2003; Mootha et al., 
2003). PGC-1 is a regulator of mitochondrial biogenesis controlling genes being part 
of a cluster of oxidative proteins. These genes encode for key enzymes in oxidative 
metabolism and mitochondrial function, hence reduced expression of this cluster has 
strong effects on mitochondrial function like OXPHOS and might also explain 
accumulation of fat in affected tissues (Schrauwen-Hinderling et al., 2007; Mootha et 
al., 2003; Patti et al., 2003). In addition to GLUT-4 translocation and glucose uptake 
mitochondrial metabolism is required for insulin secretion upon increasing glucose 
levels. Obese individuals develop diabetes most likely due to failure of β-cells to 
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increase insulin secretion in response to the growing demand of insulin to elevated 
glucose levels. This is caused by inadequate compensation of the existing β-cell 
mass and/or inappropriate β-cell response to higher glucose levels (Lowell and 
Shulman, 2005; Rhodes, 2005; Gerich, 2003). Patients suffering type 2 diabetes 
show decreased β-cell mass caused by increased apoptosis (Butler et al., 2003; Pick 
et al., 1998). Defective glucose sensitivity of β-cells might particularly be caused by 
mitochondrial malfunction. Adequate β-cell response to glucose requires oxidative 
mitochondrial metabolism generating the appropriate amount of ATP. Mitochondria 
increase ATP levels by oxidative phosphorylation arising from glucose oxidation and 
consequently alter the ATP/ADP ratio in β-cells. Increased ATP/ADP ratios initiate 
inhibition of ATP/ADP regulated potassium channel (KATP). Subsequently opening of 
voltage gated calcium channel stimulates calcium influx into the cell, resulting in 
insulin secretion. Uncoupling protein 2 (UCP-2) lowers oxidative mitochondrial ATP 
synthesis by collapsing the inner membrane potential of mitochondria, decreasing 
ATP/ADP ratio and finally insulin secretion from β-cells. Since the amount of ATP 
generated by oxidation of glucose is diminished by UCP-2, glucose stimulated insulin 
secretion is negatively controlled by this protein. UCP-2 expression is stimulated by 
hyperglycemia (glucotoxicity) and high lipid levels (lipotoxicity) in animal models with 
type 2 diabetes and UCP-2 deficiency is associated with improved β-cell function. 
UCP-2 expression is elevated by superoxide and superoxide levels are increased in 
β-cells of type 2 diabetic individuals, leading to enhanced β-cell dysfunction (Prentki 
et al., 2002; Chan et al., 2001; Joseph et al., 2002; Bindokas et al., 2003; Zhang et 
al., 2001; Krauss et al., 2003; Krauss et al., 2002; Lowell and Shulman, 2005; 
Maechler and Wollheim, 2001).  
 
In addition to this so called “mitochondrial dysfunction” negative effects on 
cytoplasmic glycogen synthesis and glucose oxidation were observed. Furthermore 
dysfunctional mitochondria show reduced ability to switch from fat oxidation in fasting 
state to glucose oxidation after insulin stimulation due to so called “metabolic 
inflexibility” (Wititsuwannakul and Kim, 1977; Schrauwen-Hinderling et al., 2007; 
Kelley and Mandarino, 2000).  
Furthermore human aging is correlated with alteration in mitochondrial DNA 
(mtDNA). Decreased mtDNA and mutated mtDNA lead to reduction in mRNA levels 
of mitochondrial genes and thereby diminishing oxidative enzyme activities. Whether 
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mitochondrial dysfunction is a consequence of accumulation of mtDNA alteration is 
controversially discussed (Kelley et al., 2002; Dufour and Larsson, 2004). 
Another unsolved issue in this field is the question if mitochondrial defects in insulin 
resistance are cause or consequence. Other theories in this field of research 
postulate that increased intramyocellular fat content lead to increased mitochondrial 
fat oxidation and subsequent resulting in enhanced generation of reactive oxygen 
species (ROS). To avoid increased cellular damage by elevated ROS and other toxic 
molecules mitochondrial oxidative phosphorylation is downregulated by cells as 
physiological response. In this case this mitochondrial defect would be a secondary 
effect to insulin resistance (Abdul-Ghani and DeFronzo, 2008; Brehm et al., 2006).  
 
 
1.5 Energy homeostasis 
 
Hypothalamic neurons play a crucial role in regulation energy homeostasis. Two 
neuron populations of the hypothalamus, proopiomelanocortin (POMC) expressing 
neurons and agouti-related protein (AgRP)/ neuropeptide Y (NPY) coexpressing 
neurons, located in the arcuate neucleus (ARC) close to the blood-brain barrier are 
mainly responsible for controlling food intake and energy expenditure. Positioning at 
the blood stream give these neurons access to hormonal signals and enables them 
to perceive changes in blood hormone levels and to respond to short- long-term 
alterations in an accurate way by activating their signaling cascades. POMC and 
AgRP/NPY neurons are part of the central melanocortin system representing the 
connecting of peripheral organs and CNS to detect energy status of the organism. 
POMC neurons mediate anorexigenic signals whereas AgRP/NPY mediate 
orexigenic signals acting as counterpart of POMC neurons. It had been shown that 
these neurons respond to changes of metabolic hormones and nutrient fluctuation, 
demonstrating a link of peripheral tissues to the CNS. (Benoit et al., 2000; Cone et 
al., 2001; Gao and Horvath, 2008; Belgardt et al., 2009). Cleavage of neuropeptide 
precursor protein POMC induces secretion of the melanocyte-stimulating hormones α 
and β (α- and β-MSH). Neuronal release of α- and β-MSH leads to activation of 
melanocortin receptor subtypes 3 and 4 (MC3R and MC4R) resulting in increased 
energy expenditure and food intake reduction (Cone, 2005; Biebermann et al., 2006; 
Lee et al., 2006). In contrast AgRP/NPY coexpressing neurons stimulate food intake 
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and reduce energy expenditure. AgRP is a natural competitive antagonist of α-MSH 
blocking MSH signaling thus reducing anorectic effects and increasing the eating 
impulse of individuals. AgRP/NPY coexpressing neurons and POMC neurons are 
nearby located in the arcuate nucleus. Therefore both neuronal populations interact 
however as known so far only in an unidirectional way. POMC cells are inhibited by 
release of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) from 
AgRP/NPY neurons. POMC inhibition by AgRP/NPY originated GABA signaling is 
important controlling body energy expenditure. GABAerigic inhibition of downstream 
effector neurons has been described for POMC and AgRP neurons (Hentges et al., 
2004; Horvath et al., 1997, 2008; Goa and Horvath, 2008; Ollmann et al., 1997; 
Stanley and Leibowitz 1984; Sanchez-Lasheras et al., 2010; Tong et al., 2008). 
POMC and AgRP neurons express leptin and insulin receptors and respond to these 
hormones. Both insulin and leptin are modulator and regulator of food intake. Central 
insulin signaling leads to activation of PI3K-pathway and phosphorylation of FoxO. 
FoxO is responsible for neurotransmitter transcription regulation in neurons. AgRP 
expression is inhibited whereas POMC expression is promoted by FoxO. In addition 
activation of neuronal insulin receptors promote hyperpolarization and inhibition of 
neuronal firing. Thereby insulin activated PI3K catalyzing phosphorylation of PIP2 
generating PIP3. PIP3 binds and activates KATP channels increasing potassium 
outflow. (Kim et al., 2006; Rezek, 1976; Havrankova et al., 1978; Kitamura et al., 
2006; Schwartz 1992; Sanchez-Lasheras et al., 2010; Plum et al., 2006).  
Glucose uptake leads to depolarization of the neuronal membrane and increased 
electrical activity of KATP channels. Glucose is metabolized and converted to pyruvate 
resulting in ATP production. ATP then binds and closes ATP-dependent potassium 
channels, reducing neuronal potassium outflow, increasing neuronal firing.  
Leptin is secreted by adipocytes and serum leptin levels are a direct indicator for 
body fat storage. Leptin mediates anorectic signals via its central receptors in the 
hypothalamus thus regulating energy homeostasis. Leptin receptor signal 
transduction activates the JAK/STAT pathway. Leptin interacts with the melanocortin 
system by catalyzing phosphorylation, homodimerization and nuclear translocation of 
the transcription factor STAT3. Upon leptin binding JAK2 binds to the leptin receptor 
leading to recruitment and phosphorylation of STAT3. STAT3 modulates POMC and 
AgRP gene expression, increasing POMC and inhibiting AgRP transcription thereby 
promoting anorectic effects. In contrast to insulin, hyperpolarizing POMC and AgRP 
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neurons, leptin hyperpolarizes AgRP neurons whereas POMC neurons are 
depolarized.  
The melanocortin system and its role in the regulation of energy homeostasis is well 
established but recent findings indicate that other hypothalamic and also extra 
hypothalamic areas may influence energy expenditure (Bates et al., 2003; Considine 
et al., 1996; Belgardt et al. 2009; Sanchez-Lasheras et al., 2010; Balthasar et al., 
2005).  
 
 
1.6 Aim of thesis 
 
The IRS-1 knockout mouse shows lifespan extension proportional dwarfism and mild 
insulin resistance (Tamemoto et al., 1994).  In addition weight gain and accumulation 
of abdominal fat pads during adult life is decreased in these mice; however food 
intake of IRS-1 knockout mice is increased compared to wildtype animals. Aim of this 
thesis was to address if the higher energy expenditure is associated with accelerated 
enzyme activity of respiratory chain complexes by using photospectroscopy and to 
clarify mechanism responsible for increased food intake and to elucidate the 
molecular mechanism of increased food intake. Since the described phenotype 
develops in adults, all animals used for experiments were 12 to 15 months of age.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 Material and methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                    
                                                                                                     Material and Methods 
2.  Material and Methods 
 
 
2.1 Chemicals 
 
Acrylamide/ Bis-acrylamid 30%   Rotiphorese® Gel 30 (37.5/1) 
Carl Roth GmbH + Co. KG, Karlsruhe, 
Germany 
 
Agarose      Invitrogen Corporation, Carlsbad CA, USA 
Aprotinin   Sigma‐Aldrich Chemie GmbH, Steinheim, 
Germany 
 
APS   Ammonium‐persulfate, AppliChem GmbH, 
Darmstadt, Germany 
 
β‐mercaptoethanol   Sigma‐Aldrich Chemie GmbH, Steinheim, 
Germany 
Bradford              Bio‐Rad Laboratories GmbH, Germany 
Bromophenol blue     AppliChem GmbH, Darmstadt, Germany 
 
BSA > 96 %      Bovine serum albumin 
Sigma‐Aldrich Chemie GmbH, Steinheim, 
Germany 
 
Protease inhibitor Cocktail  Roche Diagnostics GmbH, Mannheim, 
Germany 
Desoxy-Ribonucleotid-Triphosphate  Fermentas GmbH, St. Leon-Rot, Germany 
(dNTPs) 
DMSO   Dimethyl sulfoxid, Sigma‐Aldrich Chemie 
GmbH, Steinheim, Germany 
 
DNase  Roche Diagnostics GmbH, Mannheim, 
Germany 
DTT   Dithiothreitol, AppliChem GmbH, Darmstadt, 
Germany 
 
EDTA   Ethylendiamintetraessigsäure, AppliChem 
GmbH, Darmstadt, Germany 
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EGTA  Ethylenglycoltetraessigsäure, AppliChem 
GmbH, Darmstadt; Germany 
 
Ethanol       AppliChem GmbH, Darmstadt, Germany 
Ethidiumbromide   Sigma‐Aldrich Chemie GmbH, Steinheim, 
Germany 
Glycerol   Glycerin, AppliChem GmbH, Darmstadt, 
Germany 
Glycine      AppliChem GmbH, Darmstadt, Germany 
HEPES  Sigma‐Aldrich Chemie GmbH, Steinheim, 
Germany  
Insulin solution, human  Sigma‐Aldrich Chemie GmbH, Steinheim, 
Germany  
Isopropanol      AppliChem GmbH, Darmstadt, Germany 
KCl Potassium chloride, Sigma‐Aldrich Chemie 
GmbH, Steinheim, Germany 
Methanol 99%   Carl Roth GmbH + Co. KG, Karlsruhe, 
Germany 
Magnesium chloride   Merck, Darmstadt, Germany 
NaCl  Sodium chloride AppliChem GmbH, 
Darmstadt, Germany 
NP‐40   FLUKA Chemika/Biochemika ChemieAG, 
Buchs, Switzerland 
PMSF  Phenylmethylsulphonylfluorid, Sigma‐Aldrich 
Chemie GmbH, Steinheim, Germany 
Proteinase K   Roche Diagnostics GmbH, Mannheim, 
Germany  
SDS                 AppliChem GmbH, Darmstadt, Germany 
Sodium flouride     NaF, Merck, Darmstadt, Germany 
Sodium orthovanadate  Na3VO4, Sigma‐Aldrich Chemie GmbH, 
Steinheim, Germany 
PMSF  Phenylmethylsulfonyl fluoride, Sigma‐Aldrich 
Chemie GmbH, Steinheim 
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TEMED      N,N,N',N'‐Tetramethylethylenediamine 
Sigma‐Aldrich Chemie GmbH, Steinheim, 
Germany 
 
Tris       AppliChem GmbH, Darmstadt, Germany 
Triton X-100      AppliChem GmbH, Darmstadt, Germany 
Trypsin  Roche Diagnostics GmbH, Mannheim, 
Germany 
TWEEN 20®    Caesar and Lorentz GmbH, Bonn, 
Germany 
Western Blocking Reagent  Roche Diagnostics GmbH, Mannheim, 
Germany 
 
2.1.1 Buffer and solution 
 
Cell lysis buffer     50 mM NaCl 
10 mM Tris‐HCl (pH 7.4) 
10 mM EDTA 
50 mM NaCl 
50 mM NaF 
0,1 µg/ml Aprotinine 
1 mM PMSF 
2 mM Na3VO4 
1 % Triton X-100 
 
Organ lysis buffer    50 mM HEPES (pH 7.4) 
50 mM NaCl 
1 % Triton X-100 
10 mM EDTA 
0.1 M NaF 
17 μg/ml Aprotinine 
2 mM Benzanidine 
0.1 % SDS 
1 mM Phenylmethylsulfonyl fluoride (PMSF) 
10 mM Na3VO4  
 
SDS‐PAGE running buffer   194 mM Glycine 
25 mM Tris 
0.1 % SDS 
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4 x SDS sample buffer   250 mM Tris‐HCl (pH 6.8) 
200 mM DTT 
40 % Glycerol 
8 % SDS 
0.01 % Bromphenol blue 
 
Stripping solution     62.5 mM Tris‐HCL pH 6.8 
100 mM β‐mercaptoethanol 
2% SDS 
 
TBS buffer (pH 7.6) 1   37 mM NaCl 
20 mM Tris 
 
TBS‐T buffer (pH 7.6)    137 mM NaCl 
20 mM Tris 
0.1 % Tween 20® 
 
Western Blot antibody solution   137 mM NaCl 
20 mM Tris 
5 % Western Blocking Reagent (Roche) 
 
Western Blot blocking solution   137 mM NaCl 
20 mM Tris 
10 % Western Blocking Reagent (Roche) 
 
Western Blot transfer buffer   194 mM Glycin 
25 mM Tris 
20 % Methanol (99%) 
0.05 % SDS 
 
–   ECL; Amersham ECLTM Western Blotting Detection Reagents, GE Healthcare 
UK Ltd; England 
–  Fetal bovine serum (FBS); Invitrogen , Corporation, Carlsbad CA, USA 
–   Pen/Strep; Penicillin Streptomycin (P/S); 10000 Units/ml Penicillin, 10000 
μg/ml Streptomycin; Invitrogen Corporation, Carlsbad CA, USA 
–  PBS 10 x (pH 7.2); Invitrogen Corporation, Carlsbad CA, USA 
–  Protein Standard Ladder; Precision Plus Protein Kaleidoscope Standards; 
Bio‐Rad Laboratories GmbH, Germany 
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2.1.2 Primary antibodies 
 
–  Actin Antibody; Monoclonal mouse antibody raised against an epitope 
conserved in human actin; MP Biomedicals, USA; Item # 69100; Western 
Blotting Dilution 1:5000 
 
–   AKT Antibody; Polyclonal rabbit antibody raised against endogenous levels of 
total AKT1,AKT2 and AKT3 proteins; Cell Signaling Technology, Inc., USA; 
Item # 9272; Western Blotting Dilution 1:1000  
 
– ANT (N-19) is an affinity purified goat polyclonal antibody raised against a 
peptide mapping near the N-terminus of ANT of human origin; Santa Cruz 
Biotechnology, Inc., USA; Item #sc‐9299; Western Blotting Dilution 1:1000 
 
– DNP Antibody; Polyclonal rabbit antibody developed in rabbit using DNP-BSA 
immunogen; Sigma Aldrich; Saint Louis, Missouri, USA; Item # 9656; Assay 
Dilution 1:1000  
  
– ERK Antibody; Polyclonal rabbit antibody raised against endogenous levels of 
total p44/42 MAP kinase (Erk1/Erk2) protein; Cell Signaling Technology, Inc., 
USA; Item # 9102; Western Blotting Dilution 1:1000 
 
–  GSK‐3β Antibody; Monoclonal rabbit antibody raised against endogenous 
levels of totalGSK‐3β protein; Cell Signaling Technology, Inc., USA; Item # 
9315; Western Blotting Dilution 1:1000 
 
–  HSP60 Antibody; Monoclonal human antibody raised against human Hsp60 
recombinant protein. Cross reactivity with mouse and rat. BD Bioscience, New 
Jersey, USA; Item # 611562; Western Blotting Dilution 1:1000 
 
 – IGF‐1 Receptor β Antibody; Polyclonal rabbit antibody raised against 
endogenous levels of IGF‐IR β. Does not cross‐react with insulin receptor; Cell 
Signaling Technology, Inc., USA; Item # 3027; Western Blotting Dilution 
1:1000 
 
–  IR‐β Antibody; Polyclonal rabbit antibody raised against a peptide mapping at 
the C-terminus of insulin Rβ (C19) of human origin; Santa Cruz Biotechnology, 
Inc., USA; Item # sc‐711; Western Blotting Dilution 1:1000 
 
–  IRS‐1 Antibody; Monoclonal rabbit antibody raised against C‐terminal 14 
amino acid peptide ([C]YASINFQKQPEDRQ) of rat liver IRS‐1. Rat, mouse 
and human crossreactivity; Upstate Cell Signaling Solutions, USA; Catalog # 
06‐248; Western Blotting Dilution 1:1000 
 
–  IRS‐2 Antibody; Polyclonal rabbit antibody raised against endogenous levels 
of total IRS‐2 protein; Cell Signaling Technology, Inc., USA; Item # 4502; 
Western Blotting Dilution 1:1000 
  30
                                                                                                     Material and Methods 
 
– MitoProfile® Total OXPHOS Rodent WB Antibody Cocktail, monoclonal mouse 
antibody containing 5 mAbs, one each against CI subunit NDUFB8 (MS105) 
CII-30kDa (MS203), CIII-Core protein 2 (MS304) CIV subunit I (MS404) and 
CV alpha subunit (MS507) optimized premixed cocktail. for Western Blotting 
analysis of the 5 OXPHOS complexes in mitochondrial preparations from 
mouse, rat, human, or bovine sources; Acris Antibodies GmBH, 
Hiddenhausen, Germany; Item #MS-604; Western Blotting Dilution 1:1000 
– MnSOD, purified rabbit polyclonal antibody; Immunogen: recombinant human 
MnSOD (manganous superoxide dismutase); Upstate (Milipore), Milipore Life 
Science Research and Biomanufacturing, USA Item # 06-984; Western 
Blotting Dilution 1:1000 
 
– pan-Acetyl, rabbit polyclonal affinity purified antibody raised against an 
acetylated peptide; Santa Cruz Biotechnology, Inc., USA; Item #sc‐8649-R; 
Western Blotting Dilution 1:1000 
 
– PGC-1α,  PGC-1 (H-300) rabbit polyclonal antibody raised against amino 
acids 1-300 mapping near the N-terminus of PGC-1 of human origin; Santa 
Cruz Biotechnology, Inc., USA; Item #sc‐13067; Western Blotting Dilution 
1:1000 
 
–  Phospho‐AKT Antibody; Polyclonal rabbit antibody raised against endogenous 
levels of AKT1 only when phosphorylated at Ser473. Also recognizes AKT2 
and AKT3 when phosphorylated at the corresponding residues; Cell Signaling 
Technology, Inc., USA; Item # 9271; Western Blotting Dilution 1:1000 
 
–  Phospho‐p44/42 MAP Kinase (Thr202/Tyr204) Antibody; Polyclonal rabbit 
antibody raised against endogenous levels of p44 and p42 MAP Kinase (Erk1 
and Erk2) when phosphorylated either individually or dually at Thr202 and 
Tyr204 of Erk1 (Thr185 andTyr187 of Erk2); Cell Signaling Technology, Inc., 
USA; Item # 9101; Western Blotting Dilution 1:1000 
 
–  Phospho‐GSK‐3β (Ser9) Antibody; Polyclonal rabbit antibody raised against 
endogenous levels of GSK‐3β only when phosphorylated at serine 9; Cell 
Signaling Technology, Inc., USA; Item # 9336; Western Blotting Dilution 
1:1000 
 
– PI 3-kinase p85α (Z-8), rabbit polyclonal antibody raised against amino 
acids 333-430 of PI 3-kinase p85α of human origin; Santa Cruz Biotechnology, 
Inc., USA; Item #sc-423; Western Blotting Dilution 1:1000 
 
– Protein A-Agarose Immunoprecipitation Reagent, Protein A-Agarose is 
suitable for immunoprecipitation of mouse IgG2a, IgG2b and IgA, rabbit IgG 
and human IgG1, IgG2 and IgG4, Santa Cruz Biotechnology, Inc., USA; Item 
#sc-2001 
 
– PTEN, Polyclonal Rabbit mAb detects endogenous levels of total PTEN 
protein; Cell Signaling Technology, Inc., USA; Item # 138G6; Western Blotting 
Dilution 1:1000 
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– p-Tyr (PY99), mouse monoclonal antibody designed to specifically detect 
phosphorylated tyrosine residues;.Santa Cruz Biotechnology, Inc., USA; Item 
#sc-7020; Western Blotting Dilution 1:1000 
 
– SIRT1 (H-300), rabbit polyclonal antibody raised against amino acids 
448-747 of SIRT1 of human origin;.Santa Cruz Biotechnology, Inc., USA; Item 
#sc-15404; Western Blotting Dilution 1:1000 
 
– UCP-1, mouse polyclonal antibody, immunogen 19 aa peptide sequence 
(designated UCP12; cytoplasmic) at the C-terminus of the mouse/rat UCP1 
(Bouillaud et al. 1986; Ridley et al. 1986; Kozak et al. 1988; Cassard et al. 
1990; Miroux et al. 1993). The peptide has no significant homology with UCP2 
or UCP3. Chemicon, Milipore Life Science Research and Biomanufacturing, 
USA,  catalog number AG382. 
 
– UCP-3 (R308), rabbit polyclonal antibody detects endogenous levels of UCP3 
protein, immunogen for this antibody was a synthetic UCP3 (R308) peptide; 
ABR Antibodies, Novus Biologicals, Novus Biologicals, Ltd, Cambridge, United 
Kingdom; Item #NBP1-51195 
 
2.1.2 Secondary antibodies 
 
–  Anti Goat IgG (whole molecule), peroxidase conjugated; Affinity isolated 
antigen specific antibody obtained from rabbit anti‐goat antiserum by 
immunospecific purification; Sigma‐Aldrich, USA; Item # A5420; Western 
Blotting Dilution 1:1000 
 
–  Anti Mouse IgG (Fab specific), peroxidase conjugated; Developed in goat 
using purified mouse IgG Fab fragment as immunogen, the antibody is 
isolated from goat anti‐mouse IgG antiserum by immunospecific purification; 
Sigma‐Aldrich, USA; Item # A9917; Western Blotting Dilution 1:10000 
 
–  Anti Rabbit IgG, peroxidase conjugated; Developed in goat using purified 
rabbit IgG as immunogen, the antibody is isolated from goat anti‐rabbit IgG 
antiserum by immunospecific purification; Sigma‐Aldrich, USA; Item # A6154; 
Western Blotting Dilution 1:1000 
 
2.1.3 Kits 
 
–   ATP Bioluminescence Assay Kit HS II  Roche Diagnostics GmbH, Mannheim, 
Germany; Catalog # 11699709001 
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–   Free Triidotyronine (fT3) ELISA Kit ALPHA DIAGGNOSTIC, San Antonio, 
USA; Catalog # 1650 
–   Insulin Mouse Ultrasensitive ELISA DRG, International, Inc., USA; Catalog 
# EIA-3440 
–   Mouse Leptin ELISA Kit IBL International, GmbH, Hamburg, 
Germany 
    
  
2.2 Material 
 
Blotting chamber TransBlot® SemiDry Transfer Cell 
BioRad Laboratories, USA 
 
Blotting membrane ImmunBlotTM PVDF Membrane for Protein Blotting 
BioRad Laboratories, USA 
 
Blotting paper Whatman® Gel Blotting Paper 
Schleicher & Schuell, Germany 
 
iCycler Thermocycler 
BioRad Laboratories, USA 
 
Gewebe-Homogenisator 
VWR International GmbH, Germany 
 
Microplate reader Mithras LB 940 multimode microplate reader 
Berthold Technologies GmbH & Co. KG, Germany 
 
Minigel Twin Gel Electrophoresis Apparatus, MinigelTwin 
Biometra GmbH, Germany 
 
NanoDrop NanoDropTM Spectrophotometer ND 1000 
ThermoFisher Scientific, USA 
 
NMR Analyzer minispec mq7.5 
Burker Optik, Ettlingen, Germany 
 
Photopaper Amersham HyperfilmTM ECL 
GE Healthcare UK Ltd, England 
 
Powerpac Biometra Standard Power Pack P25 
Biometra GmbH, Germany  
PowerPac300 Bio-Rad Laboratories, Germany 
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Thermomixer 
Eppendorf, Thermomixer 5436, Eppendorf AG, Hamburg, Germany 
 
Western blot transfer device 
Trans-Blot SD Semi Dry Transfer Cell, Bio-Rad Laboratories, Germany 
Fastblot B 34, Biometra GmbH, Germany 
 
Luminometer 
Mithras LB 940, Berthold 
 
 
Incubator 
HeraCell 150, Thermo Scientific 
 
Magnetic stir bar  
Heizbarer Magnetrührer Combimag RCT, IKA Werke GmbH & Co. KG, Staufen, 
Germany 
Heizbarer Magnetrührer MONOTHERM, Variomag, Daytona Beach, USA 
 
Microscope 
Fluorescence Microscope Eclipse E800, Nikon Instech Co., Ltd. Kanagawa, Japan 
Mikroskop CKX41, Olympus 
 
pH meter 
Docu-pHmeter, Sartorius 
 
Pipettes  
Eppendorf research 0,5-10 μL  
Eppendorf research 10-100 μL 
Eppendorf research 100-1000 μL 
 
Pipettierhilfe 
Pipetus, Hirschmann Laborgeräte 
 
Laminar flow 
HERA safe, Thermo Scientific 
 
Water bath 
Wasserbad SFB-68-TB14, GFL Gesellschaft für Labortechnik mbH, Burgwedel, 
Germany 
 
Cell culture dishes 
 10cm  Schalen, TPP AG, Trasadingen, Schweiz  
 6cm Schalen, TPP AG, Trasadingen, Schweiz  
6-well-, 24-well- & 96-well-Schalen, TPP AG, Trasadingen, Schweiz 
 
Centrifuge 
Megafuge 11R , Thermo Scientific 
Biofuge Fresco, Heraeus Instruments GmbH, Osterode, Germany 
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Step one plus Real-time PCR system 
Applied Biosystems, Carlsbad, California, USA 
 
Oroboros Oxygraph 2k 
Oroboros instruments GmbH, Innsbruck, Austria 
 
 
   
 
2.3 Methods 
 
Protein analysis 
 
2.3.1 Protein- and cell-lysate preparation  
Proteinextraction was carried out at 4°C avoiding degradation of proteins. Organs 
were lysed in 50 mM HEPES (pH 7,4), 50 mM NaCl, 1 % Triton X-100, 10 mM EDTA, 
0,1 M NaF, 17 µg/ml aprotinine, 2 mM benzanidine, 0,1 % SDS, 1 mM 
phenylmethylsulphonyl fluoride (PMSF) and 10 mM sodium orthovanadate (Na3VO4) 
containing buffer. Homogenates were dissolved in 4 x SDS sample buffer (250 mM 
Tris-HCl (pH 6,8), 200 mM DTT, 40 % glycerol, 8 % SDS, 0,04 % bromophenol blue) 
and applied to 8 % to 15 % SDS-PAGE depending on protein size.  
Cells were grown in cell culture dishes, media was aspirated and cells were washed 
with ice-cold 1 x PBS. PBS was removed and cell lysis buffer (0,1 % Triton X-100, 10 
mM Tris-HCl, 10 mM EDTA, 50 mM NaCl, 50 mM NaF, 0,1 µg/ml aprotinine, 1 mM 
PMSF, 2 mM Na3VO4) was added to cells. Cells were harvested using a cell-scraper, 
transferred into 1,5 ml Eppendorf-tubes and incubated on ice for 30 min. 
Subsequently cells were resuspended with a 20 gauche syringe and centrifuged for 
30 min and 13000 rpm at 4°C. Cell pellet was discarded and supernatant was used 
for further procedures. Cell homogenates were dissolved in 4 x SDS sample buffer 
(250 mM Tris-HCl (pH 6,8), 200 mM DTT, 40 % glycerol, 8 % SDS, 0,04 % 
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bromophenol blue) and applied to 8 % to 15 % SDS-PAGE depending on protein 
size.  
Concentrations of protein and cell lysates were determined by Bradford assay. This 
assay is based on the ability of Coomassie brilliant blue G 250 dye to binding to 
aromatic amino acids of proteins. Binding of Coomassie brilliant blue G 250 to 
proteins causes a shift in absorption maximum of the dye of 595 nm to 465 nm in 
relation to amount of protein. Protein amount of sample solution was calculated using 
a standard curve.  
 
2.3.2 Preparation of nuclear cell fraction 
Cells were washed with ice-cold 1 x PBS, harvested and resuspended in 100 µl 
cytosolic extraction buffer (20 mM HEPES, 10 mM KCl, 1 mM EDTA, 0,1 mM sodium 
orthovanadate (Na3VO4), 10 % (v/v) glycerol, 0,2 % (v/v) NP 40, adjusted to pH 7,4). 
MEFs were incubated in lysis buffer for 5 minutes on ice, resuspended with a 20 
gauche syringe and centrifuged for 30 seconds at 16000 rpm and 4°C. Supernatant 
was additionally centrifuged for 5 minutes at 16000 rpm and 4°C and resulting 
supernatant used as cytsolic extract for further experiments. The precipitate of the 
first centrifugation step was resolved in 100 µl nuclear extraction buffer (420 mM KCl, 
20 mM HEPES, 1 mM EDTA, 0,1 mM Na3VO4, 20 % (v/v) glycerol, adjusted to pH 
7,6) and incubated for 30 minutes on ice. Nuclear lysate was centrifuged for 5 
minutes at 16000 rpm and 4°C, resulting supernatant served as nuclear extract for 
subsequent experiment. 
 
2.3.3 SDS polyacrylamide gel electrophoresis (Laemmli et al., 1970) 
SDS-PAGE (sodium dodecylsulfate polyacrylamide gel electrophoresis) is a gel 
electrophoresis to separate proteins based on their molecular size under denatured 
conditions in an electric field. Thus molecules are separated on the basis of distinct 
molecular weights of each protein in a protein conglomerate. SDS, an anionic 
detergent binds to proteins negative charge to each protein in proportion to its mass 
or polypeptide chain length, respectively. Proteins are linearized by SDS and β-
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mercaptoethanol. Electric tension causes migration of negative charged (anionic) 
proteins (due to SDS binding) in a size depending manner. The SDS-protein complex 
migrates to the anode and proteins are separated.  
The electrolyte for this electrophoresis is a discontinuous tri-chloric/tris-glycine buffer 
(25 mM Tris; 192 mM glycine; 0,1 % (w/v) SDS. The matrix for protein separation is a 
polyacrylamide gel consisting of acrylamide, bisacrylamide (37,5 : 1 acrylamide N,N`-
methylenebisacrylamide) (Laemmli, 1970; Wilson and Goulding, 1991), TEMED 
(N,N,N,N-tetramethylethylenendiamine) and APS (Ammoniumpersulfate(-
(NH4)2S2O8)). A small pore resolving gel (with an acrylamide percentage of 10% up 
to 15%; 3 M Tris/HCl, pH 8,8; 0,8 % (w/v) SDS) for sample separation is covered by 
a large pore stacking gel (usually with an acrylamide fraction of 5 %; 1 M Tris/HCl, pH 
6,8; 0,8 % (w/v) SDS) used for sample concentration and sample focusing providing 
a simultaneous start of protein separation. APS and TEMED catalyse linking of two 
acrylamide molecules and finally polymerization of the polyacrylamide gel by radical 
reaction. Various polyacrylamide concentrations resulting in different pore sizes 
cause retention of high molecular weight proteins in the resolving gel whereas 
proteins of low molecular migrate to the anode causing a distinct separation of 
proteins due to their molecular weight.  
100 µg of analyzed samples were admitted to SDS sample buffer (4x : 250 
mMTris/HCL, pH 6,8; 10 % (w/v) SDS; 50 % (v/v) glycerol; 0,01 % bromophenol blue; 
500 mM DTT), denatured for 5 min at 95°C destroying secondary and tertiary 
structures of proteins. Molecular weight standards were run on every SDS-PAGE gel 
allowing identification of proteins due to their molecular weights. Stacking gel was run 
at constant tension of 120 V, resolving gel at constant tension of 180V. 
 
2.3.4 Western Blot 
Western Blots are used to transfer the separated proteins of the SDS-PAGE gel 
matrix to a nitrocellulose or polyvinylidenediflouride (PVDF) membrane. An electric 
field horizontal to the polyacrylamide gel provides the transfer of protein samples. 
Based on hydrophobic interactions proteins are immobilized and fixed to the surface 
of the membrane, maintaining the separation pattern of the polyacrylamide gel. For 
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the electrophoretic transfer a semi-dry blot system was used in which the resolving 
gel and PVDF membrane are sandwiched between buffer soaked filter paper sheets. 
This stack is placed between two plate electrodes with anode plate on top and 
cathode plate on the bottom of the stack providing a horizontal electric field. For one 
SDS-PAGE gel the transfer was performed for 60 min at 200 mA. For target proteins 
of 100 kDa or larger proteins transfer time was adjusted up to 90 min.  
In a second step proteins are immuno-detected and visualized by incubating the 
membrane with specific antibodies. Therefore PVDF membrane was immersed in 
blocking solution for at least 60 minutes at RT to block unspecific binding sites, 
avoiding nonspecific antigen-antibody interactions. Blocking solution was prepared 
with tris buffered saline (TBS) and Western Blocking Reagent (Roche, Mannheim, 
Germany), saturating unspecific binding sites with irrelevant proteins (e.g. bovine 
serum albumin, BSA) avoiding unspecific interaction with or unspecific detection by 
the primary antibody, thus reducing background staining. Subsequently the 
membrane was incubated with an appropriate dilution of primary antibody over night 
at 4°C. Primary antibodies are raised against the protein of interest and diluted in 5 % 
Western Blocking Reagent. Next the membrane was washed at least 5 times for 15 
minutes at room temperature removing unbound and unspecific bound primary 
antibody. Washing buffer consisted of TBS containing 0,1 % TWEEN 20 (TBS-T). 
Following the washing procedure secondary antibodies in appropriate dilution were 
applied to the PVDF membrane for 60 minutes, followed by another washing 
procedure with TBS-T. Secondary antibodies are species and domain specific for the 
primary antibody recognizing primary antibodies of a defined species. The secondary 
antibodies are linked to horseradish peroxidase (HRP) catalyzing. a chemical 
conversion of luminol in its oxidized form is catalyzed by HRP.  
 
2.3.5 Enhanced Chemiluminescence Assay 
For detection of membrane bound proteins enhanced chemiluminescence (ECL) 
assay was applied to PVDF membranes. Basic principle of this assay is the reaction 
of secondary antibody conjugated of horseradish peroxidase (HRP) with the ECL 
substrate luminol. HRP catalyzes the oxidation of luminol causing light emission. 
Light is chemical enhanced and recorded on film. Membrane was transferred to the 
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two component detection solution (Amersham ECLTM Western Blotting Detction 
Reagent) and exposed to photosensitive film (AmershamTM Hyperfilm ECL), exposing 
times varied between 10 sec and 30 min.  
 
2.3.6 Membrane stripping  
PVDF membranes were stripped for detection of different protein of interest. 
Membranes were cleared of previously bound antibodies by incubation in stripping 
solution (62,5 mM Tris-HCl (pH 6,8),  2 % SDS and 100 mM  2-β-mercaptoethanol) 
for 20 minutes at 55°C. Membrane was washed using TBS and blocked for 1 h and 
re-incubated with designated primary antibody.  
 
2.3.7 Immunoprecipitation (IP) 
Immunoprecipitation was performed by incubating 1 mg protein or cell lysate 
overnight at 4°C on an overhead shaker using designated antibody with agarose 
beads (Protein A-Agarose immunoprecipitation reagent, Santa Cruz Biotechnology, 
Santa Cruz, USA). Samples were washed, resuspended in 4 x SDS sample buffer 
and analyzed by Western blotting.  
 
2.3.8 Enzym-linked-immunosorbend assy (ELISA) 
Sera for ELISA analysis were collected from mice by taking blood from the heart of 
the dazed/anaesthetized animal. Blood samples were centrifuged at 6000 rpm for 30 
min at 4°C separating sera from erythrocytes and other blood cells avoiding 
hemolytic sera samples for ELISA analysis. Insulin, leptin and triiodothyronine (T3) 
ELISAs were performed following manufacturer´s protocol. Read out was carried out 
in a microplate reader (Mithras LB 940 multimode microplate reader, Berthold 
Technologies GmbH & Co. KG, Germany).  
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2.3.9 OxyBlot assay 
Carbonyl groups that are introduced into the amino acid side chain (lysine, arginine, 
proline or threonine residues) after oxidative modification of proteins can be identified 
by OxyBlot analysis. Measurement of protein carbonyls represents an indirect 
analytic toll of reactive oxygen species. In the OxyBlot assay carbonyl groups on 
protein side chains were detected derivatizing with 2,4-dinitrophenylhydratone (DNP-
hydrazone) by reaction with 2,4-dinitrophenylhydrazine (DNPH). DNHP-derivatized 
proteins can then be separated, analyzed by Western Blotting and visualized by an 
anti-DNP antibody and a horseradish peroxidase conjugated secondary antibody 
(Shacter et al., 2000; Levine et al., 1994).  
 
Mouse handling 
 
2.3.10  Mouse breeding 
IRS-1 knock-out mice were generated as described in introduction (Tamemoto et al., 
1994). IRS-1 knock-out mice and wildtype littermate controls were obtained from IRS-
1+/- breeding pairs. Mice were housed in groups of 4 to 5 in a 12-h light/dark cycle 
(7:00 am on / 7:00 pm off) at 20 to 23°C. Animals were fed standard rodent diet 
(Altromin Spezialfutter GmbH & Co. KG, Lage, Germany). Handling and breeding of 
mice was performed in accordance to the German Laws for Animal Protections and 
were approved by the local animal care committee and the Bezirksregierung Köln.  
 
2.3.11  Mouse genotyping 
3 weeks after birth mice were weaned and mouse tail biopsies were taken. Biopsies 
were incubated in tail lysis buffer (100 mM Tris-HCl (pH 8,5), 5 mM EDTA, 0,2 % 
(w/v) SDS, 200 mM NaCl, 500 mg/ml proteinase K) in a thermomixer at 55°C and 
800 rpm over night. On the following day DNA was precipitated with isopropanol and 
centrifuged at 13000 rpm and RT for 10 minutes. Supernatants were removed; pellet 
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was resuspended in 100 µl 70 % ethanol and centrifuged at 13000 rpm and for 5 
minutes. Pellet was resolved in 50 µl double destilled water (ddH2O).  
DNA was applied to polymerase chain reaction (PCR) for genotyping of mice. 
Primers used for PCR are listed in table 2. PCR reaction were performed in a total 
reaction volume of 50 µl containing 100 ng template DNA, 25 µM dNTP Mix, 10 x 
goTaq reaction buffer, 25 pmol of each primer and 1 unit of goTaq DNA polymerase. 
PCR protocol: 
 
 
 
Step 1: 1 x   94°C  5 min 
Step 2:   94°C  1 min 
  35 x  55°C  0,5 min 
    72°C  1 min 
Step 3: 1 x  72°C  10 min 
Step 4:     4°C    ∞ 
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Table 2.1: List of oligonucleotides used for PCR reaction 
Primer Sequence 5´- 3´ Orientation
IRS-1   5´ GCA GCC CCA CCT GCC TCG AAA GGT AGA CAC sense 
IRS-1   3´ CTG CCC AAC TCA ACT CCA CC antisense 
IRS-1   neo TTC TAT CGC CTT CTT GAC GAG TTC neosense 
 
 
2.3.12  Body composition 
Body composition of mice was determined by using nuclear magnetic resonance 
(NMR) (NMR analyzer minispec mq7.5). Radiofrequency pulse sequences are 
transmitted into animals. In response, RF signals are generated by the hydrogen in 
tissues and detected by minispec. Amplitude and duration of signals are related to 
properties of tissues.  
 
2.3.13  Indirect calorimetry and physical activity measurement 
Open circuit calorimetry system (CaloSys calorimetry module, TSE System GmbH, 
Bad Homburg, Germany) was used for metabolic rate determination (energy 
expenditure, respiratory quotient, Food and water intake, CO2 production, O2 
consumption). Food and water were provided ad libitium. Activity of mice was 
analyzed with an video tracking system (VideoMot2, TSE Systems GmbH, Bad 
Homburg, Germany).  
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2.3.14  Glucose and insulin tolerance test 
Animals were starved overnight (16 h) and intraperitoneally injected with 0,75 U/kg 
bodyweight of human insulin (Novo Nordisk, Copenhagen, Denmark) for insulin 
tolerance test or with 2 g/kg bodyweight of glucose (DeltaSelect, Munich, Germany) 
for glucose tolerance test respectively. Blood was collected from tail tips of mice and 
blood glucose values were measured immediately before and 15, 30, 60 minutes 
after injection for insulin tolerance test or 15, 30, 60, 120 minutes after injection for 
glucose tolerance test, respectively. Blood glucose levels were determined using 
GlucoMen glucose meter (A. Menarini diagnostics, Berlin-Chemie, Neuss, Germany). 
Results were expressed as percentage of initial blood glucose concentration. 
 
2.3.15  MEF generation and MEF cell culture 
Primary mouse embryonic fibroblast were isolated from E13,5 embryos. Embryos 
were dissected from the uterus of female mice of IRS-1+/- breeding pairs. MEFs were 
isolated following protocol as previously described (Brüning et al., 1996). Primary 
MEFs were immortalized by SV 40 transformation (Todaro and Green, 1965) at early 
passages.  
MEFs were cultured using Dulbecco´s Modified Eagle Medium (DMEM) (Invitrogen, 
Carlsbad, CA, USA) with 4,5 g/L D-glucose, 10 % fetal bovine serum (FBS) 
(Invitrogen), 1 % penicillin/streptomycin (Invitrogen), 100 µM non essential amino 
acids (Invitrogen), 2 mM L-glutamine (Invitrogen) and 1 mM sodium pyruvate 
(Invitrogen). Cells were grown at 37°C in an humid atmosphere with 5 % CO2 
content.  
 
2.3.16  Insulin stimulation of mice 
Mice were fasted overnight and treated with insulin 0,75 U/kg body mass by 
interperitoneal injection (Sabio et al., 2008). Liver, WAT and muscle were removed 
10 minutes after insulin injection. Tissues were homogenized in 1 ml 
proteinextraction buffer and further preceded for Western blot determination.  
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2.3.17  Isolation of adipocytes 
Animals were sacrificed and epididymal fat pads were removed under sterile 
conditions. Adipocytes were isolated by collagenase (1 mg/ml) digestion for 45 min at 
37°C in DMEM/Ham's F-12 1:1 (DMEM/F12) containing 1% BSA. Digested tissues 
were filtered through sterile 150-µm nylon mesh and centrifuged at 250×g for 5 min. 
The floating fraction consisting of pure isolated adipocytes was then removed and 
washed three more times. Adipocytes sizes were measured using a culter counter 
(collaboration with Professor M Blüher, Leipzig). 
 
Cell biology 
 
2.3.18  Insulin stimulation of MEF 
MEFs were starved overnight and stimulated with insulin final concentrations 1, 10 
and 100 mM, respectively. Following 4 minutes incubation at 37°C MEFs were 
harvested, resuspended in cell lysis buffer (10 mM HCl (pH 7,4), 50 mM NaF, 50 mM 
NaCl, 10 mM EDTA, 1% Triton X-100, 0,1 µg/ml aprotinin, 1 mM PMSF, 2 mM 
Na3VO4) and applied to biochemical analysis.  
 
2.3.19  ATP Bioluminescence Assay 
ATP Bioluminescence Assay Kit HS II (Roche, Mannheim, Germany) was used for 
quantitative determination of ATP. Assay is based on the ATP dependency of light 
emitting luciferase catalyzed oxidation of luciferin (De Luca and McElroy, 1978). The 
luciferase catalyzes the adenosine triphosphate dependent oxidative decarboxylation 
of luciferin by simultaneous emission of light (wavelength 562 nm). Light output is 
directly proportional to ATP concentrations.  
ATP + D-luciferin + O2 → oxyluciferin + PPi + AMP + CO2 + light  
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1 x 106 cells were harvested and pelleted. Pellets were resuspended in equal 
amounts of dilution and cell lysis buffer provided in the kit. Light emission was 
detected by luminometer (Mithras LB 940 multimode microplate reader, Berthold 
Technologies GmbH & Co. KG, Germany). ATP concentrations were calculated from 
ATP standard, standard was diluted with dilution buffer by serial dilutions. ATP 
content was measured in triplicate according to manufacturer’s guidelines.  
 
2.3.20  Isolation of mitochondria from primary mouse embryonic 
fibroblasts 
Mitochondria of primary mouse embryonic fibroblasts (MEFs) were isolated by 
differential centrifugation of harvested cell homogenates. Fibroblasts were harvested, 
washed in ice-cold PBS and subsequently resuspended in 5 ml isotonic 
homogenization buffer (250 mM sucrose, 5 mM Tris-HCl pH 7,5; 0,1 mm PMSF). 
Resulting cell suspension was homogenized; nuclei and unbroken cells were 
removed by centrifugation (10 min, 1200 g, 4°C). Received supernatant was applied 
to additional centrifugation (20 min, 16000 g, 4°C) for collecting mitochondria. Pellet 
was washed and resuspended in a suitable volume of suspension buffer (250 mM 
sucrose, 5 mM Tris-HCl, pH 7,5, 1 mM EDTA, 0,1 mM PMSF). Protein concentration 
determination was performed by using Bradford assay according to manufactor´s 
guideline (Bio-Rad). 
 
Biochemistry  
 
2.3.21  Polarography  
Polarographic analysis is based on the determination of oxygen consumption of cells 
or isolated mitochondria, respectively. The polarographic device (Polarograph, 
Hansatech Instruments limited, King´s Lynn, UK) is based on the principle of a Clark 
electrode consisting of a platinum cathode and an argentic/argentic-chloride anode 
submerged by a potassium chloride rich electrolyte solution. For determination of 
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oxygen consumption reaction tank was sealed, excluding atmospheric oxygen, 
heated to 37°C and stirred at 850 U/min. Clark electrode was connected to reaction 
chamber by an oxygen permeable PTFE membrane. A total reaction volume of 250 
µl of isolated mitochondria and buffer E (10 mM KH2PO4; 300 mM mannitol, 10 mM 
KCl, 5 mM MgCl2, 1 mg/ml BSA) were applied to chamber.  
Applying a polarizing electric tension to this device leads to induction of two 
electrochemical processes at the anode and cathode within the ionized analytic 
chamber.  
Chemical reaction argentic anode:   
Ag + Cl- → AgCl + e- 
Chemical reaction platinum cathode:  
O2 + 2 H2O + 4 e- → H2O2 + OH- + 2 e- → 3OH- 
Oxygen is converted at the platinum cathode in a first step reaction to hydrogen 
peroxide (H2O2) and finally in a second step reaction to three hydroxide (OH-) ions. 
The chemical reaction at the argentic anode is an oxidation of argent to argentic 
chloride. These two chemical reactions lead to a constant electric flow proportional to 
the current oxygen concentration within the electrolyte solution. 
Blank value was determined by application of sodium dithionite, reducing total 
amount of oxygen within the chamber. Oxygen content of mitochondria buffer used 
for this set up was approximately 216 nmol O2/ml. Received data were recorded on a 
Linseis plotter and calculated to oxygen consumption (nmol/mg protein*min).  
Oxygen consumption determination was carried out with isolated liver mitochondria. 
For analysis mitochondria were isolated using the protocol described in (Fernandez-
Vizarra et al., 2002). Mitochondrial content of suspensions was determined by 
Bradford analysis. All analyses were carried out following protocols described by 
(Rustin et al., 1994). Integrative determination of respiratory function including 
function of pyruvate dehydrogenase complex and of TCA cycle can be identified and 
calculated by addition of various substrates. Coupling and interplay of respiratory 
chain complexes, TCA cycle and pyruvate dehydrogenase are determined by 
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polarography however no detailed analysis of malfunctions in single enzymes of 
these metabolic cycles is achieved by this method.  
Pyruvate oxidation was determined via MPox protocol, analyzing activity of 
respiratory chain complex I, pyruvate dehydrogenase and TCA cycle. Addition of 
ADP to mitochondria suspension lead to an increase in oxygen consumption 
switching mitochondrial respiration from state 4 (basal state) to state 3 (forced 
respiration).  
Pyruvate kinase functionality was addressed by determination of malate-glutamate 
oxidation (MGox). Malate and glutamate were applied to mitochondrial suspension. 
Malate is metabolized by the TCA cycle to oxaloacetate. Oxaloacetate is removed by 
glutamate thus avoiding endproduct accumulation and attenuation of TCA enzymatic 
reactions. 
Evaluation of succinate oxidation (Sox) after inhibition of complex I by rotenone 
showed information about activity capacity of complex II. In this scenario electrons for 
the mitochondrial respiratory chain are provided by succinate and its enzymatic 
reaction with complex II. Following inhibition of complex V by oligomycin and 
subsequent uncoupling by CCCP enzymatic activity of complex II could be 
determined.  
Addition of complex II inhibitor malonate in this context allowed enzyme activity 
determination of complex III and complex IV. Electrons are supplied by glycerol-3-
phosphate (G3P) via G3P dehydrogenase (GPox) or directly by quinone (Qox). 
Measured oxygen consumption is directly linked to complex III and complex IV 
enzymatic activity.  
 
2.3.22  Spectrophotometry 
In difference to polarographic analysis spectrophotometric evaluation of respiratory 
chain and TCA cycle enzyme performance can activate single respiratory chain 
complexes independent of each other by defined assays. Absorption spectra consist 
of interfering wave absorptions generated by energy transitions of molecules. 
Absorption spectra of molecules in reductive or oxidize states differ and chemical 
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changes of molecular energy states can be calculated. Thus enzymatic turnover of 
substrates of single respiratory chain complex can be determined by this method. 
Musculus soleus and musculus gastrocnemius were freshly isolated from mice, 
transferred into extraction buffer (20 mM Tris, 250 mM Saccharose, 2 mM EGTA, 40 
mM KCl, 1 mg/ml BSA, pH 7,2 )and homogenized on ice with finger grinder. 
Homogenized muscle sample were stored at -80°C overnight and analyzed by 
photospectroscopy the following day. Same procedure was applied to liver samples. 
MEFs were harvested 1 x 107 cells were resuspended in 1 x PBS. Mitochondria were 
isolated following protocol described in 2.3.3. Assays were carried out under Vmax 
conditions. Activities of complex I, II, I+III, II+III, IV and V were analyzed sequentially 
by using different electron donors or acceptors, respectively. Additionally activities of 
TCA cycle enzymes and cytoplasmatic enzymes were determined. 
Respiratory chain enzyme activities of muscle, liver, MEFs and MEF isolated 
mitochondria were measured using a temperature controlled double-wavelength 
spectrophotometer (Varian Cary 50 Scan photo spectrometer; Varian Inc., 
Spectroscopy instruments, Mulgrave, Australia). Enzyme activity evaluations were 
carried out following protocols as described in Rustin et al., 1994. Detected activities 
were calculated to protein concentration of samples determined by Bradford analysis. 
 
2.3.23  Mitochondrial respiration (skinned fiber technique)  
Permeabilized muscle fibers were obtained from muscle biopsy and mitochondrial 
chain function was analyzed in situ following protocols previously described 
(Kuznetsov et al., 2008). M. soleus was dissected into individual muscle fibers and 
plasma membrane was permeabilized in saponine skinned muscle medium (49 mM 
MES, 3 mM KH2PO4, 20 mM taurine, 0,5 mM DTT, 20 mM imidazole, 10 mM MgCl2, 
5 mM ATP, 15 mM phosphocreatine, 10 mM Ca-EGTA (2,77 mM CaK2EGTA, 7,23 
mM K2EGTA), 0,1 µM calcium, pH 7,1), rotated and incubated for 30 min at 4°C.  
Respiratory rates were measured at 30°C by polarographic oxygen sensors in a 2-
chamber oxygraph (OROBOROS Instruments, Innsbruck, Austria). Oxygen 
consumption was recorded using DataLab 4.2® software (OROBOROS Instruments, 
Innsbruck, Austria). Addition of specific substrates of the respiratory chain complexes 
allow determination of basal respiration of complexes I-IV (state 2), maximal oxidative 
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capacity was measured after addition of saturating concentration of ADP (state 3, 
active respiration). Glutamate and malate were used to address complex I dependent 
respiration. With these substrates maximal physiological capacity is obtained, 
reconstituting the operation of tricarboxylic acid cycle, preventing depletion of key 
metabolites (Brands et al., 2011). Results were expressed as nmol oxygen/min*mg 
fibers (dry weight of fibers was determined after high resolution respirometry). 
 
2.3.24  Proton leak measurement (proton motive force (PMF)) 
Mitochondrial respiration was measured in the presence of oligomycin to inhibit ATP 
synthesis (state 4 respiration). The mitochondrial respiration rate in this setting is 
proportional to the rate at which protons leak across the inner mitochondrial 
membrane. Kinetic response of proton conductance to its driving force (proton motive 
force) was determined as relationship between respiration rate and membrane 
potential. Membrane potential can be varied by titration with specific electron 
transport chain inhibitors, in this case membrane potential was varied by adding 
malonate (Jastroch et al., 2009; Nicholls et al., 1974; Brand et al., 1990). 
Mitochondria from liver (0,5 mg/ml) were incubated in standard assay medium  (120 
mM KCl, 5 mM KH2PO4, 3 mM HEPES and 1 mM EGTA, pH 7,2) at 37°C with 5 µM 
rotenone, 80 ng nigericin/ml and 1 µg oligomycin/ml. Respiration rate and membrane 
potential were measured simultaneously using electrodes (AD Instruments, 
Spechbach, Germany) sensitive to oxygen and to the potential-dependent probe 
triphenylmethylphosphonium (TPMP+). 4-hydroxy-2-nonenal (4-HNE), major product 
of oxidant-induced peroxidation of membrane phospholipids, was used to specifically 
uncouple mitochondria (Jastroch et al., 2009; Echtay et al., 2002 a,b, Echtay  et al., 
2003; Cadenas et al. 2002).  
 
2.3.25  Carnitine palmitoyl transferase (CPT-) assay  
CPT-I assay was carried out following protocols previously described (Bremer et al., 
1985, Kerner et al., 2008; de Vries et al., 1997). CPT-I activity was determined by 
measuring formation of L-[3H]-labeled palmitoylcarnitine from L-[3H]-carnitine and 
palmitoyl-CoA. Reaction was started by adding 2,5 mM L-[3H]-carnitine. Samples 
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were incubated for 6 minutes at 37°C. After stopping the reaction formed L-[3H]-
labeled palmitoylcarnitine was extracted and organic layer was used for scintillation 
counting. CPT-I activity was determined by subtracting CPT-II activity (malonyl-CoA 
sensitive part of reaction) from total CPT activity.  
 
RNA analysis 
 
2.3.26  RNA Extraction (Chomczynski and Sacchi, 1987) 
RNA from tissues was extracted according to the TRIzol (Invitrogen GmbH, 
Darmstadt, Germany) protocol established by Chomczynski and Sacchi (1987).  
 
2.3.27  cDNA synthesis  
RNA was translated to cDNA by reverse transcription polymerase chain reaction. 
Reverse transcription was carried out using SuperScriptTM Kit (Invitrogen GmbH, 
Darmstadt, Germany). Protocol for first-strand cDNA synthesis was applied according 
to manufacturer´s guideline.   
 
2.3.28  Real time quantitative PCR (RT-PCR) 
RT-PCR is based on the principle of conventional PCR. In contrast to conventional 
PCR amount of amplified sample cDNA is directly quantified by determination of 
fluorescence during PCR cycles. Fluorescence intensity increases in proportion with 
amplified DNA amounts. TaqMan-Assay probes (Applied Biosystems) were used for 
cDNA quantification in this work. Eukaryotic 18S rRNA served as reference. TaqMan 
probes consist of two components a quencher and fluorescent dye (FAM, 6-FAM-
phosphoramidite). 5´-3´ exonucleolitic activity of the Taq-polymerase detaches the 
reporter dye during DNA elongation and distant fluorescent dye and quencher hence 
suppression of fluorescence by quenching is abrogated and fluorescence intensity 
can be determined at 518 nm. Relative gene expression levels were calculated by 
  50
                                                                                                     Material and Methods 
comparative 2-ΔΔCT. List of gene expression assays used in RT-PCR reactions are 
listed in table 1 
 
Table 2.2: List of gene expression assays used for RT-PCR 
 
Gene 
 
Assay ID-Nr. 
 
Company 
 
UCP-1 
 
Mm00494069_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
UCP-2 
 
Mm00627597_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
UCP-3 
 
Mm00494077_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
PGC-1α 
 
Mm01208835_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
NPY 
 
Mm00445771_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
AgRP 
 
Mm00475829_g1 
Applied Biosystems, 
Carlsbad, California, USA 
 
POMC 
 
Mm01242886_g1 
Applied Biosystems, 
Carlsbad, California, USA 
 
CART 
 
Mm00489086_m1 
Applied Biosystems, 
Carlsbad, California, USA 
  51
                                                                                                     Material and Methods 
  52
 
IRS-4 
 
Mm01340253_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
Insulin receptor 
 
Mm01211875_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
Ob-R 
 
Mm00440181_m1 
Applied Biosystems, 
Carlsbad, California, USA 
 
IRS-2 
 
Mm03038438 
Applied Biosystems, 
Carlsbad, California, USA 
 
Eucaryotic 18S rRNA 
endogenous control 
 
4333760T 
Applied Biosystems, 
Carlsbad, California, USA 
 
 
2.8 Statistical analysis 
Western Blot images were scanned and analyzed densitometrically using AIDA 
(AIDA 2 D Densitometry Software, Version 4.00.027, Raytest, Straubenhardt, 
Germany). Background was subtracted and protein load was normalized to 
corresponding β-actin control. Statistical analysis was performed using Student´s t-
test. Statistical significance was defined as *p<0,05.  
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3. Results 
 
 
3.1 Expression of IRS-1 protein in different tissues  
 
Insulin receptor substrate 1 knockout mice display growth retardation resulting in 
dwarfism, mild insulin resistance, elevated food intake associated with higher energy 
expenditure and a lack of accumulation of abdominal fat with age. In order to 
evaluate the underlying mechanism responsible for thess phenotype conventional 
IRS-1 mouse and black six (BL6) wild-type animals as controls were used in this 
study. Knockout was obtained by insertion of a stop codon in exon 1 of the IRS-1 
gene. IRS-1 knockout animals were generated by crossing heterozygous IRS-1 mice. 
Offspring animals were weaned 21 days after birth and tailcuts were used for 
genotyping PCR. To verify functional IRS-1 deletion in knockout animals IRS-1 
expression in different organs of knockout and wild-type animals was analyzed by 
western blotting.  
 
Lung
Brain
Kidney
RasGAP
Liver
Muscle
WAT
RasGAP
WT IRS-1-/-IRS-1-/- WT  
Fig. 3.1  Western blot analysis of IRS-1 protein expression in different tissues 
Western blot analysis of IRS-1 expression in lysates of liver muscle, white adipose tissue, lung, brain 
and kidney. 100 µg of proteinlysate were applied on 8 % SDS-PAGE gel. RasGAP expression was 
used as loading control. Liver was analyzed by anti-IRS-1 immunoprecipitation of 9 mg organ lysate 
subjected to western blotting with polyclonal anti IRS-1 antibody.  
 
Analysis of major sites of insulin action (liver, muscle, WAT) and non insulin 
responsive tissues (lung, brain, kidney) displayed complete IRS-1 deletion only in 
IRS-1 knockout animals although detection of liver IRS-1 in wild-type controls was 
only achieved with high amounts of lysate administered to immunoprecipitation and 
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western blot analysis due to low expression levels of IRS-1 in liver (Araki et al., 
1994). Eight independent derived organ lysate samples for liver, muscle and WAT or 
six independent derived organ lysate samples for lung, brain and kidney, respectively 
were used for western blotting. In order to investigate influence of IRS-1 deletion on 
energy homeostasis, liver, muscle and WAT tissues were used for further 
experiments.  
 
3.2 Expression of IRS-1 protein and basal expression of molecules of the 
insulin receptor cascade in MEFs 
 
In order to address if systemic effects or signaling effects are the underlying 
mechanisms for the observed phenotype embryonic fibroblast were isolated from 
embryos of females of IRS-1+/- breeding pairs at day 13,5 post conception, 
transferred to cell culture and immortalized serving as an in vitro system in this 
project. To validate IRS-1 deletion in mouse embryonic fibroblasts (MEFs) derived 
from IRS-1 knockout embryos, cell lysates were administered to Western blotting for 
analyzing IRS-1 expression as well for analyzing basal expression of IRS-2, IR-β and 
IGF-1R.  
 
IGF-1R
Actin
Actin
IR-β
WT IRS-1-/-
IP: IRS-1
IB: IRS-1
Actin
IRS-2
WT IRS-1-/-
 
Fig. 3.2  Western blot analysis of IRS-1, IRS-2, IGF-1R and IR-β in MEFs 
Western blot showing expression of IRS-1, IRS-2, IGF-1R and IR-β expression in cell lysate of IRS-1 
knockout and wild-type derived MEFs as well as the respective corresponding loading control. 100 µg 
were applied to 8 % SDS-Page. For IRS-1 detection 1 mg cell lysate was used for 
immunoprecipitation with IRS-1 antibody and subjected to western blot detected by IRS-1 polyclonal 
antibody.  
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Western blot analysis revealed a total albescence of IRS-1 expression in transgenic 
IRS-1 MEFs whereas IRS-1 expression in wild-type control MEFs has been detected 
by IRS-1 immunoprecipitation of 1 mg cell lysate followed by IRS-1 Western blot 
detection. Abundance of IRS-2 and IGF-1R is unchanged in IRS-1 deficient MEFs 
compared with wild-type controls. However reduction of IR-β expression has been 
observed in IRS-1 knockout MEFs when compared with IR-β expression in wild-type 
MEFs. For Western blot experiments actin was used as loading control. Analysis was 
determined three times utilizing discrete PDVF membranes and samples were 
derived from independent cell lysates.          
 
3.3 Basal expression of IRS-2 and of the insulin receptor signaling cascade 
key molecules in muscle and liver of IRS-1-/- mice and wild-type controls 
 
Liver and muscle of IRS-1 knockout mice and wild-type were analyzed for basal IRS-
2, IR-β and IGF-1 expression. Amount of proteins were determined by Western 
blotting. Deviations in the amount of protein samples loaded to gels were checked by 
β-actin staining of each membrane.  
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Fig. 3.3  Western blot analysis of basal IRS-2, IGF-1R and IR-β expression in liver and muscle of 
IRS-1 knockout and wild-type control animals 
Basal expression states of IRS-2, IGF-1R, IR-β and actin (loading control) in organ lysates of liver and 
muscle of wild-type and IRS-1-/- mice. 100 µg of protein were applied to each 8 % SDS-PAGE gel.  
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Basal expression of IRS-2 protein was unchanged in both liver and muscle of IRS-1 
knockout mice as well as wild-type littermates. Same expression pattern of IGF-1R 
has been detected in muscle and liver samples of wild-type and IRS-1-/- mice. No 
variations of IR-β expression in liver could be detected among knockout and wild-
type animals, whereas evaluation of IR-β expression levels in muscle samples of 
both groups showed decreased IR-β expression in the knockout animals, resembling 
IR-β expression pattern seen in MEFs.  
 
3.4 Insulin signaling in MEFs after acute insulin stimulation 
 
For analyzing insulin signal transduction MEFs both genotype were starved over 
night (16 h) and stimulated with insulin in different concentrations. Unstimulated 
MEFs represent basal expression of key signaling molecules of the insulin signaling 
cascade after over night starvation. MEFs of each genotype were titrated with insulin 
endconcentrations of 1 nM, 10 nM and 100 nM. MEFs were stimulated with insulin for 
4 minutes under standard cell cultivation conditions (37°C and 5 % CO2). Insulin 
stimulation was stopped by removing insulin supplemented media, washing cells with 
ice cold PBS, followed by direct cell lysis.  
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Fig. 3.4  Phosphorylation status of insulin signaling key proteins following insulin stimulation  
Expression of phospho-AKT (Ser473), phospho-ERK-1/-2 (Thr202/Tyr204) and phospho-GSK-3β (Ser9) 
following insulin stimulation. MEFs were incubated in basal medium eagle with various insulin 
concentrations and without insulin supplementation representing basal protein expression after 
overnight starvation. Western blot analysis of unphosphorylated AKT, ERK-1/-2 and GSK-3α/β 
(Ser21/Ser9) expression serves as loading controls. 100 µg of protein samples were applied on 10 % 
SDS-PAGE gel. 
 
Western blot analysis of protein phosphorylation patterns proved despite leakage of 
IRS-1 in MEFs derived from knockout animals no signaling deficiencies following 
insulin stimulation compared with wild-type MEFs. Phosphorylation intensities of the 
key kinases AKT, ERK and GSK-3β following insulin donation were indistinguishable 
in knockout and wild-type derived MEFs, suggesting no reduction of downstream 
effects in IRS-/- MEFs. Phosphorylation of AKT, ERK and GSK-3β rose with raised 
insulin concentrations. Only slight differences in phosphorylation degree of AKT, ERK 
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and GSK-3α/β could be observed between 10 nM and 100 nM insulin treatment 
indicating that stimulation with 10 nM of insulin is sufficient for full activation of the 
insulin signaling cascade.  
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Fig. 3.5  PTEN expression pattern following insulin stimulation 
PTEN expression in wild-type and knockout derived MEF upon insulin stimulation. Actin serves as 
loading control. 100 µg of protein samples were applied on 10 % SDS-PAGE gel for analysis. 
Immunoprecipitation of p85α (regulatory subunit of PI3K) and PTEN. 1000 µg of protein sample were 
subjected to immunoprecipitation with anti p85α and detected with polyclonal anti-PTEN antibody. 
  
PTEN is a constitutively active phosphatidylinositol phosphate phosphatase 
catalyzing dephosphorylation of PI(3,4,5)P3 to PI(3,4)P2, resulting in disruption of the 
PI3K-AKT/PKB pathway revealing opposing effects of PTEN and PI3K on cell 
proliferation and survival. PTEN interacts dynamically with the plasma membrane 
and function as tumor suppressor since elevated PIP3 levels confer advantage to 
cancer cells (Gericke et al., 2006; Vazquez et al., 2006). Western blot analysis of 
PTEN showed decreased protein expression in wild-type animals compared to 
knockout mice. Interestingly wild-type PTEN expression increased with insulin 
stimulation whereas expression in IRS-1 knockouts remained rather unchanged. 
Parallel to PTEN expression increase in wild-types a decrease of a ~165 kDa protein 
complex was observed.  
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p85/PTEN immunoprecipitation showed decreased PTEN signal in knockout 
compared to wild-type mice under basal conditions and upon stimulation with 1 mM 
insulin. PTEN signal decrease was not observed upon insulin stimulation with higher 
doses. 
 
3.5 Insulin signaling in liver and muscle of IRS-1-/- and wild-type mice after 
intraperitoneal insulin application 
 
In order to evaluate the effect of the IRS-1 knockout on insulin signaling in an in vivo 
system mice were starved overnight (16 h) and intraperitoneal injected with 0,75 U/kg 
body weight of human insulin (Novo Nordisk, Copenhagen, Denmark) and 0,9 % 
NaCl (Berlin-Chemie-AG, Berlin, Germany).  Western Blot analysis was used to 
assess phosphorylation status of AKT after insulin or NaCl treatment, respectively. 
Unphosphorylated AKT was used as loading control. 
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Fig. 3.6  Phosphorylation status of AKT, ERK and GSK-3β following intraperitoneal insulin 
injection  
Phospho-ERK-1/-2 (Thr202/Tyr204), phospho-GSK-3β (Ser9) and phospho-AKT (Ser473) expression in 
knockout and wild-type mice following insulin treatment. Basal phospho-ERK-1/-2 (Thr202/Tyr204), 
phospho-GSK-3β (Ser9) and phospho-AKT (Ser473) expression after overnight starvation is 
represented by NaCl injected wild-type and knockout animals. Western blot analysis of 
unphosphorylated ERK-1/-2, GSK-3β and AKT expression served as loading control. 10 minutes after 
insulin injection skeletal muscles and livers were removed, homogenized and applied to Western blot 
analysis. 100 µg of protein samples were applied on 10 % SDS-PAGE gel. Examples of three 
independent experiments.  
 
No causal decline in ERK-1/-2, GSK-3β and AKT phosphorylation after 
intarperitoneal insulin injection has been observed in liver, muscle and WAT of 
knockout in comparison to the ERK-1/-2, GSK-3β and AKT phosphorylation in wild-
type mice. Basal phosphorylation pattern of ERK-1/-2 in WAT, GSK-3β in liver and 
AKT in liver and muscle determined by Western blot analysis of NaCl injected 
animals seemed to be increased in IRS-1 deficient mice compared with wild-type 
controls. ERK-1/-2 phosphorylation in WAT, GSK-3β phosphorylation in liver and 
AKT phosphorylation in liver and muscle upon insulin stimulation were increased to 
the same degree in knockout mice compared with wild-type animals. 
The group of Kadowaki could show that degree of compensation for IRS-1 deficiency 
appears to be correlated with the amount of tyrosine-phosphorylated IRS-2 (in IRS-1-
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deficient mice) relative to that of IRS-1 (in wild-type mice) (Yamauchi et al., 1996). 
Therefore IRS-1 deficient and wild-type control mice were starved other night (16 h) 
and insulin stimulated with 0,75 U/kg body weight. Insulin responsive tissues were 
removed 10 minutes after injection and homogenized. 3 mg liver lysates of 
intraperitoneal injected NaCl and insulin wild-type and knockout mice were used for 
an immunoprecipitation with polyclonal anti-phosphotyrosine antibody, followed by 
IRS-2 detection by Western blotting.  
  
         
IP: α-PY
IB: IRS-2
Ins NaClNaCl Ins
WT IRS-1-/-
 
Fig. 3.7  Anti-phophotyrosine immunoprecipitation and IRS-2 detection in livers of 
intraperitoneal NaCl and insulin injected IRS-1 deficient and control mice 
Immunoprecipitation of phosphotyrosine proteins after insulin stimulation and IRS-2 detection by 
Western blot in livers from wild-type (WT) and IRS-1-deficient (IRS-1-/-) mice. Livers were removed 10 
min after intraperitoneal insulin injection, homogenized and supernatants were subjected to 
immunoprecipitation with anti phosphotyrosine (α-PY) and then detected with polyclonal anti-IRS-2 
antibody (IRS-2). 
 
Immunoprecipitation with anti-pohosphotyrosine antibody indicated a higher IRS-2 
phosphorylation degree upon intraperitoneal insulin injection in liver of IRS-1 deficient 
mice compared with wild-type controls. No difference was detected in basal IRS-2 
expression after NaCl application. No differences of IRS-2 phosphorylation patterns 
were detected in muscles.  
 
3.6 Phenotypic and metabolic characterization 
 
IRS-1-/- deficient mice show embryonic and postnatal growth retardation compared 
with wild-type littermates previously described by different groups. Glucose tolerance 
and insulin tolerance tests revealed mild insulin resistance with normal glucose 
tolerance (Araki et al., 1994; Tamemoto et al., 1994). Despite mild insulin resistance 
IRS-1 deficient females showed increased life span (Selman et al., 2008). For further 
characterization of the IRS-1-/- phenotype; 12 to 24 month old mice were analyzed 
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regarding energy expenditure, food intake, body composition, activity and glucose 
metabolism.  
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Fig. 3.8  Insulin tolerance test (ITT) of male and female wild-type and IRS-1-/- mice 
Average decrease of blood glucose levels in [% of initial] of 12 weeks old wild-type (black line) and 
knockout (red line) mice. Upper panel ITT of female wild-type (n = 12) and knockout animals (n = 12). 
Lower panel ITT of male wild-type controls (n = 10) and knockout mice (n = 10). Values are means ± 
SEM, * unpaired Student´s t-test p-value ≤ 0,05. 
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Insulin sensitivity was determined by insulin tolerance test, applying 0,75 U/g body 
weight of human insulin by intraperitoneal injection, blood glucose levels [mg/dl] were 
determined at indicated time points. Insulin administration decreased blood glucose 
levels. However glucose decrease was reduced in IRS-1 deficient female and male 
mice compared to wild-type controls indicating insulin resistance. Blood glucose 
levels in female IRS-1-/- mice dropped to 69 % of starting glucose levels after 60 
minutes whereas glucose levels in wild-type mice dropped to 53 %, however this 
difference failed to be significant. For all time points decrease in glucose levels of 
IRS-1 deficient mice was reduced in comparison with the wild-types. ITT in the male 
group revealed a drop to 67 % of starting glucose levels in the knockout group and to 
48 % in the wild-type control group. Like in the female group drop of insulin levels in 
the knockout group was less at every time point compared with the wild-types, 
reaching significance at 60 minutes. 
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Fig. 3.9  Glucose tolerance test (GTT) of male and female wild-type and IRS-1-/- mice  
Average increase of blood glucose levels in 13 weeks old wild-type (black line) and knockout (red line) 
mice upon glucose administration. Upper panel GTT of female wild-type (n = 12) and knockout 
animals (n = 12). Lower panel GTT of male wild-type controls (n = 10) and knockout mice (n = 10). 
Values are means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05. 
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Glucose homeostasis in animals was evaluated by performing glucose tolerance test, 
by administration of 2 g glucose/ kg body. Intraperitoneal glucose administration 
increased blood glucose levels. Glucose levels [mg/dl] or glucose clearance 
respectively was controlled at indicated time points. In tested males no significant 
changes were detected, both groups displayed increase in blood glucose levels and 
glucose clearance following glucose administration. However IRS-1 deficient animals 
showed elevated blood glucose levels at 15, 30 and 60 minutes compared to 
wildtype controls. Both groups returned to normal blood glucose levels after 120 
minutes. Female animals showed same degree of glucose clearance after glucose 
administration up to 60 minutes however after 120 minutes blood glucose levels were 
significantly higher in IRS-1 deficient mice.  
ITT and GTT data revealed mild insulin resistance for the IRS-1 knockout animals. 
For further evaluation of the indicated insulin intolerance ELISA was performed for 
determination of serum insulin levels in wild-type and IRS-1 deficient mice.  
0
0,5
1
1,5
2
2,5
3
In
su
lin
 [n
g/
m
l]
WT IRS-1-/-
In
su
lin
 [n
g/
m
l]
 
Fig. 3.10  Determination of serum insulin levels of 12 month old mice 
Insulin serum levels of both wild-type (n = 7) and IRS-1-/- (n = 7) mice were determined by ELISA.  
Mice were starved overnight (16 h) and serum was isolated from blood of animals. Values are means 
± SEM. 
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Analysis of insulin serum levels of starved (16 h) wild-type and IRS-1 knockout mice 
confirmed the observed phenotype of the ITT. ELISA analysis revealed elevated 
insulin serum levels in IRS-1 deficient mice compared with wild-type controls, due to 
mild insulin resistance in these animals. Determined mean value of serum insulin 
levels in the knockout group was 85 % higher in comparison with wild-type group.   
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Fig. 3.11  Reduced body weight of IRS-1 deficient mice compared with littermates control in 
female and male study group  
Average weight of 12 month old IRS-1-/- mice (black bars) and wild-type controls (WT; white bars). Left 
panel representing male groups, IRS-1-/- (n = 12) and WT (n = 15); right panel representing female 
groups, IRS-/- (n = 15) and WT (n = 17). Values are means ± SEM, * unpaired Student´s t-test p-value 
≤ 0,05. 
 
Figure 3.11 shows the average body weight of 12 month old female and male 
animals of each group. Due to observed embryonic and postnatal growth retardation 
leading to body size alterations, IRS-1 deficient mice showed significant decreased 
body weights in comparison with wild-type littermates. Thus body size alterations in 
IRS-1 knockout mice result in body weight reduction in female and male group. Body 
weight of female WT mice was about 70 % higher compared with IRS-1 deficient 
females. For the wild-type male mice 40 % increased body weight compared to IRS-1 
knockout males was observed.  
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Fig 3.12  Anatomical view of IRS-1-/- and wild-type mice and normalized epigonadal white 
adipose tissue (WAT) content in female and male mice 
Anatomical view of 12 month old female wild-type and IRS-1-/- mice revealed reduced body length, 
leanness and lack of abdominal fat pads in IRS-1-/- mice. Isolated WAT fat pads of female wild-type (n 
= 4) and IRS-1 deficient (n = 4) and male wild-type (n = 7) and IRS-1-/- (n = 7) mice were dissected 
weighed and correlated to body weight.  
 
Additionally to reduced body size 12 month old IRS-1-/- mice showed reduced 
accumulation of abdominal fat pads compared to wild-type control mice. Dissected 
abdominal fat pads weighed and normalized to body weight revealed 50 % reduction 
of abdominal fat mass in IRS-1 deficient females compared to control mice and a 25 
% reduction of WAT in IRS-1 knockout males in comparison with wild-type males. 
Overall female and male IRS-1-/- mice showed reduced gain of weight and gain of 
abdominal fat between 12 and 24 month of age. During this period body weight in the 
wild-type control groups increased about 20 – 25 % whereas in IRS-1 knockout 
animals body weight increased just about 10 %. Gain of abdominal fat during this 
period was about 55 % for wild-type animals but just 10 % in the IRS-1 deficient mice 
(Fig. 3.13).  
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Fig. 3.13  Gain of body weight and increase of abdominal fat mass in wild-type and IRS-1-/- mice 
during 12 and 24 months of age. 
Increase of body weight and increase in abdominal fat mass determined in wild-type (n = 10) and IRS-
1-/- (n = 10) mice.  
 
Histological analysis of WAT of IRS-1 knockout and wild-type controls, revealed 
distinct anatomical differences. Volume of adipocytes of IRS-1-/- mice was decreased 
compared to control group, indicating decreased lipid storage in adipocytes of IRS-1 
knockout mice. Another characteristic of small sized adipocytes is improved insulin 
sensitivity. Interestingly another cell population was detected between the adipocytes 
membranes of knockout animals (dark blue formations) whereas in wild-type animals 
this cell population was absent.  
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Fig. 3.14  Toluidine blue staining and cell volumetry determination of adipocytes 
Adipocytes morphology of IRS-1 deficient mice and wild-type controls were compared by toluidine 
blue staining. Volume of adipocytes was determinded by volumetry using coulter counter (Beckman, 
Multisizer COULTER COUNTER) (in collaboration with Prof. M. Blüher, Leipzig). 
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To address the question if reduced food intake of IRS-1 deficient mice was causative 
for the observed somatic phenotype in 12 month old animals food intake of wild-type 
and IRS-1 -/- mice was determined by using food hayrack.  
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Fig. 3.15  Determination of food intake of IRS-1-/-  and wild-type mice 
Food intake of wild-type (n = 10) and IRS-1 deficient mice (n = 10) was analyzed using food hayracks. 
Data represent overall food intake of both genders. 
 
Despite decreased weight gain and non present accumulation of abdominal fat pads 
IRS-1 deficient mice showed significantly enhanced food intake compared to wild-
type controls. Reduced weight gain and reduced fat accumulation might be due to 
improved fitness of IRS-1-/- mice. Therefore activity (spontaneous and activity in the 
wheel) of wild-type and IRS-1 knockout mice was tested and analyzed by video-
tracking analysis software.  
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Fig. 3.16  Activity of wild-type and IRS-1 knockout mice per day 
Activity of wild-type and knockout mice of both genders were tested in an activity center setup. Data 
represent mean activity per day. Activity was determined in minutes/day for wild-type (n = 10) and 
knockout (n = 10) animals (in collaboration with Prof. Schröder , Anatomy, Cologne).  
 
Wild-type as well as knockout mice showed a typical murine nocturnal activity 
pattern, spontaneous and wheel activity displayed no significant differences between 
the knockout and wild-type group neither in photophase nor in scotophase.  
 
Indirect calorimetry was used to address alterations in the energy expenditure of 
wild-type and IRS-1 deficient mice in the photo as well as in the scotophase.  
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Fig. 3.17  Determination of energy expenditure of wild-type and IRS-1-/- mice via indirect 
calorimetry 
Wild type (n = 5) and knockout (n = 5) animals were analyzed in a CaloSys system determining 
energy expenditure in photo- and scotophase of each genotype. Both genders were included in tested 
groups of wild-type and knockout mice (in collaboration with Prof. Schröder, Anatomy, Cologne). 
 
Analyzing wild-type and IRS-1-/- deficient mice via indirect calorimetry revealed 
significant higher energy expenditure in IRS-1 knockout mice. Knockouts showed 
1,4- to 1,6-fold increased energy conversion compared with the wild-type control 
group. Hyperthyroidism leads to increased food intake and energy expenditure. 
Thyroid hormones induce marked stimulation of basal metabolic rate associated with 
loss of body fat, creating a state of negative energy balance leading to increased 
energy intake (Havel, 2001). Serum levels of free triiodothyronine (T3) the biological 
active form of triiodothyronine were determined in wild-type and knockout mice by 
ELISA. 
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Fig 3.18 Determination of free triiodotyronine (T3) serum levels 
Free T3 serum levels in wild-type controls and IRS-1 knockout mice were analyzed by ELISA. Serum 
samples of eight wild-type (white bars) and seven knockout mice (black bars) were collected and used 
for ELISA. Values are means ± SEM.  
 
Analysis of free triiodothyronine (T3) revealed no alteration in T3 serum levels 
towards hyperthyroidism in IRS-1 deficient mice compared with wild-type control 
mice, indicating normal thyroid function in the knockout mice.  
Mitochondria have a key role in energy conversion and metabolic rate of animals. 
Concerning the molecular mechanisms of higher energy expenditure in IRS-1 
deficient animals mitochondrial function, mitochondrial enzyme activity and 
expression of mitochondrial proteins in IRS-1-/- mice were compared with wild-type 
controls. 
 
3.7 Mitochondrial activity and function in IRS-1 deficient mice 
 
In order to verify if hyperactivity of mitochondrial respiratory chain enzymes could be 
the underlying mechanism of elevated energy expenditure in IRS-1 knockout mice, 
respiratory chain enzymes were analyzed in respect to differences in expression 
pattern by Western blot and towards their activity and turnover capacities by photo-
spectroscopy under Vmax conditions. 
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3.7.1 Expression of mitochondrial respiratory chain complexes 
 
Mitochondrial respiratory chain enzyme expression levels were determined in muscle 
and liver of IRS-1-/- mice and wild-type controls by Western blotting using MitoProfile 
Total OXPHOS Rodent WB Antibody Cocktail (MitoScience, Acris Antibodies, 
Hiddenhausen, Germany) and monoclonal complex specific antibodies (Molecular 
Probes, Mo Bi Tec, Göttingen, Germany). For detection with Total OXPHOS Rodent 
WB Antibody Cocktail lysate samples were not heated to 95°C, avoiding destruction 
of epitopes detected by antibody.  
 
Complex IV
Complex III
Actin
Actin
HSP-60
WT IRS-1-/-
Complex I
Complex II
Complex V
RasGAP
Actin
WT IRS-1-/-  
Fig. 3.19  Western blot analysis of respiratory chain complexes I, II, III, IV and V in muscles of 
IRS-1-/- and wild-type mice 
Protein expression of respiratory chain complexes I-V, HSP 60 and corresponding loading controls, β-
actin or RasGAP, respectively. Two female wild-type and two male wild-type animals were compared 
with two female knockout and two male knockout animals on one gel. 100 µg of each protein lysate 
were applied on 10 % SDS-PAGE gel. Sample lysates were consisting of M.soleus and M. 
gastrocenemius. Examples of 2 independent experiments. 
 
Determination of protein levels or representative subunits of the five mitochondrial 
respiratory chain complexes, respectively, revealed no obvious decrease in the 
expression pattern of respiratory chain enzymes of complex I, III, IV and IV in the 
muscle of IRS-1 deficient mice compared to wild-type controls. However a tendency 
of a slight decrease in the expression of complex II in the IRS-1-/- mice has been 
detected. Western blot against HSP-60 served as reference for mitochondrial mass. 
HSP-60 is a chaperone located in the mitochondrial matrix (D´Souza et al., 1998; 
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Rospert and Hallberg, 1995). Protein levels of HSP-60 were unchanged, indicating 
no effect of the IRS-1 knockout on mitochondrial content. 
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Fig. 3.20  Western blot analysis of respiratory chain complexes I, II, III, IV and V in livers of IRS-
1-/- and wild-type mice  
Levels of respiratory chain complexes I-V, HSP 60 and corresponding loading controls, β-actin or 
RasGAP, respectively, determined by Western blotting. Two female wild-type and two male wild-type 
animals were compared with two female knockout and two male knockout animals on one gel. 100 µg 
of each protein lysate were applied on 10 % SDS-PAGE gel. Examples of 2 independent experiments. 
 
Steady-state levels of respiratory chain complexes subunits representing fully 
assembled complexes in liver of wild-type controls and IRS-1-/- mice analyzed by 
Western blots. No increased or decreased expression of one of the complexes in one 
of the two compared groups was detected. Like in muscle unaltered levels of HSP-60 
protein in the liver of all analyzed animals, indicating normal mitochondrial content in 
livers of all mice.  
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Fig. 3.21  Western blot analysis of respiratory chain complexes I, II, III, IV and V in MEFs of IRS-
1-/- and wild-type mice  
Expression levels of respiratory chain complexes I-V, HSP 60 and β-actin as corresponding loading 
control, determined by Western blot. Four wild-type cell lystes were compared with four knockout cell 
lysates on one gel. 100 µg of each cell lysate were applied on 10 % SDS-PAGE gel. Examples of 2 
independent experiments. 
 
Figure 3.21 presents expression of respiratory chain complexes I-V and HSP-60 in 
wild-type and IRS-1 deficient MEFs. No detectable difference in mitochondrial mass 
of wild-type and IRS-1 knockout MEFs represented by HSP-60 were observed. Same 
expression of respiratory chain complexes I, II, III and IV in wild-type and IRS-1-/- 
MEFs. However respiratory chain complex V (ATP synthetase or ATPase, 
respectively) was elevated in IRS-1 deficient MEFs compared to wild-type MEFs.  
 
To confirm unchanged expression of mitochondrial respiratory complex in liver 
muscle and MEFs of IRS-1-/- mice and wild-type controls protein expression levels of 
peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha; 
PGC-1α), key regulator of mitochondrial biogenesis were determined by Western blot 
analysis. PGC-1α stimulates mitochondrial biogenesis by binding to and coactivating 
PPAR family members, transcription factors involved in extra and intramitochondrial 
fatty acid transport and oxidation. In addition PGC-1α interacts with and co-activates 
the NRF transcription factors which in turn activate nuclear genes required for 
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respiration, mitochondrial DNA transcription and replication (Wu et al., 1999; Liang 
and Ward, 2006; Ventura-Clapier et al., 2008).  
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Fig. 3.22  Western blot analysis of PGC-1α in liver, muscle and MEFs of IRS-1-/- mice and wild-
type controls 
Western blot images showing expression levels of PGC-1α in liver, muscle and MEFs in control and 
knockout group and actin as the corresponding loading control. Four wild-type cell or organ lystes, 
respectively were compared with four knockout lysates on one gel. 100 µg of each sample were 
applied on 10 % SDS-PAGE gel. Examples of 2 independent experiments.  
 
The results of Western blot analysis of PGC-1α expression in muscle, liver and MEFs 
of IRS-1-/- and wild-type mice indicated no differences in the expression of PGC-1α 
protein in the knockouts compared with the wild-type controls. PGC-1α expression 
pattern confirm Western blot results for mitochondrial respiratory chain complexes 
and HSP-60 in liver, muscle and MEFs for both genotypes, showing no significant 
impact of the IRS-1 knockout on mitochondrial mass, mitochondrial biogenesis and 
mitochondrial chain complexes in muscle and liver.  
PGC-1α is a relatively unstable protein interacting with various transcription factors. 
PGC-1α localizes predominately in the nucleus and its activity is decreased by 
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acetylation. To further investigate the biological active form of PGC-1α nuclear 
fractions of muscle tissue were prepared and subjected to immunoprecipitation 
addressing acetylation status of PGC-1α in wild-type and knockout derived samples 
(Feige et al., 2007; Lerin et al., 2006, Rodgers et al., 2005). 
 
SIRT-1
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IP: PGC-1α
WB: pan-Acetyl
 
Fig. 3.23  PGC-1α acetylation status in nuclear extracts prepared from muscle 
Immunoprecipitation of PGC-1α in muscle derived nuclear extracts. Samples were immunoprecipitated 
with anti PGC-1α antibody, applied to Western blot analysis and detected by anti-pan-acetyl antibody. 
Western blot determination of SIRT-1 and actin (loading control) expression in nuclear extracts of wild-
type and IRS-1 knockout muscle.  
 
Immunoprecipitation displayed increased PGC-1α acetylation status in knockout 
derived nuclear extracts. PGC-1α acetylation is directly regulated by GCN5, an 
acetyltransferase and NAD+-dependent SIRT-1 deacetylase. SIRT-1 expression was 
determined in muscle nuclear extracts and was found downregulated in nuclear 
extracts derived from IRS-1 deficient mice compared to wild-type extracts.  
 
3.7.2 Respiratory chain complex activity 
 
3.7.2.1 Respiratory chain activity in MEFs and MEF isolated mitochondria 
 
Mitochondrial cellular respiration is a central physiological function for all cells. To 
address influence of IRS-1 knockout on mitochondrial activity photospectroscopy was 
applied for analyzing enzyme activities of the respiratory chain complexes in red (M. 
soleus) and white (M. gastrocnemius) muscle, liver, MEFs and MEF isolated 
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mitochondria. Via photospectrometric analysis enzyme activities of single 
mitochondrial chain complexes can be determined. Measurements were performed 
under Vmax conditions. Enzyme activity analysis contained complex I, complex II, 
complex II + III, complex III, complex IV complex V and glycerol 3-phosphate 
dehydrogenase.  In addition activities of tricarboxylic acid cycle (TCA cycle) enzymes 
aconitase, fumerase, isocitrate dehdryogenase and citrate synthase were determined 
for reference. 
Mitochondria isolated from MEFs were analyzed towards enzyme activity of 
respiratory complexes I-V and glycerol 3-phosphate dehydrogenase.  
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Fig. 3.24  Photospectroscopy of mitochondria isolated from MEFs  
Enzyme activities of complexes I, II, II + III, IV, V and glycerol 3-phosphate dehydrogenase (by 
GPCCR) in mitochondria of wild-type and knockout MEFs. Measured activities were normalized to 
mitochondrial content determined by Bradford analysis. 5 different samples of isolated mitochondria of 
each genotype were applied to activity determination. Values are means ± SEM. 
 
No significant differences in activity of respiratory complexes in isolated MEF 
mitochondria between the knockout and wild-type group have been detected, 
although knockout mitochondria showed a tendency towards decreased enzyme 
activity most prominent for complex III.  
To further investigate the mitochondrial performance of IRS-1 deficient MEFs, 5 
samples of isolated fibroblasts of each genotype were analyzed towards their 
respiratory chain activity. In this approach activity of enzymes outside the respiratory 
 79
                                                                                                                                         Results                         
were additionally addressed. Furthermore activities of TCA cycle enzymes fumerase 
and citrate synthase were measured. However activities of complex I and complex V 
can not be analyzed in this set. 
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Fig. 3.25  Determination of respiratory chain activity in MEFs  
Activities of respiratory chain complexes II, II + III, IV, glycerol 3-phosphate dehydrogenase (GPCCR) 
and additionally TCA cycle enzymes fumarase and citrate synthase in wild-type and knockout MEFs 
analyzed by photospectroscopy. 5 different samples of each genotype were applied to activity 
analysis. Values are means ± SEM. 
 
Analysis of MEFs regarding respiratory chain and TCA cycle enzyme activities 
showed no significant discrepancy in knockout compared to wild-type MEFs. The 
trend detected in isolated mitochondria of slight decreased activity in knockout 
derived mitochondria was also observed in the MEF samples, even though activity of 
complex III was increased in knockout MEFs in contrast to the obtained results for 
isolated mitochondria.  
Citrate synthase (CS) is a key enzyme of the TCA cycle, catalyzing the conversion of 
acetyl-CoA and oxalacetate to citrate. Additionally CS activity is used as an indirect 
indicator for mitochondrial mass (Walenta et al., 1989; Bredel-Geissler et al., 1992; 
Schwerzmann et al., 1989). Therefore obtained results of enzyme activities in MEFs 
were normalized to CS activity (Fig. 3.26).  
 
 80
                                                                                                                                         Results                         
0
1
2
3
4
5
6
Co
mp
lex
 II/
CS
GP
CC
R/
CS
Co
mp
lex
 II 
+ I
II/C
S
Co
mp
lex
 III
/C
S
Co
mp
lex
 IV
/C
S
Fu
ma
ras
e/C
S
ac
tiv
ity
 [(
nm
ol
/m
g 
pr
ot
ei
n*
m
in
)/C
S] WT
IRS-1 KO
*
*
ac
tiv
ity
 [(
nm
ol
/m
g 
pr
ot
ei
n*
m
in
)/C
S]
Fig. 3.26  Enzyme activities in knockout and wild-type MEFs normalized to mitochondrial mass 
Enzyme activities of respiratory chain complexes II, II + III, IV, glycerol 3-phosphate dehydrogenase 
(GPCCR) and fumarase in wild-type and knockout MEFs normalized to mitochondrial mass by CS 
ratio. Values are means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05. 
 
Normalized enzyme activities in MEFs support the trend detected by absolute 
determination of respiratory chain enzymes in MEFs. Normalized IRS-1 deficient 
MEFs show slightly decreased mitochondrial performance in almost all complexes of 
the respiratory chain, reaching significance in the activity of complex II and the 
combined activity of complex II and III.  
The mitochondrial electron transport chain is the main source of reactive oxygen 
species (ROS) generated as a by-product during metabolism. Complex I and 
complex III of the electron transport chain are the major sites for ROS production in 
cells (Chen et al., 2003; Lesnefsky et al., 2001; Wallace, 2000; Sugioka et al., 1998; 
Turrens and Boveris, 1980). Impaired electron transport leads to decreased ATP 
production and increased formation of free oxygen radicals (Calabrese et al., 2005). 
Combined activity determination of complex II + III by photospectroscopy revealed a 
decreased activity in knockout MEFs. This impairment in electron transport might 
lead to enhanced generation of ROS in these mice. Therefore expression patterns of 
superoxide dismutase (MnSOD), an enzyme catalyzing dismutation of superoxide 
free radicals to hydrogen peroxide and oxygen (2O2− + 2H+ → H2O2 + O2), were 
determined by western blotting. MnSOD is localized in the mitochondrial matrix 
therefore an important antioxidant defence mechanism for reactive oxygen species 
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released towards the mitochondrial matrix by complex I or complex III, respectively 
(Chen et al., 2003; Raha et al., 2000; Arai et al., 1999; Radi et al., 1991).  
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Fig. 3.27  Expression pattern of MnSOD in wild-type and knockout MEFs  
Western blot analysis of MnSOD in wild-type and knockout derived MEFs. 100 µg of cell lysate were 
applied on a 15 % SDS-PAGE gel. Examples of 3 independent experiments.  
 
Determination of the MnSOD expression pattern in wild-type and knockout MEFs 
revealed no increased MnSOD expression in IRS-1 deficient MEFs, suggesting no 
elevated ROS production in IRS-1-/- samples.  
 
3.7.2.2 Respiratory chain analysis in IRS-1-/- and wild-type muscle 
 
Muscle of wild-type and knockout mice were dissected. M. solues (representing red 
muscle) and M. gastrocenmius (representing white muscle) were separated. 
Separated muscles were homogenized and applied to photospectroscopy analyzing 
respiratory chain and TCA enzyme activities. All complexes were analyzed by single 
or combined activity measurements. Activity of TCA enzymes isocitrate 
dehydrogenase, aconitase, fumerase and citrate synthase were determined 
functioning as additional indicators for metabolic malfunction, as reference parameter 
for respiratory chain enzymes and in the case of citrate synthase as an indirect index 
for mitochondrial mass. 
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Fig. 3.28  Determination of respiratory chain and TCA enzyme activity in red and white muscles 
of female wild-type and IRS-1 knockout mice  
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout mice analyzed by 
photospectroscopy.  
Lower panel: Activities of TCA cycle enzymes isocitrate dehydrogenase (IDH), aconitase, fumarase 
and citrate synthase in wild-type and knockout mice analyzed by photospectroscopy. 8 different 
samples of each muscle and genotype were applied to activity assays. Values are means ± SEM, * 
unpaired Student´s t-test p-value ≤ 0,05.  
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Fig. 3.29  Enzyme activities in red and white muscles of female wild-type and IRS-1 knockout 
mice normalized to mitochondrial mass 
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout animals 
normalized to mitochondrial mass by CS ratio.  
Lower panel: Activities of TCA cycle enzymes isocitrate dehydrogenase (IDH), aconitase and 
fumarase in wild-type and knockout animals normalized to mitochondrial mass by CS ratio. Values are 
means ± SEM.  
 
Photospectrometric analysis of respiratory chain and TCA enzyme activities showed 
no significant alterations neither in red muscle nor white muscle samples between 
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wild-type and IRS-1 deficient females, besides in activity of citrate synthase. The 
tendency observed in MEFs and isolated MEF mitochondria of slight decreased 
activities of respiratory chain and TCA enzymes in the IRS-1 knockout group were 
also obtained for the muscle samples with a significant decrease of citrate synthase 
(CS) activity in IRS-1 knockout females. However this CS activity drop shifted the 
calculated results of muscle samples when normalized to mitochondrial mass to a 
situation of non altered mitochondrial performance in these mice or even slight 
increased activities for some complexes. Hence no mitochondrial dysfunction could 
be observed in muscles of female IRS-1-/- mice compared with the wild-type group 
under maximum stimulation (Vmax) conditions.  
In order to elucidate differences between genders regarding mitochondrial function, 
muscle of males were prepared according to the protocol applied for muscle 
dissection of females. Wild-type and knockout samples were analyzed towards 
enzyme activities by photospectroscopy using the same protocols for activity assays. 
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Fig. 3.30  Determination of respiratory chain and TCA enzyme activity in red and white muscles 
of male wild-type and IRS-1 knockout mice  
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout mice analyzed by 
photospectroscopy. 
Lower panel: Activities of TCA cycle enzymes isocitrate dehydrogenase (IDH), aconitase, fumarase 
and citrate synthase (CS) in wild-type and knockout mice analyzed by photospectroscopy. 7 different 
samples of each muscle- and genotype were applied to activity assays. Values are means ± SEM, * 
unpaired Student´s t-test p-value ≤ 0,05. 
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Fig. 3.31  Determination of respiratory chain and TCA enzyme activity in red and white muscles 
of male wild-type and IRS-1 knockout mice normalized to mitochondrial mass  
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout mice normalized 
to mitochondrial mass by CS ratio. 
Lower panel: Activities of TCA cycle enzymes isocitrate dehydrogenase (IDH), aconitase and 
fumarase in wild-type and knockout mice normalized to mitochondrial mass by CS ratio. Values are 
means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05. 
 
Determination of enzyme activities in muscle of wild-type and IRS-1 knockout males 
displayed significant alteration between IRS-1-/- animals and the control group. 
Calculated results showed decreased enzyme activities in IRS-1 deficient mice for 
 87
                                                                                                                                         Results                         
ATPase (complex V) in red muscle, for TCA enzymes IDH, aconitase and fumerase 
in white muscle as well as for fumerase in red muscle. On the hand complex III 
activity in red muscle of knockout animals was significantly increased. Normalizing 
calculations to mitochondrial mass relativized these results however significantly 
decreased activity of complex V and fumerase in red muscles in IRS-1 deficient 
animals maintained. Mitochondrial enzyme activity of complex III was increased in 
both muscle types of the knockout males; even combined activity determination of 
complex I+III displayed this phenotype for complex III in the IRS-1 knockouts. All 
other respiratory complexes remained unchanged. The observed decreases in TCA 
enzyme activity were relativized by normalization although a slight tendency for a 
decrease maintained, whereas in the case of fumerase a decrease in both muscle 
types of IRS-1-/- mice was apparent. 
Taken together analysis of enzyme activities in red and white muscle of male mice 
revealed a decreased mitochondrial performance in complex V and fumerase in the 
red muscle of IRS-1 deficient mice, whereas activity of complex III was increased in 
both muscle types of IRS-1 knockout mice compared to wild-type controls. No 
mitochondrial deficiency was detected for complex I and complex III, the main 
sources for ROS generation. In order to confirm this, expression of MnSOD in the 
muscles of wild-type and knockout animals of both genders were analyzed by 
Western blot. 
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Fig. 3.32  Expression pattern of MnSOD in wild-type and knockout muscle samples  
Western blot analysis of MnSOD of muscle samples derived from wild-type and knockout mice. 100 µg 
of cell lysate were applied on a 15 % SDS-PAGE gel. Wild-type and knockout fraction are represented 
by two female and two male derived muscles. For Western blot analysis muscle were not separated 
into M. soleus and M. gastrocnemius, whole muscle lysates were used for experiments. Examples of 3 
independent experiments.   
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Determination of the MnSOD expression patterns in in muscle of wild-type and IRS-1 
deficient mice showed no increase or decrease in MnSOD expression in IRS-1 
knockouts compared to wild-type controls. In addition to a slightly better performance 
of complex III and unchanged activity pattern for complex I in the muscles of IRS-1 
knockout mice elevated levels of reactive oxygen species is rather unlikely. 
 
Enzyme activity analysis using photospectroscopyis carried out under maximum 
stimulation conditions. To verify results obtained by photospectroscopy oxygen 
consumptions of wild-type and IRS-1-/- muscle fibers were analyzed in an oxygraph 
(OROBOROS, Innsbruck, Austria), representing a more physiological system with 
intact muscle fibers. Muscle fibers were isolated of 5 male mice each genotype since 
the male group showed more considerable results in the photospectrometric activity 
determinations. 
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Fig. 3.33  Analysis of oxygen consumption of freshly isolated muscle fibers derived from IRS-1 
knockout male (n = 5) mice and wild-type controls (n = 5)  
State 2 respiration of mitochondria is represented by determination of oxygen consumption under pyr-
ADP conditions. Addition of ADP switched mitochondrial respiration to state 3. Glutamate and malate 
provide electrons for complex I of the respiratory chain. Determination of oxygen consumption after 
glutamate and malate addition is an indicator for function or dysfunction of complex I. Values are 
means ± SD. (in collaboration with Prof. R. Wiesner, Cologne) 
 
Determination of oxygen consumption of muscle fibers derived of IRS-1 knockout 
and wild-type males via OROBOROS oxygraph showed same oxygen consumption 
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of IRS-1-/- mice compared with wild-type controls. In contrast to results under 
maximum stimulation conditions mitochondrial function seemed to be unaltered in 
IRS-1-/- mice in comparison with wild-type controls. Mitochondrial state 2 respiration 
(standard state) was determined by addition of respiratory chain substrates and 
providing oxygen as electron acceptor in the absence of any added ADP. No 
differences in state 2 respiration was detected indicating functional inner 
mitochondrial membranes in IRS-1-/- mice. Determination of mitochondrial state 3 
respiration (maximal stimulated mitochondrial respiration in the presence of 
substrate) was achieved by supplementation of state 2 conditions with ADP as 
phosphate acceptor. This led to raised oxygen consumption however to the same 
extent in wild-type and the knockout group. Addition of glutamate and malate 
evaluates the integrity of TCA cycle and the elctrontransport chain (complex I, III and 
IV). Maximum phosphorylation capacity was determined since sufficient levels of 
oxygen, ADP, inorganic phosphate, substrates (glutamate/malate) were provided to 
fibers. No dysfunction in any the complexes has been detected in wild-type or 
knockout mice, indicating full functional mitochondria in the IRS-1-/- muscle.  
 
3.7.2.3 Determination of respiratory chain activity in liver of IRS-1-/- and 
wild-type mice 
 
In order to elucidate mitochondrial function in liver of wild-type and knockout animals 
dissected livers were homogenized and enzyme activities of respiratory chain and 
TCA enzymes were determined by photo spectroscopy. Citrate synthase was used 
as indicator for mitochondrial mass. 5 animals of each gender and genotype were 
analyzed separately. 
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Fig 3.34  Determination of respiratory chain and TCA enzyme activity in livers of female wild-
type and IRS-1 knockout mice  
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout male mice 
analyzed by photospectroscopy. 5 samples each genotype were applied to activity assays. 
Lower panel: Activities of TCA cycle enzymes isocitrate dehydrogenase (IDH), aconitase, fumarase 
and citrate synthase (CS) in wild-type and knockout animals. Values are means ± SEM, * unpaired 
Student´s t-test p-value ≤ 0,05.  
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Fig. 3.35  Determination of respiratory chain and TCA enzyme activity in livers of female wild-
type and IRS-1 knockout mice normalized to mitochondrial mass  
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout mice normalized 
to mitochondrial mass by CS ratio.  
Lower panel: Activities of TCA enzymes in wild-type and knockout animals normalized to 
mitochondrial mass by CS ratio. Values are means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05.  
 
Statistically significant alterations in mitochondrial respiratory chain activity in female 
mice were detected for isocitrate dehydrogenase (IDH) and fumerase for calculated 
absolute values. IRS-1-/- females showed an increased activity for these TCA 
enzymes, additionally an activity elevation of complex IV in the IRS-1 knockout 
females was detected not reaching significance. All other enzymes were basically 
unchanged. Normalizing absolute values to mitochondrial mass displayed distinct 
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activity alterations for complex IV, IDH, aconitase and fumerase in IRS-1-/- females 
compared to wild-type controls. Overall female IRS-1 deficient mice showed a 
tendency towards increased mitochondrial enzyme activities for the respiratory chain 
as well as for the TCA cycle.    
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Fig 3.36  Determination of respiratory chain and TCA enzyme activity in livers of male wild-type 
and IRS-1 knockout mice  
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout male mice 
analyzed by photospectroscopy. 
Lower panel: Activities of TCA enzymes isocitrate dehydrogenase (IDH), aconitase, fumarase and 
citrate synthase (CS) in wild-type and knockout animals. 5 samples each genotype were applied to 
activity assays. Values are means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05.  
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Fig 3.37  Determination of respiratory chain and TCA enzyme activity in livers of male wild-type 
and IRS-1 knockout mice normalized to mitochondrial mass  
Upper panel: Activities of respiratory chain complexes I-V in wild-type and knockout male mice 
normalized to mitochondrial mass by CS ratio.  
Lower panel: Activities TCA enzymes in wild-type and knockout animals normalized to mitochondrial 
mass by CS ratio. Values are means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05.  
 
Photospectrometric analysis of livers dissected from IRS-1 knockout and wild-type 
males displayed increased enzyme activities for complex IV and fumerase in IRS-1-/- 
mice as observed in female mice, however not reaching significance. On the other 
hand IRS-1 deficient males showed decreased enzyme activity for complex V and 
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significantly decreased activity for IDH. Normalizing absolute values to mitochondrial 
mass did not change relation of absolute values; enzyme activities of complex IV and 
for fumerase were still increased in IRS-1 knockout males compared to wild-type and 
on the other hand complex V activity was decreased in the animals. Differences in 
IDH activity were not obvious anymore after normalization. The tendency of slight 
increased mitochondrial performance of all enzymes as observed in females was not 
present in livers derived from males with the exceptions for IDH and complex IV. On 
the other hand activity attenuation for complex V was also observed in soleus 
muscles of both genotypes with a significant complex V activity reduction in males 
(Fig. 3.29; 3.31). 
 
In order to analyze the mitochondrial respiratory chain in a functional context polaro 
graphic determination of oxygen consumption was applied to freshly isolated liver 
mitochondria. Oxygen consumption was determined after oxidation of substrates 
added to isolated mitochondria. Complex I, complex II, combined activity of complex 
II+IV and activity of pyruvate dehydrogenase were determined by oxygen 
consumption via polarographic analysis.    
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Fig. 3.38  Oxygen consumption of isolated liver mitochondria derived from IRS-1-/- and wild-                         
type males  
MPox analysis characterizes complex I, TCA cycle and pyruvate dehydrogenase activity. MGox 
represents activity of pyruvate dehydrogenase complex. Sox determination displays complex II 
activity. GPox and Qox detect complex III and IV activities. 5 samples of isolated mitochondria of IRS-
1 knockout and wild-type controls were analyzed. Values are means ± SD. 
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In contrast to photospectrometric analysis not single complex activities are 
determined by polarography coupling of the different complexes in electron transfer, 
the TCA cycle and pyruvate dehydrogenase complex are addressed by this method, 
thus elucidating defects in electron transfer of mitochondria.  No differences in 
oxygen consumption were detected by polarographic analysis of IRS-1 knockout and 
wild-type derived mitochondria. Enzymatic activities of analyzed complexes were 
unchanged indicating functional mitochondrial respiratory chain complexes, TCA 
cycle enzymes and pyruvate dehydrogenase complex in IRS-1 deficient mice.   
 
No activity decrease for complex I and III was detected by the different methods in 
both genotypes and genders. Dysfunction in either complex I or complex III leads to 
increased ROS generation and induction of MnSOD as one possible physiological 
response to that. MnSOD expression was analyzed by Western blot concerning 
mitochondrial dysfunction of complex I and complex III.  
 
 
 
                       
Liver
MnSOD
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WT IRS-1-/-  
Fig. 3.39  Expression pattern of MnSOD in wild-type and knockout muscle samples  
Western blot analysis of MnSOD liver samples derived from wild-type and knockout mice. 100 µg of 
cell lysate were applied on a 15 % SDS-PAGE gel. Wild-type and knockout fraction are represented 
by two female and two male derived livers. Examples of 3 independent experiments. 
 
Expression pattern of MnSOD in liver samples of female and male knockout mice 
and wild-type controls analyzed by Western blot revealed no differences between 
both groups, thus excluding dysfunction of complex I or complex III. 
In order to further exclude mitochondrial dysfunction in IRS-1 deficient animals, liver 
samples were applied to OxyBlot analysis, detecting carbonylated proteins. Carbonyl 
groups are introduced into amino acid chain after oxidative modification of proteins 
(Tezel et al., 2005). Increased production of hydroxyl radicals leads to formation of 
 96
                                                                                                                                         Results                         
lipid hydroperoxides, producing α-,β-unsaturated aldehydes. These are subjected to 
Michael addition leading to reactive carbonyl functional groups on lysine, histidine 
and cysteine residues on side chains of proteins. Hyxdroxyl radicals, short lived but 
the most reactive radicals, are formed via the Harber-Weiss reaction from O2⎯ and 
H2O2 (both produced by mitochondria and mitochondria and SOD, respectively). 
Therefore analyses of protein carbonyls give an insight into oxidative damage at 
protein level caused by oxidative stress (Grimsrud et al., 20008, Zhang et al., 2006). 
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Fig. 3.40  OxyBlot of wild-type and IRS-1 knockout derived liver samples  
Proteins modified by reactive species are detected by OxyBlot. OxyBlot provides an indirect evidence 
of mitochondrial generated ROS indicating defective mitochondrial respiratory chain (complex I and 
complex III) by detection of protein oxidation. 2,4-dinitrophenylhydrazine (DNPH) was used as 
derivatizing reagent of protein carbonyls and DNP antibody (Sigma-Aldrich, Cat-Nr. D9656) for 
detection of DNP-protein-derivatization. BSA plus NaClO was used as control for functional detection 
of carbonylated proteins. NaClO was used to produce free radicals leading to an increase in protein 
carbonylation compared to untreated BSA.  
Left panel: Coomassie Brilliant Blue gel served as loading control (Oh-Ishi et al., 2002, Kalyanaraman 
et al., 1985). 
 
No difference in protein carbonylation was observed comparing wild-type with 
knockout samples, indicating no elevated ROS production or mitochondrial 
dysfunction, respectively in either wild-type or IRS-1 deficient animals. Functionality 
of carbonylated protein detection by OxyBlot was proved by NaClO treated and 
untreated BSA. NaClO treated BSA showed an increase of carbonylated proteins in 
comparison to untreated BSA sample.  
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To address functional relevance of decreased complex V activity in the photo 
spectroscopic analysis in muscle and liver homogenates of male IRS-1 deficient 
mice, isolated mitochondria of IRS-1 knockout and wild-type mice were analyzed by 
proton motive force measurement in order to investigate if decreased complex V 
activity might be due to proton leakage suggesting an uncoupling phenomenon in 
these mice. Proton leak measurements were carried out in the presence of 
oligomycin inhibiting ATP synthesis in complex V hence mitochondrial membrane 
potential is not consumed by ATP synthase. Oxygen consumption of mitochondria in 
this state is proportional to leakage across the inner mitochondrial membrane. The 
kinetic response of the proton conductance to its driving force (proton motive force) 
can therefore be measured as relationship between respiration rate and membrane 
potential when the potential is varied by titration with electron transport chain 
inhibitors (Brand, 1990; Nicholls, 1974; Jastroch et al., 2009). Addition of 4-
hydroxynonenal (4-HNE), an α,β-unsaturated hydroxyalkenal and major product of 
oxidant induced peroxidation of membrane phospholipids in cells, uncouples 
mitochondria and verified functional detection of proton leakage in mitochondria. 
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Fig. 3.41  Proton leakage determination of isolated liver mitochondria of knockout and wild-
type male mice 
Measurement of proton conductance in freshly isolated mitochondria derived from wild-type (n = 5) 
and IRS-1 knockout (n = 5) males. Right panel displays proton leak of liver mitochondria. Left panel 
inducible proton conductance in liver mitochondria after addition with 4-HNE in comparison with proton 
leak of liver mitochondria without addition of 4-HNE. Data are means ± SD. Independent experiments, 
each performed in duplicates. (in collaboration with Prof. R. Wiesner, Cologne) 
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Proton leakage analysis showed higher oxygen consumption in IRS-1-/- mice 
compared with wild-type controls. The IRS-1 deficient males required a higher 
substrate turnover for building up their membrane potential. Mitochondria of IRS-1 
knockout mice consumed about 50 nmol oxygen for creating a membrane potential of 
160 mV, whereas wild-type mitochondria used about 40 nmol of oxygen creating this 
membrane potential. Addition of 4-HNE shifted the graphs to higher oxygen 
consumption creating distinct membrane potential due to the induced uncoupling 
effect by 4-HNE. However potential difference for defined oxygen quantities between 
the two genotypes remained. Shifting of graphs after 4-HNE addition showed that 
proton leakage is well detected by this assay. Overall, proton leakage determination 
indicates that IRS-1 knockout animals lowered membrane potential by enhanced 
leakage of protons across the inner mitochondrial membrane, indicating an 
uncoupling phenotype in knockout mice.  
 
3.7.3 Identification of mitochondrial respiratory chain uncoupling in IRS-1 
deficient mice 
 
To further investigate an uncoupling phenomenon in IRS-1 deficient animals liver, 
muscle and WAT samples of knockout and wild-type mice were analyzed by Real-
time PCR and protein lysate were exposed to Western blot analysis. RNA of tissues 
was extracted using TRIzol (Invitrogen, Darmstadt, Germany), proteins were 
extracted using standard protein lysate protocol as described in materials and 
methods. 
Uncoupling protein 3 (UCP-3) is mainly expressed in muscle. Photospectrometric 
data suggested uncoupling in IRS-1-/- mice. Thus UCP-3 expression in muscle of 
IRS-1 knockout and wild-type mice were analyzed using Real-Time PCR (RT-PCR) 
and Western blot analysis. 
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Fig. 3.42  mRNA expression of UCP-3 in muscles of IRS-1 knockout mice and wild-type controls 
mRNA expression of UCP-3 (uncoupling protein 3) in muscles of IRS-1 deficient (n = 8) and wild-type 
mice (n = 8). mRNA levels were determined by using UCP-3 and 18s (internal control) TaqMan probes 
(Applied Biosystems, Darmstadt, Germany). Data represent ΔΔCT calculation. Data are means ± 
SEM.  
 
mRNA levels determined by RT-PCR showed increased UCP-3 levels in IRS-1 
deficient mice compared with the wild-type group. Results are expressed as fold 
increase relative to control group. RT-PCR analysis revealed a 184 % (2,84-fold) 
increase for UCP-3 expression in IRS-1-/- mice. mRNA does not directly represent 
protein expression since mRNA can be degraded before been translated, therefore 
UCP-3 expression was checked by Western blot analysis, trying to link elevated 
mRNA levels to increased UCP-3 protein expression.  
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Fig 3.43  Western blot analysis of UCP-3 protein expression in muscle of wild-type controls and 
IRS-1-/- mice  
UCP-3 and ANT (Adenine nucleotide translocase) protein expression in wild-type (n = 4) and knockout 
(n = 4) mice. Actin and RasGAP were used as loading control. 300 µg of protein lysate were applied 
on 10 % SDS-PAGE gel.  
 
Western blot analysis showed slightly increased expression of UCP-3 in IRS-1-/- 
mice. Quantification of Western blot results determined a 15 % increased UCP-3 
expression in muscle of IRS-1 knockout mice. Highly elevated levels of UCP-3 
detected by RT-PCR were partially confirmed by the Western blot. Expression levels 
of ANT another protein involved in proton conductance were additionally checked by 
Western blot analysis. Protein expression levels of ANT remained unchanged 
indicating no effect of this protein on elevated oxygen consumption detected by 
proton leakage measurements. 
To address uncoupling in livers of IRS-1-/- animals UCP-2 mRNA expression was 
determined by RT-PCR. Kupffer cells are the dominant site of uncoupling protein 2 
expression in liver (Larrouy et al., 1997).  
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Fig. 3.44  mRNA expression of UCP-2 in livers of IRS-1 knockout mice and wild-type controls 
mRNA expression levels of UCP-2 (uncoupling protein 2) in livers of IRS-1 deficient (n = 7) and wild-
type mice (n = 7). mRNA levels were determined by using UCP-2 and 18s (internal control) TaqMan 
probes (Applied Biosystems, Darmstadt, Germany). Data represent ΔΔCT calculation. Data are 
means ± SEM.  
 
An increased UCP-2 mRNA expression of 41 % was detected in IRS-1 knockout 
mice compared to the wild-type control group. If 41 % increase of UCP-2 mRNA 
levels is sufficient explaining increased oxygen consumption detected by proton 
leakage measurements or decreased complex V activity determined by 
photospectroscopy remained questionable. However this phenomenon might 
contribute to the uncoupling phenotype.  
 
 
 
 
 
 
 
 
 
 102
                                                                                                                                         Results                         
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
2
R
el
at
iv
e 
U
C
P-
1
 m
R
N
A
 e
xp
re
ss
io
n 
[%
]
WT IRS-1-/-
*
R
el
at
iv
e 
U
C
P-
1
 m
R
N
A
 e
xp
re
ss
io
n 
[%
]
 
Fig. 3.45  mRNA expression of UCP-1 in white adipose tissue (WAT) of IRS-1 knockout mice 
and wild-type controls 
mRNA expression of UCP-1 (uncoupling protein 1) in WAT of IRS-1 deficient (n = 6) and wild-type 
mice (n = 8). Values are means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05.  
 
UCP-1 is a common marker for brown adipose tissue (BAT) (Klaus et al., 2004). 
Brown fat has a central function in thermogenesis of creatures. Lately UCP-1 was 
linked to body weight regulation and discussed as therapeutic tool for obesity 
treatment (Nedergaard et al., 2010). Figure 3.45 shows UCP-1 mRNA expression in 
WAT of IRS-1 knockout compared with wild-type mice. UCP-1 mRNA levels were 
significantly elevated in the IRS-1 deficient group, indicating development of discrete 
brown adipocyte characteristics in abdominal white fat depots. 
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Fig 3.46  Western blot analysis of UCP-1 protein expression in WAT in wild-type controls and 
IRS-1-/- mice  
UCP-1 protein expression in wild-type (n = 4) and knockout (n = 4) mice. Left panel. Actin was used as 
loading control. 300 µg of protein lysate were applied on 10 % SDS-PAGE gel.  
 
Determination of protein expression by Western blot displayed slight upregulated 
UCP-1 levels in the knockout group. Quantification of protein expression levels 
revealed 33 % increased UCP-1 protein levels in the knockout group. Real-time PCR 
results are supported by the Western blot determination, however in contrast to 
results obtained by RT-PCR Western blot results do not reach significance.  
 
UCP-1 expression in WAT is an indicator for BAT sections inside WAT. BAT is 
characterized by high density of mitochondria. Since PGC-1α is essential for 
mitochondrial biogenesis, PGC-1α mRNA expression in WAT was determined by RT-
PCR. Elevated PGC-1α mRNA levels might provide mitochondrial biogenesis thus 
providing an indirect proof for BAT sections inside the white adipose tissue. 
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Fig. 3.47  mRNA expression of PGC-1α in white adipose tissue (WAT) of IRS-1 knockout mice 
and wild-type controls 
mRNA expression of PGC-1α in WAT of IRS-1 deficient (n = 6) and wild-type mice (n = 8). mRNA 
levels were determined by using PGC-1α and 18s (internal control) TaqMan probes (Applied 
Biosystems, Darmstadt, Germany). Data represent ΔΔCT calculation. Data are means ± SEM. * 
unpaired Student´s t-test p-value ≤ 0,05.  
 
Figure 3.47 shows the result of RT-PCR analysis of PGC-1α mRNA expression in 
WAT. Results are expressed as fold increase relative to the control group. IRS-1 
deficient mice showed a 1600 % increased mRNA expression of PGC-1α. This might 
represent an indirect effect of BAT sections in WAT, reflecting elevated mitochondrial 
density in IRS-1-/- mice.  
Brown adipose tissue is the key component in regulation of thermogenesis. BAT 
uncouples mitochondrial respiratory chain and ATP synthesis by UCP-1 using the 
energy of the inner mitochondrial membrane potential for releasing heat. Therefore 
increased energy expenditure observed in IRS-1 knockout mice might be induced by 
elevated uncoupling of BAT. In order to address this question BAT was analyzed 
towards mRNA expression of uncoupling proteins and enhanced mitochondrial 
biogenesis by PGC-1 alpha.  
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Fig. 3.48  mRNA expression of UCP-1 in brown adipose tissue (BAT) of IRS-1 knockout mice 
and wild-type controls 
mRNA expression of UCP-1 in BAT of IRS-1 deficient (n = 5) and wild-type mice (n = 5). mRNA levels 
were determined by using UCP-1 and 18s (internal control) TaqMan probes (Applied Biosystems, 
Darmstadt, Germany). Data represent ΔΔCT calculation. Data are means ± SEM. 
 
mRNA expression of UCP-1 in BAT determined by RT-PCR revealed no alteration in 
mRNA expression levels of knockout animals compared with wild-type controls. 
Increased numbers of mitochondria in BAT could also contribute to higher energy 
expenditure in IRS-1 deficient mice. Hence mRNA expression of PGC-1 alpha in BAT 
was checked by RT-PCR.  
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Fig. 3.49  mRNA expression of PGC-1α in brown adipose tissue (BAT) of IRS-1 knockout mice 
and wild-type controls 
mRNA expression of PGC-1α in BAT of IRS-1 deficient (n = 5) and wild-type mice (n = 5). mRNA 
levels were determined by using PGC-1α and 18s (internal control) TaqMan probes (Applied 
Biosystems, Darmstadt, Germany). Data represent ΔΔCT calculation. Data are means ± SEM. 
 
No significant alteration in mRNA expression levels of PGC-1 alpha were detected by 
RT-PCR in IRS-1 knockout animals excluding elevated mitochondrial mass in BAT as 
underlying mechanism for increased energy expenditure in these mice. No 
differences in BAT composition of IRS-1 deficient mice compared to wild-type 
controls could be detected rather decreased levels of UCP-1 or PGC-1α were 
observed. Therefore neither increased mitochondrial biogenesis nor increased 
uncoupling in BAT is the basis of increased energy expenditure in knockout animals.  
Taken together muscle, liver and WAT data indicate uncoupling in these tissues 
supporting obtained results of respiratory chain activity and proton motive force 
determinations. 
 
3.8 Generation of ATP in IRS-1 deficient animals  
 
The mitochondrial respiratory chain is the main source for ATP in cells. Dysfunctional 
mitochondrial respiratory chain complexes can lead to disturbance in ATP content 
and consequently energy supply of cells. Inner mitochondrial membrane potential is 
used by ATP synthase, complex V of the respiratory chain, generating ATP. Thus 
lowering of membrane potential by uncoupling proteins in IRS-1 deficient mice is 
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supposed to reduce cellular ATP content in these animals. Therefore an ATP 
bioluminescence assay kit was used for determination of mitochondrial content in 
MEFs of wild-type and knockout mice.  
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Fig. 3.50  Determination of ATP content in wild-type and knockout MEFs  
ATP content of wild-type (n = 5) and knockout (n = 5) derived MEFs. ATP concentrations were 
determined by ATP bioluminescence assay (Roche, Mannheim, Germany). ATP was measured in 
triplicates and calculated from standard curve data. Results are expressed as fold increase in relation 
to the wild-type control group. Values are means ± SEM, * unpaired Student´s t-test p-value ≤ 0,05.   
 
MEF derived from IRS-1 deficient mice showed elevated ATP levels. Since no 
increased complex V activity was detected by photospectroscopy in IRS-1 knockout 
MEFs, ATP seemed to be generated by an alternative pathway to OXPHOS. One 
example of an alternative source for ATP generation is represented by metabolism of 
glucose via glycolysis to lactate. Therefore enzyme activity of lactate dehydrogenase 
(LDH) was determined by photospectrometric analysis.  
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Fig. 3.51  Determination of lactate dehydrogenase activity in MEF derived from wild-type and 
IRS-1 knockout mice  
Upper panel: Activity of LDH in wild-type and knockout MEFs analyzed by photospectroscopy. 5 
different samples of each genotype were to applied analysis. 
Lower panel: LDH activity in wild-type and knockout animals normalized to mitochondrial mass by CS 
ratio. Values are means ± SEM. 
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No alteration in LDH activity has been determined between wild-type and IRS-1-/- 
mice, IRS-1-/- mice showed rather decreased LDH activity. Apparently enhanced 
glycolysis and elevated lactic acid fermentation were not the liable source of 
increased ATP levels in MEFs.  
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Fig. 3.52  Determination of lactate dehydrogenase activity in red and white muscle of wild-type 
and IRS-1 knockout female mice  
Upper panel: Activity of LDH in wild-type and knockout females analyzed by photo spectroscopy. 8 
different samples of each muscle and genotype were applied to analysis. 
Lower panel: LDH activity in wild-type and knockout animals normalized to mitochondrial mass by CS 
ratio. Values are means ± SEM. 
 
Liver and muscle of IRS-1 knockout mice showed decreased activity of ATP 
synthase indicating decreased ATP levels. Therefore LDH activity was determined in 
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both tissues in order to check if complex V deficiency is probably compensated by 
high LDH activity providing an alternative ATP source.  
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Fig. 3.53  Determination of lactate dehydrogenase activity in red and white muscle of wild-type 
and IRS-1 knockout male mice  
Upper panel: Activity of LDH in wild-type and knockout males analyzed by photo spectroscopy. 7 
different samples of each muscle and genotype were applied analysis. 
Lower panel: LDH activity in wild-type and knockout animals normalized to mitochondrial mass by CS 
ratio. Values are means ± SEM. 
 
Photospectrometric analysis of LDH showed increased activity M. gastrocnemius in 
IRS-1 deficient male and female mice. M. soleus of male IRS-1 knockout mice 
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displayed slight increased LDH activity, whereas activity in females remained 
unchanged compared with wild-type controls. 
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Fig. 3.54  Determination of lactate dehydrogenase activity in livers of wild-type and IRS-1 
knockout female mice  
Upper panel: Activity of LDH in wild-type and knockout females analyzed by photo spectroscopy. 5 
different samples of each muscle and genotype were applied analysis. 
Lower panel: LDH activity in wild-type and knockout animals normalized to mitochondrial mass by CS 
ratio. Values are means ± SEM. * unpaired Student´s t-test p-value ≤ 0,05.  
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Fig. 3.55  Determination of lactate dehydrogenase activity in livers of wild-type and IRS-1 
knockout male mice  
Upper panel: Activity of LDH in wild-type and knockout males analyzed by photospectroscopy. 5 
different samples of each muscle and genotype were applied analysis. 
Lower panel: LDH activity in wild-type and knockout animals normalized to mitochondrial mass by CS 
ratio. Values are means ± SEM. 
 
LDH activity determination in female (Fig. 3.54) and male (Fig. 3.55) knockout and 
wild-type mice, displayed unchanged LDH activity in male mice whereas LDH activity 
in females was elevated compared to wild-type controls, reaching significance when 
normalized to mitochondrial mass. Taken together obtained results for LDH activity in 
muscles and livers of IRS-1-/- and wild-type mice showed a tendency of increased 
LDH activity in the knockout group, may be caused by a physiological compensatory 
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reaction facing low ATP levels due to decreased ATP synthase activity, observed in 
these tissues. 
 
 
3.9 Analysis of fat metabolism in IRS-1-/- mice 
 
To verify the phenotypic characteristic of nearly abrogated abdominal fat 
accumulation in IRS-1-/- mice body composition was examined by nuclear magnetic 
resonance analysis (NMR) of female and male knockout and wild-type mice.  
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Fig. 3.56  Fat content in IRS-1 deficient and wild-type mice at the age of 12 month 
Average fat content of 12 month old wild-type (black bars), females (n = 12) and males (n = 16) and 
knockout (white bars), females (n = 8) and males (n = 9). Data are means ± SD 
 
Surprisingly no significant differences in fat content of IRS-1 deficient mice compared 
to wild-type controls could be detected by NMR. Overall fat contents in IRS-1-/- 
females were slightly decreased (about 5 %) in female knockouts whereas fat 
content in knockout males were indistinguishable from wild-types. Lean mass 
analysis (data not shown) underlined the NMR results, no difference in lean tissue 
mass in male mice and a slight increased lean tissue mass in IRS-1-/- females were 
detected.  
Lack of abdominal fat accumulation was observed in IRS-1 knockout animals 
whereas total fat content in mice is not altered in comparison with wild-type mice 
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indicate redistribution of fat in IRS-1-/- mice. It is known that the brain body ratio is 
increased in IRS-1-/- mice compared with wild-type controls (Schubert et al., 2003). 
To evaluate whether proportions of other organs besides brain are increased in 
relation to body weight, livers were dissected and correlated to body weight.  
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Fig. 3.57  Liver-Body ratio of 12 month old mice 
Average liver-body ratio of wild-type (n = 7) and knockout (n = 6) mice 12 month of age. Results were 
normalized to wild-type controls and expressed as means ± SEM. * unpaired Student´s t-test p-value ≤ 
0,05. 
 
Significant differences in liver-body ratio between wild-type and knockout mice were 
detected. Ratio in IRS-1 deficient animal was elevated indicating enlarged liver sizes 
in relation to body weight in these mice compared to the wild-type controls. This 
suggests that abdominal fat may be redistributed to the liver of the animals resulting 
in unchanged overall fat content.  
 
Besides redistribution of abdominal fat to the livers or other organs of IRS-1 knockout 
mice, inhibited lipid metabolism might be responsible for unaltered total fat content. 
Therefore activity of the mitochondrial acid transporter carnitine palmitoyl transferase 
I (CPT-I) in mitochondria isolated from livers was measured. CPT-I is associated with 
the outer mitochondrial membrane. CPT-I mediates the transport of free fatty acids 
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FFA) across the membrane by binding to carnitine, providing FFA from cytosol for β-
oxidation in the mitochondrial matrix. 
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Fig. 3.58  Determination of CPT-I enzyme activity in isolated liver mitochondria 
Enzyme activities were determined by 14C-carnitine incorporation into acylcarnitines. Isolated 
mitochondria from livers of male wild-type (n = 5) and male knockouts (n = 5) were analyzed. Results 
were normalized to wild-type controls and expressed as means of ± SD.  
 
Considerably decreased CPT-I activities resulting in impaired transfer of FFA from 
cytosol to mitochondrial matrix were not detected in mitochondria of IRS-1-/- livers. 
However IRS-1 knockout mice presented slightly decreased CPT-I activity levels 
compared with wild-type controls not reaching significance.  
 
3.10 Determination of increased food intake 
 
In order to address increased food intake in IRS-1 deficient mice, leptin serum levels 
were determined. Lowered leptin levels in IRS-1-/- mice could be the underlying 
mechanism for the observed hyperphagic phenotype in these mice.  
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Fig. 3.59  Leptin serum levels of 12 month old mice  
Leptin serum levels of both wild-type (n = 7) and IRS-1-/- (n = 7) mice were determined by ELISA.  
Mice were starved overnight (16 h) and serum was isolated from blood of animals. Data represent 
serum insulin levels of 12 month old male animals. Values are means + SEM. 
 
Serum leptin concentrations were decreased in IRS-1-/- mice compared with wild-type 
controls and consequently accompanied by increased food intake in these mice. 
Leptin is secreted by adipocytes and serum leptin levels are positively correlated with 
adipose storage. Additionally serum adiponectin levels (wildtype 5,74±0,37 [µg/ml]; 
knockout 7,2±1,26 [µg/ml]) were slightly increased in knockout mice. In order to 
elucidate this effect mRNA expression levels of hypothalamic neuropeptides, POMC, 
AgRP, CART and NPY were determined by RT-PCR in IRS-1 knockout and wild-type 
mice.  
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Fig 3.60  Determination of POMC, CART, NPY and AgRP mRNA levels in wild-type and  
knockout mice  
Relative mRNA expression levels of anorectic hypothalamic neuropeptides POMC and CART and 
orectic hypothalamic neuropeptides NPY and AgRP in random fed wild-type (n = 6) and knockout (n = 
6) mice determined by RT-PCR analysis. Results were normalized to wild-type controls and expressed 
as means ± SEM. * unpaired Student´s t-test p-value ≤ 0,05. 
 
Investigation of mRNA expression levels of hypothalamic neuropeptides essential for 
energy homeostasis in mammals revealed significant increased mRNA levels for the 
orectic neuropeptides NPY and AgRP. This observed mRNA expression patterns 
correlates with the hyperphagic phenotype of IRS-1 deficient mice. On the other hand 
also the anorectic hypothalamic neuropeptides POMC and CART showed elevated 
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mRNA levels in IRS-1-/- mice however not reaching significance. POMC mRNA levels 
were 25 % higher compared with wild-type controls. Additionally CART was 36 % 
increased in IRS-1-/- hypothalami. Overall data of leptin and hypothalamic 
neuropetide in IRS-1 deficient mice represent a possible mechanism explaining 
increased food intake in these mice. 
 
To elucidate if IRS-1 deficiency is compensated in brain mRNA expression of IRS-2 
and IRS-4 was determined by RT-PCR. IRS-4 expression is restricted to 
hypothalamus with high expression in the arcuate nucleus (including NPY/AgRP and 
PMOC/CART neurons) and therefore could be a strong candidate for partially 
compensation of IRS-1 deficiency in this part of the hypothalamus (Numan et al., 
1999).  
Furthermore insulin receptor and leptin receptor expression was addressed by RT-
PCR analysis.  
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Fig. 3.61  Determination of IRS-2, IRS-4, insulin receptor (IR) and leptin receptor (Ob-R) mRNA 
levels in arcuate nucleus of wild-type and  knockout mice  
Relative mRNA expression levels IRS-2, IRS-4, IR and Ob-R in random fed wild-type (n = 6) and 
knockout (n = 6) mice determined by RT-PCR analysis. Results were normalized to wild-type controls 
and expressed as means ± SEM.  
 
RT-PCR analysis of insulin receptor and leptin receptor displayed unchanged 
expression levels in knockout mice compared with wild-type animals. IRS-2 mRNA 
levels were almost unchanged however IRS-4 mRNA levels were increased in IRS-1 
deficient animals without reaching significance, maybe indicating a compensatory 
mechanism in hypothalamus of IRS-1 knockout animals.   
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Summarizing the results of regulation of energy homeostasis in IRS-1 knockout mice 
revealed possible molecular mechanisms explaining the described phenotype in this 
mouse model.  
 
i) Increased energy expenditure is based on mitochondrial respiratory chain 
uncoupling. 
ii) Hyperphagic phenotype mediated via changes in expression patterns of 
orectic hypothalamic neuropeptides  
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4. Discussion 
 
 
Mild insulin resistance, dwarfism as well as increased mean and maximum lifespan 
have been described as denotative phenotypes of IRS-1 knockout mice (Tamemoto 
et al., 1994; Selman et al., 2008). Interestingly, during aging gain of body weight and 
abdominal fat accumulation was reduced in IRS-1 deficient mice compared to wild-
types. Surprisingly, this phenotype was accompanied by increased food intake and 
increased energy expenditure in IRS-1-/- mice.  
To elucidate underlying mechanisms for these phenotype, aged IRS-1-/- mice were 
applied to biochemical, molecular and cellular analysis. Additionally MEFs derived 
from females of IRS-1-/+ breeding pairs were analyzed serving as an in vitro system 
to discriminate between pure cellular or signaling effects caused by IRS-1 deficiency 
and effects influenced or compensated by a fully functional endocrine environment in 
vivo.  
 
4.1 Basal insulin signaling in IRS-1-/- mice and MEFs 
 
Western blot analyzes from muscle, liver, WAT, lung, brain and kidney revealed IRS-
1 expression in these tissues in wild-type mice and confirmed IRS-1 deletion in IRS-
1-/- mice (Fig. 3.1). Furthermore, IRS-1 was clearly detectable in MEFs generated 
from wild-type mice but as expected not in MEFs derived from IRS-1-/- mice (Fig. 
3.2).  
Basal expression of IRS-2 and IGF-1R in wild-type and IRS-1 knockout MEFs 
remained unchanged whereas IR expression of IRS-1-/- MEFs was significantly 
reduced compared to wild-type MEFs. No alteration in protein abundance of IRS-2 
and IGF-1R in liver and muscle of IRS-1-/- and wild-type were detected. However as 
observed in MEFs IR expression was reduced in muscle of IRS-1 deficient mice 
whereas in liver tissue no changes in IR protein levels were observed suggesting a 
specific effect of IRS-1 deficiency in skeletal muscle. Hyperinsulinism due to insulin 
resistance or chronic insulin treatment respectively has been proposed to moderately 
decrease insulin receptor expression (Yuan et al., 2002, Venkatesan et al., 1995). 
Since insulin levels are elevated (Fig. 3.10) in IRS-1 -/- mice, downregulation of IR 
might be induced by hyperinsulinism. Previous studies suggested that increased 
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insulin signaling affects upstream receptor density in a feed back inhibition leading to 
decreased insulin signaling (Werner et al., 1995). In IRS-1 knockout mice this effect 
might be less pronounced due to only mild insulin resistance and hyperinsulinemia 
(3.8 and 3.9). In liver of IRS-1 knockout mice insulin resistance is compensated via 
an upregulation of IRS-2 (Fig. 3.7) contributing to nearly unchanged IR signaling. In 
skeletal muscle IR signaling might be impaired due to IRS-1 deficiency since no 
compensatory effect was detected and muscle is thought to be responsible for insulin 
resistance in these mice. Consequences of IRS-1 deficiency for IR signaling are 
more pronounced in muscle than in liver since IRS-2 seem to be the predominant 
IRS protein in hepatocytes nearly fully compensating IRS-1 deficiency (Kido et al., 
2000; Yamauchi et al., 1996). However, the reduction of IR in skeletal muscle and in 
MEFs of IRS-1-/- mice but not in liver argues against chronic increased IR signaling 
stimulation as leading cause for the reduced IR expression and favors a hypothesis 
where slightly decreased IR signaling in a tissue-specific manner might be 
responsible.  
 
4.2 Role of IRS-1 in Insulin signaling 
 
To elucidate the role of the IRS-1 for insulin signaling in cells and tissues 
phosphorylation of downstream signaling proteins were analyzed by Western blots 
after acute insulin stimulation. Determination of phosphorylation states of key kinases 
of the insulin signaling cascade in MEFs displayed phosphorylation increment. ERK 
phosphorylation rose upon insulin titration to the same degree in both wild-type and 
IRS-1-/- MEFs. Concentrations of 10 nM insulin seemed to be sufficient for full 
activation of the insulin signaling cascade since no further phosphorylation increment 
was observed by stimulating MEFs with 100 nM insulin. A slight decreased insulin 
respond was observed using 1 nM insulin for stimulation suggesting an impact of 
IRS-1 on mediation of insulin receptor signaltransduction in MEFs. In the line with 
these data basal phosphorylation after overnight starvation was also lowered in IRS-
1 deficient cells (0 nM insulin). Similarly to ERK, GSK-3β showed decreased 
phosphorylation at Ser9 following treatment with 1nM insulin. However, no further 
differences between WT and IRS-1-/- MEFs upon insulin stimulation using higher 
insulin concentration were observed.  
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PTEN expression in wild-type derived MEFs was decreased compared with PTEN 
expression in knockout derived MEFs under basal as well as under stimulated 
conditions (Fig. 3.5). However PTEN expression in wild-type MEFs increased upon 
insulin stimulation, no alteration of PTEN expression in knockout MEFs was detected 
indicating disrupted insulin response of PTEN protein in IRS-1 deficient MEFs. 
Additionally a double band at ~140 kDa and ~165 kDa was exclusively detected in 
wild-type derived MEFs. In correlation with PTEN expression increment upon insulin 
stimulation this double band decreased approximately to the same degree as PTEN 
expression increased. PTEN is described to be incorporated into a high molecular-
weight complex (PTEN associated complex [PAC]). p85 is suggested to be part of 
the PAC. Unphosphorylated PTEN associates with p85 (regulatory subunit of PI3K) 
promoting its stabilization. Phosphorylation of the PTEN tail regulates its stability and 
activity. Phosphorylated PTEN protein is more stable but less active compared to 
unphosphorylated PTEN. PTEN protein is phosphorylated by casein kinases, Src 
family members and GSK-3β (Vazquez et al., 2000; Rabinovsky et al., 2009; Barber 
et al., 2006). Co-immunoprecipitation of p85α and PTEN showed enhanced 
p85/PTEN signal in wild-type derived MEFs in basal state (0 nM) and upon insulin 
stimulation with 1nM. p85α/PTEN expression upon stimulation with 10 nM or 100 nM 
insulin, respectively revealed no alteration between wild-type and knockout MEFs. 
This correlates with the decline of the 140/165 kDa double band and the increase of 
PTEN expression in the PTEN Western blot, suggesting double bands reflecting 
p85/PTEN association (p85 (85 kDa) + PTEN (55 kDa), associated 140 kDa) and 
p110/PTEN (p110 (110 kDa) + PTEN (55 kDa), associated 165 kDa) as described in 
literature (Rabinovsky et al., 2009). Absence of PTEN aggregates in knockout MEFs 
could be a compensatory mechanism as a result of mild insulin resistance. PTEN 
aggregates consist of unphosphorylated but more active PTEN. Lack of these 
aggregates would indicate a high proportion of phosphorylated less active form of 
PTEN in knockout MEFs resulting in declined PTEN activity. Reduction of PTEN 
activity downregulates PIP3/PIP2 conversion resulting in prolonged activation of the 
PI3K pathway (Barber et al., 2006).  
p85 might associate with PTEN in basal and slight stimulation state (1nM). With 
higher insulin stimulation levels p85 is recruited to tyrosine phosphorylated IRS 
proteins probably releasing PTEN. This might be an explanation for observed 
p85/PTEN association discrepancy between wild-type and knockout MEFs in basal 
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and low stimulated state and diminished discrepancy in higher stimulation states. 
Due to mild insulin resistance in IRS-1-/- animals or MEFs respectively, GSK-3β is 
less phosphorylated and hence more active in knockout MEFs. Fig. 3.4 shows 
slightly decreased GSK-3β phosphorylation in basal state and low stimulated 
knockout MEFs this effect disappeared with higher insulin concentrations. Since 
GSK-3β one of the kinases responsible for PTEN phosphorylation is less 
phosphorylated and therefore more active in basal and slight stimulated knockout 
MEFs PTEN gets more phosphorylated. The decreased detection of p85α/PTEN 
complex in knockout MEFs is probably a result of this since unphosphorylated PTEN 
associates with p85. With increased GSK-3β phosphorylation up to wild-type levels 
this effect is abolished due to inactivated GSK-3β and decreasing PTEN 
phosphorylation. However the role of IRS-1 for p85α/PTEN association needs further 
investigation.  
 
To analyze insulin signaling in a systemic and more physiological context IRS-1 
knockout and wild-type animals were stimulated after 16 h starvation via 
intraperitoneal insulin injection. Phosphorylation states of downstream targets of the 
IR signaling cascade were determined by Western blotting from muscle, WAT and 
liver of IRS-1 deficient and wild-type animals (Fig. 3.6). Surprisingly, insulin response 
of IRS-1 deficient mice was enhanced compared with wild-type mice. Basal 
phosphorylation levels of AKT in muscle and liver of IRS-1-/- were increased resulting 
in enhanced increment of phosphorylation upon stimulation in IRS-1-/- animals 
compared to wild-types. No differences upon AKT phosphorylation were determined 
in WAT. AKT phosphorylation at Ser473 following insulin treatment showed no 
signaling malfunction in muscle WAT and livers of IRS-1 deficient mice compared to 
wild-type supporting the results obtained for in vitro stimulation in MEFs. However 
previous studies (Yamauchi et al., 1996) reported decreased PI3-kinase activity in 
muscles of IRS-1 knockout mice. Mice used in this previous study were 8 to 12 
weeks of age, mice used here were at least 60 weeks of age; therefore a possible 
adaptation with age due to mild insulin resistance in knockout mice could be 
responsible for improved PI3-kinase activity in these mice. Additionally no differences 
in GSK-3β and ERK-1/-2 phosphorylation response upon insulin stimulation were 
determined in muscle liver or WAT in IRS-1 knockout animals compared to wild-type 
controls.  
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In conclusion the presented data indicate that besides deletion of IRS-1 protein and 
downregulation of IR in muscle acute intracellular signaling upon insulin treatment is 
only mildly impaired in IRS-1-/- mice. This might be due to compensation by 
alternative insulin receptor substrates as shown in liver for IRS-2 (Fig. 3.7) or 
increased insulin signaling via the IGF-1R or hybrid receptors or even alternative 
pathways. Additionally lack of p85α/PTEN association might be a compensatory 
mechanism in IRS-1 knockout animals. PTEN is positively regulated by p85, 
decreased p85/PTEN levels reduce PTEN phosphatase activity, hence sustaining 
PIP3 levels and PI3 signaling (Chagpar et al., 2010; Fernadez et al., 2001, Higaki et 
al. 1999; Wojtaszewski et al. 1999).  
 
4.3 Metabolic characterization  
 
Mild insulin resistance in IRS-1 knockout mice has been described in literature 
(Tamemoto et al., 1994; Araki et al., 1994). Insulin tolerance tests revealed slower 
decrease of blood glucose levels in IRS-1 deficient mice following insulin treatment 
compared to wild-type mice for both genders indicating insulin resistance. Even 
though the effect exerted by IRS-1 deficiency seems to be small compared for 
example in animals fed a high fat diet, but still visible in ITTs. However, glucose 
tolerance tests showed only minor alterations of glucose metabolism in female IRS-1 
knockout mice suggesting pancreatic β-cell compensation whereas GTTs in males 
revealed mild glucose intolerance. Accordingly, serum insulin levels in IRS-1 deficient 
mice were elevated as physiological respond to insulin resistance (Brüning et al., 
1997; Haffner et al., 1996). Further explanations for the only mild effects on glucose 
metabolism despite IRS-1 deficient might be compensation via alternative substrates 
for the IR combined with other factors improving insulin sensitivity. Particularly, small 
adipocytes express and secrete adiponectin, which stimulates insulin sensitivity in 
various cell types (Takahashi et al., 2009). Accordingly, serum adiponectin levels 
were slightly increased in IRS-1 deficient mice. Thus reduced abdominal fat mass, 
smaller adipocytes and pancreatic β-cell compensation improve glucose metabolism 
in IRS-1-/- mice leading to remarkable different phenotypes between the non-diabetic 
IRS-1 and diabetic IRS-2 knockout mice (Burks et al., 2000; Withers et al., 1999). 
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4.4 Energy metabolism in IRS-1-/- mice 
 
Growth retardation decreased abdominal fat mass and increased lifespan are known 
and reproduced phenotypes of IRS-1-/- mice (Tamemoto et al. 1994; Araki et al., 
1994, Kadowaki et al., 1996; Tamemoto et al., 1997). To elucidate possible 
mechanisms contributing to these phenotypes we analyzed energy metabolism and 
mitochondrial function of IRS-1-/- mice in detail.  
As describe previously IRS-1 deficient mice showed significantly reduced body 
weight in males and females. Anatomical examination revealed reduced epigonadal 
fat mass normalized to body weight in aged female and male IRS-1-/- mice. Typical 
mice gain abdominal fat mass during life leading to a age-associated increase of 
body weight. However, body weight increase during aging and age-associated gain 
of abdominal fat mass was significant reduced in IRS-1 deficient mice compared to 
wild-type controls.  
First, food intake was measured. Surprisingly, food intake in IRS-1 knockout 
mice was increased excluding reduced energy intake as possible mechanism for the 
reduced age-associated fat accumulation. Furthermore, we analyzed locomotor 
activity. The experiments excluded elevated locomotor activity as underlying 
mechanism for the lean phenotype in IRS-1 knockout mice. Since elevated energy 
expenditure would explain the decreased gain of fat mass in aged IRS-1-/- mice we 
used indirect calorimetry. However it should be considered that smaller animals show 
elevated energy expenditure levels relative to their body size compared with larger 
animals due to a disadvantageous surface/volume ratio (Speakman, 1997). 
Accordingly, we measured increased energy expenditure when normalized to body 
weight in IRS-1-/- mice compared to WT mice possible contributing to the reduced fat 
mass during aging. It would be reasonably to normalize data generated by indirect 
calorimetry to lean body mass  
Despite elevated food intake IRS-1-/- females showed increased survival 
(Selman et al., 2008) contradicting the theory of caloric restriction leading to 
increased survival in animals in these mice favoring alternative mechanisms inducing 
longevity (Bartke et al., 2002; Roth et al., 2002; Mattison et al., 2003; Bodkin et al., 
1995). On the other hand reduced abdominal fat content due to potentially increased 
metabolism could be an eventual explanation for increased survival of IRS-1 deficient 
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mice. Mutant mice with disrupted growth hormone show combined dwarfism with 
extended lifespan (Carter et al., 2002). Thus, dwarfism combined with higher 
metabolism might be a possible mechanism for increasing lifespan in IRS-1 deficient 
mice (Oklejewicz and Daan, 2002; Oklejewicz et al., 1997; Lin et al., 2002).  
High metabolic rates and increased food intake are linked to hyperthyroidism 
(Mitchell et al., 2010; Havel, 2001). Therefore, free T3 serum levels were determined 
in wild-type and IRS-1-/- mice revealing no significant alterations excluding 
hyperthyroidism as underlying mechanism for observed phenotype in IRS-1 deficient 
mice.  
IRS-1-/- mice are described with increased maximum lifespan (Selman et al., 
2008) possibly due to enhanced mitochondrial performance as underlying molecular 
mechanism.  
 
4.5 Role of IRS-1 for mitochondrial performance 
 
Recent studies have linked mitochondrial performance to insulin sensitivity and life 
expectancy. Since increased lifespan, insulin resistance and increased energy 
expenditure are denoted phenotypes of IRS-1-/- mice alterations in mitochondrial 
function would at least partially explain the phenotypes of these mice. Therefore 
mitochondrial performance in IRS-1-/- mice and IRS1 deficient MEFs was analyzed in 
detail. In the present study protein expression for each complex of the respiratory 
chain was determined separately. Furthermore, function of the different complexes 
was investigated using state of the art technologies.  
 
Mitochondrial mass and expression of respiratory chain complexes  
Mitochondrial dysfunction or decreased mitochondrial content as possible 
cause for insulin resistance is postulated and described by several groups (Lowell 
and Shulman 2005; Szendroedi et al., 2009). Therefore we investigated abundance 
of HSP-60 as indicator of mitochondrial mass (Fig. 3.19, 3.20, 3.21). HSP-60 protein 
levels detected by Western blots were unchanged in WT and IRS-1-/- MEFs, muscles 
and liver, excluding a decrease or compensatory increment of mitochondrial content 
in IRS-1-/- mice. Additionally PGC-1α expression levels, as marker for mitochondrial 
biogenesis (Wu et al., 1999; Liang and Ward, 2006; Ventura-Clapier et al., 2008), 
were analyzed (Fig. 3.22). Western blot revealed no alteration in PGC-1α expression 
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levels in IRS-1 knockout cells and tissues compared to wild-type mice confirming 
HSP-60 data. Thus mitochondrial mass is unaltered in IRS-1-/- mice.  
In order to exclude changes in concentrations of respiratory chain due to IRS-
1 deficiency, abundance of the individual complexes were determined. Interestingly, 
a slight decrease in muscle complex II and an increased MEF complex V expression 
was observed. Since PGC-1α is one of the master regulators for mitochondria 
biogenesis, nuclear extracts derived from knockout and wild-type muscle samples 
were checked upon PGC-1α acetylation. Enhanced acetylation would indicate an 
elevated fraction of non-active PGC-1α proteins not functioning as co-activators for 
transcription factors required for mitochondrial biogenesis. Immunoprecipitation 
revealed enhanced acetylation of PGC-1α proteins in IRS-1-/- derived samples (Fig. 
3.23). Additionally SIRT-1, NAD+ dependent deacetylase was downregulated in IRS-
1 deficient animals probably explaining increased PGC-1α acetylation. Taken 
together these data indicate less active nuclear PGC-1α in knockout muscle.  
Decreased mitochondrial biogenesis caused by PGC-1α acetylation might be 
counteracted by lowered autophagy in IRS-1-/- animals resulting in decreased 
mitochondrial regeneration but unchanged mitochondrial content. Lowered 
autophagy and reduced mitochondrial biogenesis would result in accumulation of 
defective mitochondria leading to enhanced mitochondrial dysfunction (Takeda et al., 
2010; Suzuki et al., 2011). Photopectrometric analysis of mitochondrial respiratory 
chain complexes (Fig. 3.24; Fig. 3.26; Fig. 3.29; Fig. 3.31; Fig. 3.35; Fig. 3.37), 
determination of oxygen consumption of respiratory chain complexes by 
polarography (Fig. 3.38) and OROBORS technique (Fig. 3.33) revealed no obvious 
and consistent dysfunction in mitochondria in IRS-1-/- mice suggesting that the 
observed changes in PGC-1α acetylation might be of minor functional relevance. 
 
Mitochondrial performance in vitro 
Severe mitochondrial dysfunction would be accompanied by elevated ROS 
levels leading to induction of scavengers like MnSOD as physiological response 
(Mitchell et al., 1996). No increased MnSOD expression was found in MEFs, muscle 
and liver of IRS-1 knockout mice (Fig. 3.27; Fig. 3.32; Fig. 3.39).  
Activity determination of respiratory chain and TCA enzymes by 
photospectrometric analysis of MEFs and MEF derived mitochondria showed a 
tendency towards decreased respiratory capacities in IRS-1 deficient MEFs and IRS-
 130
                                                                                                                      Discussion                      
1-/- derived mitochondria. However effect were less prominent in isolated MEF 
mitochondria (Fig. 3.24) but reaching significance in CS normalized activity for 
complex II and combined determination of complex II and III indicating possibly 
complex II dysfunction, at least under Vmax conditions. Impaired coenzyme Q10 could 
be a potential factor limiting complex II and complex III turnover rates. GPCCR 
activity determination in MEF lysates (Fig. 3.25) might support impaired coenzyme 
Q10 being the underlying mechanism for complex II and complex III activity 
reductions. GPCCR activity and additionally coenzyme Q10 dependent complex I 
activity in IRS-1-/- MEF mitochondria were unaltered to wild-types, hence 
contradicting coenzyme Q10 impairment. Moreover, the reduced complex II activity 
could not be confirmed by respiratory chain activity analysis of isolated MEF 
mitochondria (Fig. 3.24). A trend to reduced complex IV activity (Fig. 3.26) was 
observed in IRS-1-/- but this trend could not be determined in isolated IRS-1-/- 
mitochondria. 
Overall spectrometric measurements in MEF and isolated mitochondria of 
MEFs showed a tendency towards a slightly decreased mitochondrial capacity in the 
IRS-1-/- background; however, not leading to increased ROS or decreased ATP 
content (Fig. 3.50), excluding severely impaired mitochondrial function due to IRS-1 
deficiency.  
 
Mitochondrial performance in vivo 
MEFs represent an in vitro system not addressing possible compensatory or 
endocrine/metabolic effects of in vivo systems. Therefore respiratory chain enzymes 
were analyzed in slow–oxidative red muscle (M. soleus), fast-glycolytic white muscle 
(M. gastrocnemius) (McAllister et al., 2008) as well as in livers of wild-type and IRS-1 
knockout mice. Results normalized to mitochondrial mass did not show any 
significant alteration in female IRS-1 knockout mice compared to wild-type controls 
for both muscle types (Fig. 3.29). Detected tendency in MEFs towards slight 
decreased respiratory function in IRS-1-/- background was not confirmed. Rather the 
opposite was observed in female mice, less prominent in muscle but significant in 
liver samples of IRS-1 deficient mice compared to wild-type controls (Fig. 3.35). 
Activities of complex IV and TCA cycle enzymes IDH, aconitase and fumerase were 
considerably increased in livers of IRS-1-/- mice although insulin resistance is 
normally accompanied by reduced TCA cycle flux (Befroy et al., 2007; Schrauwen 
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and Hesselink, 2008) suggesting molecular compensation of IRS-1 deficiency in liver 
(Fig. 3.7). Elevated TCA cycle enzyme activities provide NADH for complex I in the 
case of IDH. Consistently, slight increase of mitochondrial activity of complex I, 
complex III and notably for complex IV was detected in liver.  
Normalized respiratory chain enzymes activities displayed unaltered or slightly 
increased activities for in IRS-1 deficient males reaching significance for complex III 
in red muscles and for combined determination of complex I and III in white muscles 
(Fig. 3.31). However, IDH in red and fumerase in red and white muscles were 
decreased. Complex IV activity in liver of male knockout mice was clearly increased 
(Fig. 3.37). Turnover rate of complex V was significantly downregulated in red 
muscles of IRS-1-/- male mice. Complex V activity reduction was also detected in liver 
of IRS-1 deficient males. Thus, data might indicate an uncoupling of respiratory chain 
from ATP synthesis in IRS-1 knockout males causing reduced complex V activities.  
Oxygen flux determined by high resolution respirometry in saponin skinned 
fibers of musculus soleus dissected from male mice, revealed no alterations in 
respiratory chain activities of IRS-1 knockout mice compared to wild-type controls. 
Hence, slightly increased mitochondrial performances detected by 
photospectrometric analysis under Vmax conditions were not supported by 
OROBORS determination. Overall no mitochondrial respiratory chain dysfunction 
was detected neither in muscles nor livers of IRS-1 knockout males by different 
methods. Apparently mild insulin resistance of IRS-1 deficient mice is not linked to 
impaired mitochondrial function in the in vivo situation. 
Furthermore, analyzed MnSOD levels (Fig. 3.27; Fig. 3.32; Fig. 3.39) underline 
functional performance of complex I and complex III, since MnSOD expression 
patterns of IRS-1-/- were unaltered in comparison to wild-type mice. Elevated MnSOD 
levels would have indicated enhanced ROS generation by complex I and complex III 
due to respiratory dysfunction (Chen et al., 2003; Raha et al., 2000; Arai et al., 1999; 
Radi et al., 1991).  
RT-PCR analysis revealed upregulated levels of UCP-3 in muscles of IRS-1 
knockout mice (Fig. 3.42) confirmed by Western blot analysis (Fig. 3.43). These data 
support the idea of enhanced uncoupling being the underlying mechanism of 
elevated energy expenditure and increased food intake in IRS-1-/- mice. However, 
high resolution respirometry indicated functional coupling of respiratory chain 
complexes in muscle mitochondrial. To definitely address increased uncoupling due 
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to IRS-1 deficiency we investigated proton leakage of isolated liver mitochondria 
revealing uncoupling in IRS-1 knockout. Elevated oxygen consumption for creating 
distinct membrane potential was supported by elevated UCP-2 mRNA expression 
levels in livers of IRS-1 deficient mice (Fig. 3.44) 
In addition, UCP-1 protein expression was detected in WAT of IRS-1-/- mice. 
Western blots supported by UCP-1 mRNA expression levels (Fig. 3.45; Fig. 3.46) 
indicating contribution of WAT to uncoupling and hence to observed hyperphagic, 
high energy turnover phenotype in IRS-1 knockout mice. Moreover PGC-1α mRNA 
expression was significantly elevated in WAT of IRS-1 deficient mice (Fig. 3.47) 
indicating enhanced mitochondrial biogenesis in WAT compared to wild-type 
controls. Increased PGC-1α levels causing mitochondrial biogenesis leading to high 
abundance of mitochondria have been linked to fat loss in adipocytes as observed in 
IRS-1 knockout mice (Fig. 3.14) (Lee et al., 2007).  
High abundance of mitochondria in WAT is often linked to transdifferentiation 
of white adipocytes into brown adipocytes. Furthermore, brown adipocyte clusters in 
WAT are believed to regulate energy balance (Kozak et al., 2008). However, other 
research groups described morphology of mitochondria in WAT and mitochondria 
detected in BAT distinctly different suggesting white adipocytes with certain 
characteristics of BAT (Deveaud et al., 2004) but not a real “transdifferentiation”. 
(Arribas et al., 2003; Fasshauer et al. 2001; Miki et al., 2001, Tseng et al., 2004, 
Valverde et al., 2003). The functional relevance of increased mitochondrial 
biogenesis indicated by PGC-1α and enhanced UCP-1 expression on energy 
homeostasis in IRS-1 deficient mice remains unclear. Abdominal fat mass is 
significantly reduced in these mice (Fig. 3.12) and elevated mitochondrial density is 
eventually due to restricted dimension of abdominal fat in knockouts and total 
mitochondrial number in might be unchanged in comparison with wild-type controls. 
UCP-1 and PGC-1α mRNA expression in BAT of IRS-1-/- mice were unaltered 
compared to wild-type controls or slightly decreased excluding elevated 
thermogenesis in BAT contributing to higher energy expenditure of IRS-1 knockout 
mice.  
Leptin action on mitochondrial is controversially discussed (Gomez-Ambrosi et 
al., 2001). Induction of PGC-1α expression by leptin is only detected after long-term 
treatment (Gomez-Ambrosi et al., 2001; Scarpace et al., 1997; Frühbeck et al., 
1998). Since leptin levels are slightly lower in IRS-1 deficient mice (Fig. 3.60), leptin 
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action is unlikely affecting PGC-1α expression and adaptive thermogenesis in these 
mice.  
 
4.6 Regulation of energy homeostasis in IRS-1 deficient mice 
 
Significant correlation between body fat content and plasma leptin concentration is 
described in literature (Frederich et al., 1995; Maffei et al., 1995). As a result of 
decreased abdominal fat mass (Fig. 3.12; Fig. 3.13) leptin serum concentrations 
were slightly decreased in IRS-1 deficient mice (Fig. 3.60). However serum reduction 
of leptin was not as striking as expected relative to decreased abdominal fat mass. 
Fig. 3.56 and Fig. 3.57 indicate a potential fat redistribution in IRS-1 knockout mice 
resulting in an unaltered overall fat content in wild-type and knockout mice. Leptin 
resistance as underlying mechanism for orectic phenotyp of IRS-1 knockout mice is 
unlikely since leptin receptor expression in the hypothalamus was unchanged in IRS-
1 deficient mice compared with wild-type controls (Fig. 3.60).  
Even slightly reduced leptin serum levels in IRS-1-/- might impact on POMC/CART 
and AgRP/NPY expressing neurons in the melanocortin system. mRNA expression 
levels of orectic neuropeptides AgRP/NPY were significantly increased (Fig. 3.61) in 
comparison to wild-type controls indicating diminished anorectic effect of leptin. 
Unexpectedly mRNA levels of anorectic hypothalamic neuropeptides POMC/CART 
were slightly increased as well (Fig. 3.61), although POMC neurons should be 
inhibited by GABAergic projections of NPY/AgRP neurons (Cone et al., 2011). 
Insulin causes anorectic effects in brain, acting agonistic to leptin (Air et al., 2002; 
Benoit et al., 2004; Bondareva and Chistyakova, 2007; Schwartz et al., 1991; 
Spanswick et al., 2000; Niswender et al., 2004). Increased insulin levels (Fig. 3.10) 
due to insulin resistance in IRS-1-/- mice did not compensate for anorectic insulin 
function in hypothalamus although insulin receptor expression was not down 
regulated in IRS-1 deficient mice (Fig. 3.62). However, IRS-1 knockout should have a 
minor effect on metabolic function regulated via the CNS since IRS-1 is not 
expressed in the ventral hypothalamus. On the other hand IRS-2 was found in the 
arcurate nuclei (ARC) of the hypothalamus in high concentrations indicating a central 
role of IRS-2 in energy homeostasis triggered by insulin. This is supported by IRS-2 
knockout in hypothalamic neurons resulting in general hypothalamic dysfunction (Lin 
et al., 2004; Bondareva and Chistyakova, 2007; Baskin et al., 1993; Kubota et al., 
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2004). No alteration in IRS-2 expression in the hypothalamus was observed in IRS-1 
knockout in comparison to control mice (Fig. 3.62), hence IRS-2 signaling deficiency 
is unlikely to negatively influence anorectic insulin effects in brain of IRS-1-/- mice. 
Additionally IRS-4 expression was elevated (Fig. 3.62) eventually causing improved 
insulin signaling in hypothalamus of IRS-1 deficient mice. 
Therefore increased orectic effects observed in IRS-1-/- mice might be based on 
reduced intracellular leptin signaling in the presence of unaltered leptin receptor 
levels. AgRP expressing neurons are not inactivated and AgRP expression was not 
inhibited by leptin. Reduced leptin receptor or insulin receptor levels in the 
hypothalamus leading to attenuated anorectic effects are not contributing to 
hyperphagic phenotype of IRS-1 deficient mice since both receptor expression levels 
remained unchanged compared with wild-type controls. Thus, role of IRS-1 
deficiency on neuropeptide regulation and leptin signaling needs further investigation.   
 
4.7 Elevated ATP levels in IRS-1-/- MEFs 
 
Besides respiratory chain other cellular processes can provide ATP and function as 
alternative ATP sources besides mitochondrial respiration. ATP content of IRS-1 
deficient MEF was significantly increased compared to wild-types (Fig. 3.50). 
However, no enhanced activity of respiratory chain enzymes, even slightly reduced 
complex V activity was detected in MEFs or MEF isolated mitochondria of knockout 
mice (Fig. 3.24; Fig 3.26). One possible option explaining elevated ATP levels is 
increased glucose utilization via alternative pathways as the TCA cycle e.g. lactate 
production via lactate dehydrogenase. Nevertheless, lactate dehydrogenase (LDH) 
acitivity determination (Fig. 3.51) revealed no upregulation in IRS-1-/- MEFs. Due to 
potential uncoupling in muscle (Fig. 3.42; Fig. 3.43) and liver (Fig. 3.41; Fig. 3.44) of 
IRS-1 knockout males LDH activity increment could compensate for ATP attenuation 
caused by proton leakage. LDH activity was slightly elevated in M. soleus and 
elevated in M. gastrocnemius (Fig. 3.53) however unchanged in liver of IRS-1 
deficient males (Fig. 3.55). Since only 2 molecules ATP are generated by lactic acid 
fermentation potential ATP depletion can not be compensated by increased LDH 
activities detected in soleus and gastrocnemius muscle of IRS-1 deficient males. 
Female IRS-1 knockout mice showed increased LDH activity in M. gastrocnemius 
(Fig. 3.52) and significantly enhanced LDH activity in liver (Fig. 3.54). Additionally 
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activities of TCA cycle enzymes in female knockout were significantly increased in 
liver (Fig. 3.35). Elevated LDH activity observed in liver of IRS-1 deficient females 
might suggest processing of lactate in gluconeogenesis (Kaloyianni and Freedland, 
1990). Furthermore, insulin resistance of IRS-1 knockout mice might provoke 
enhanced activation of gluconeogenesis in liver. Gluconeogenesis is an energy 
consuming process; consequently fatty acid oxidation could provide energy for 
gluconeogenesis. However CPT-1 activity of isolated liver mitochondria of male IRS-
1-/- was rather decreased (Fig. 3.59).  
Increased activity of TCA cycle enzymes IDH and fumerase in liver of female 
knockouts might be indirect indicators for enhanced gluconeogenesis. NADH 
demand might be provided by IDH. Additionally fumerase reaction product 
oxaloacetate represents an intermediate of gluconeogenesis. Enhanced 
gluconeogenesis in IRS-1-/- mice indicated by increased PAS staining suggesting 
elevated glycogen storage probably explaining increased liver/body weight quotient 
in knockout mice as shown by previous work (Dong et al., 2006). 
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5. Summary 
 
Insulin and insulin-like growth factor-1 receptor signaling plays a crucial role in 
regulation of growth, lifespan and energy homeostasis. Insulin receptor substrates 
(IRS) mediate intracellular effects of the insulin and insulin-like growth factor-1 
receptor. IRS-1 deficient mice (IRS-1-/-) display dwarfism, increased food intake, 
elevated energy expenditure and reduced accumulation of epigonadal fat compared 
to wild-type littermates. To investigate the molecular basis of increased energy 
expenditure activity of respiratory chain complexes were determined. Mitochondrial 
performance was analyzed in liver, musculus soleus, musculus gastrocnemius, 
embryonic fibroblast (MEF) of wild-type and IRS-1 knockout mice as well as 
mitochondria isolated from MEFs using different techniques. The molecular 
mechanism of elevated food intake of IRS-1 deficient mice was addressed by Real-
time PCR analysis of hypothalamic neuropeptides. Determination of mitochondrial 
respiratory chain complex activities revealed no significant and consistent alteration 
in mitochondrial performance in muscle and liver of IRS-1 knockout mice compared 
to wild-type controls. Additionally no mitochondrial dysfunction was detected on the 
cellular level analyzing MEFs and isolated mitochondria. However, complex V 
activities in liver and musculus soleus IRS-1-/- males were significantly decreased. 
Additionally female knockout mice showed decreased performance of complex V in 
musculus soleus. Determination of mitochondrial respiratory chain coupling using 
proton motive force measurements revealed enhanced uncoupling in the IRS-1-/- 
mice. This was supported by Real-time PCR analysis of uncoupling protein 
expression in different tissues. Furthermore elevated food intake in the IRS-1 
deficient mice was linked to enhanced expression of orectic neuropeptides in 
hypothalamus in these mice. Taken together the results of present study indicate 
enhanced uncoupling in IRS-1 deficient mice as underlying mechanism for increased 
energy expenditure. Elevated food intake of IRS-1 knockout mice might be a 
consequence of increased energy expenditure leading to enhanced expression of 
orectic neuropetides NPY/AgRP providing adequate supply of metabolic fuel (e.g. 
glucose) in knockout mice in response to higher energy demand.  
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6. Zusammenfassung 
 
Bei der Regulation der Energiehomöostase kommt der Insulin-/Insulin-like growth 
factor-1 Signaltransduktion eine bedeutende Rolle zu. Die Insulinrezeptor-Substrate 
(IRS) vermitteln die intrazellulären Effekte des Insulin- und Insulin-like growth factor-1 
Rezeptors. IRS-1 defiziente Mäuse (IRS-1-/-) zeigen im Vergleich zu 
Wildtypgeschwistern neben einer milden Insulinresistenz einen Minderwuchs sowie 
eine vermehrte Futteraufnahme und eine reduzierte abdominale Fettakkumulation bei 
gesteigertem Energieumsatz. Die molekulare Grundlage dieses gesteigerten 
Energieumsatzes ist unklar. Eine mögliche Ursache hierfür könnte eine erhöhte 
Aktivität der mitochondrialen Atmungskette sein. Zur Untersuchung der 
mitochondrialen Atmungskettenfunktion wurden Leber und Muskel (musculus soleus, 
musculus gastrocnemius) Homogenate, embryonale Fibroblasten und extrahierte 
Mitochondrien embryonaler Fibroblasten von IRS-1-/- Mäusen und 
Wildtypgeschwistern bezüglich der Aktivität der einzelnen Komplexe der 
Atmungskette analysiert. Mögliche molekulare Mechanismen der erhöhten 
Futteraufnahme in IRS-1 defizienten Tieren wurden mit Hilfe von 
Expressionsanalysen der hypothalamischer Neuropeptide untersucht. IRS-1-/- Mäuse 
zeigten keine einheitlichen signifikanten Veränderungen der mitochondrialen 
Atmungskettenfunktion in Muskel und Leber verglichen mit Wildtyp-Kontrollen. Auch 
auf zellulärer Ebene konnten keine Aktivitätsveränderungen der Atmungskette 
zwischen den verschiedenen Genotypen detektiert werden. Komplex V Aktivität in 
Leber und musculus soleus in IRS-1 defizienten Männchen war signifikant verringert. 
Proton motive force Analysen zeigten ein erhöhtes mitochondriales Uncoupling in 
IRS-1 Knockout Männchen. Real-time PCR Analysen der Expression mitochondrialer 
Uncoupling Proteinen unterstützten dieses Ergebnis. Die erhöhte 
Nahrungsaufnahme IRS-1 defizienter Tiere ist mit einer verstärkten Expression 
orektischer hypothalamischer Neuropeptide in IRS-1-/- Mäusen assoziiert.  
Zusammenfassend zeigen die Ergebnisse ein verstärktes mitochondriales 
Uncoupling in IRS-1 defizienten Mäusen als zugrunde liegenden Mechanismus des 
erhöhten Energieumsatzes. Die vermehrte Futteraufnahme der IRS-1 Knockout 
Mäuse könnte eine direkte Konsequenz der erhöhten metabolischen Rate sein, die 
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zu einer verstärkten Expression der orektischen Neuropetide NPY/AgRP führt, um 
ausreichend Energie bereitzustellen, den erhöhten energetischen Bedarf in diesen 
Tieren zu kompensieren. 
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